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Abstract 
At every moment, our brain is bombarded with sensory information. How we filter and 
process sensory information is critical for daily functioning and cognition. Examples of sensory 
filtering include habituation (a progressive decrease in responding) and prepulse inhibition (PPI, 
gating of responding).  Our aim is to understand the differential role acetylcholine (ACh) plays in 
these processes. 
To study this we used both reflexive (acoustic startle response: ASR) and non-reflexive 
(locomotor) behaviours.  PPI is hypothesized to occur via inhibitory cholinergic projections from 
the Pedunculopontine Tegmental Nucleus (PPT) to the startle pathway. The role of ACh in 
habituation of reflexive and non-reflexive behaviours is controversial. We found that, contrary 
to the predictions of the field, ACh modulated, not mediated, PPI. There was no impairment of 
PPI in cholinergic deficient mice.  When we inhibited PPT cholinergic neurons using DREADDs 
we did not detect an impairment of PPI. Likewise, we were unable to induce PPI by optogenetic 
activation of these neurons.  
Instead we found that cholinergic function is critical for long-term habituation 
(decrement occurring across days) as cholinergic deficient mice showed an impairment which 
was rescued by galantamine.  Furthermore, inhibition of PPT cholinergic cells decreased startle 
magnitude, whereas optogenetic activation of cholinergic PPT neurons increased startle. This 
demonstrates that these neurons are critical for regulating startle reactivity. Despite 
modulating reflexive behaviours, PPT cholinergic inhibition did not impact habituation of 
locomotion, re-affirming differential regulation of habituation of reflexive and non-reflexive 
behaviours. 
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To uncover which cholinergic receptor type mediates effects on PPI and habituation we 
used an α7-nicotinic acetylcholine receptor (nAChR) knock-out mouse. These mice displayed a 
mild impairment of PPI, and no enhancement of startle magnitude or PPI via nicotine. This 
suggests ACh modulates PPI through this receptor, and confirms that cholinergic function 
enhances startle. Of interest, optogenetic enhancement of startle was blocked by nAChR 
antagonism.  
In conclusion, we demonstrate that ACh modulates PPI through α7-nAChRs and that 
ACh is critical for regulating startle reactivity, indicating a potential role in long-term 
habituation or sensitization of startle. In contrast to the common view, cholinergic PPT function 
does not inhibit startle, ruling out a mechanistic role in PPI.  
 
Keywords: Sensory Filtering, Sensorimotor Gating, Acoustic Startle Response, Habituation, 
Prepulse Inhibition, Acetylcholine, Pedunculopontine Tegmental Nucleus, Nicotinic Receptors, 
α7 Nicotinic Receptors, Locomotion, Sensitization, DREADDs, Optogenetics  
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1.1 Modulations of the Acoustic Startle Response as a Tool to Study Information Processing 
Within the Brain 
We live in a complex sensory world. The ability to filter sensory information is critical for 
accurate sensory information processing. In most instances, the filtering of sensory information 
is pre-attentive and can occur on different levels within sensory pathways.  The ability to reduce 
the brain’s awareness and behavioural responding to unnecessary sensory information is critical 
for proper daily functioning. Several psychiatric syndromes, including Schizophrenia and Autism 
Spectrum Disorders, are associated with disrupted sensory filtering. Sensory filtering can be 
analyzed in many different ways. However, in rodents and humans a commonly used measure is 
the acoustic startle response (ASR). 
The ASR, as will be discussed in more detail in the following section, is a plastic response. 
It is subject to both enhancement, e.g. sensitization or prepulse facilitation, or attenuation, e.g. 
habituation and prepulse inhibition (PPI). Briefly, habituation is defined as the gradual decrease 
in startle magnitude to a startling stimulus after repeated exposure. This is an example of sensory 
filtering, which is thought to reduce the cognitive load of redundant sensory information so that 
the brain has more available resources to exert elsewhere. Prepulse Inhibition also reflects a 
decrease in startle; however it is due to the presence of a pre-pulse prior to the startling stimulus. 
PPI can be thought of as a gate-keeper, preventing irrelevant information from conscious 
awareness and thus precluding useless attentional and energy expenditure; it is often referred 
to as sensorimotor gating.  Many studies in both animals and humans use habituation and PPI of 
the ASR as measures of sensory filtering and/or sensorimotor gating. 
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1.1.1 How We Process Sensory Information is Critical for Higher Order Cognitive Function 
Sensory filtering and sensorimotor gating are pre-attentive processes. This type of basic 
cognition can provide the building blocks for higher-order cognitive function. By reducing the 
cognitive load of unnecessary sensory information, the brain has more available resources to 
exert elsewhere. On the other hand, PPI and habituation may be a proxy measure for the speed 
or efficiency of information processing within the brain. Evidence for this idea stems from studies 
that have found that sensory filtering and sensorimotor gating mechanisms correlate with higher 
cognitive function. For example, PPI efficacy has been correlated with spatial working memory in 
rodents (Singer et al., 2013; Oliveras et al., 2015). Additionally, rats selectively bred for low PPI 
showed increased perseverative errors across spatial and operant conditioning tasks 
(Freudenberg et al., 2007).  
Many psychiatric illnesses display sensory filtering and PPI deficits (see section 1.1.2 for 
more detail), and within these disorders the severity of PPI or habituation deficits can correlate 
with cognitive functions across a variety of tasks. For example, in Schizophrenic patients, PPI 
deficits correlate with performance on the Global Assessment of Functioning Scale (Swerdlow et 
al., 2006) and severity of symptoms as assessed by the 18-item Brief Psychiatric Rating Scale score 
(Hazlett et al., 2007). 
As sensory filtering and sensorimotor gating seem to be indicative of higher cognitive 
function, understanding the mechanisms underlying these processes may provide principles that 
could apply to the understanding of higher cognitive function and their disruptions as well.   
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1.1.2 Habituation and PPI Deficits are Present in a Number of Psychiatric Illnesses 
A major behavioural hallmark of Schizophrenia is a deficit in sensorimotor gating as 
assessed by a disruption in PPI (Braff and Geyer, 1990; Parwani et al., 2000; Braff et al., 2001; 
Wynn et al., 2007; Takahashi et al., 2008). This deficit in inhibitory gating has been proposed to 
be linked to the hyper-vigilance displayed by these patients, suggesting that they over-process 
information within their environment (Freedman et al., 1994). PPI deficits are also present in a 
number of other psychiatric illnesses including Obsessive Compulsive Disorder (OCD), Tourette’s 
Syndrome, Anxiety Disorders, and Huntington’s Disorder (as reviewed by Braff et al., 2001; Geyer, 
2006).  
Impairments of PPI are thought reflect fundamental aspects of inhibitory processing that 
are differentially impacted in a variety of illnesses. For example, deficits of PPI in OCD and 
Schizophrenia may reflect a deficit in the gating of sensory and cognitive information whereas 
Tourette’s and Huntington’s reflect a reduced ability to gate motor responses. Whether this 
reflects co-morbidity or diagnostic overlap of impaired global inhibitory processes is unclear 
(Geyer, 2006).  
Impairments of habituation of the startle response has been shown in animal models of 
Fragile X Syndrome (Nielsen et al., 2002), and Autism Spectrum Disorders (Ornitz et al., 1993) 
(however see Perry et al., 2007). Schizophrenic patients display impairments of both habituation 
and PPI of the startle response (Braff et al., 1992; Ludewig et al., 2002; Ludewig et al., 2003); 
whereas people suffering from OCD have normal habituation but impaired PPI (Hoenig et al., 
2005). Impairments of habituation versus PPI may reflect subtle differences in cognitive deficits, 
but what these might be has not been extensively examined. Regardless, understanding the 
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mechanisms underlying both habituation and PPI may help improve treatment of these disorders 
and provide new drug targets.  
1.1.3 The Acoustic Startle Response is an Excellent Tool to Investigate Information Processing 
As mentioned, we use the ASR as a tool to study both habituation and PPI. The startle 
response is highly conserved across evolution. It occurs across species from invertebrates to 
humans.  It is a multi-modal response and can be induced by visual, tactile, vestibular, and or 
auditory stimuli (Davis, 1984; Koch, 1999). Any sudden acoustic stimulus louder than 80 dB can 
elicit the ASR (Koch, 1999). This reflex commences with closure of the eyelids, followed by muscle 
contractions in the face, neck and skeletal muscles (Koch and Schnitzler, 1997; Koch, 1999). This 
is also accompanied by acceleration in heart rate and an arrest of ongoing behaviour (Gogan, 
1970). 
The ASR is highly adaptive, and it is an instinctive behaviour. Pilz and Schnitzler (1996) 
suggested that startling to an intense stimulus allows an organism to orient to potentially 
threatening stimuli and assess behavioural output accordingly. As startling halts ongoing 
behaviour, induces stiffening of neck musculature, limb flexion, and eyelid closure, it prepares 
the organism for a fight or flight response and protects vital organs in case of attack or injury.  
The ASR is an innate behaviour and requires no learning. It is functional as soon as the auditory 
system has been developed, which in rodents is as early as postnatal day 12 (Sheets et al., 1988; 
Kungel et al., 1996). The simplicity of the ASR pathway is fitting with the very short motor 
response latency (5-10 ms) observed following the onset of acoustic stimulation.  
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The primary startle pathway is well described.  The sound is transduced into neuronal 
signals by hair cells of the inner ear which are innervated by spiral ganglion cells that project to 
the cochlear root (in rodents) and cochlear nucleus.  The cochlear root neuron sends direct 
glutamatergic sensory afferents to the caudal pontine reticular nucleus (PnC), where they 
synapse on giant neurons. The giant neurons in turn directly synapse on facial, cranial and 
motoneurons in the spinal cord which when activated elicit a motor response (Davis et al., 1982a; 
Davis et al., 1982b; Koch et al., 1992; Lingenhohl and Friauf, 1992; Koch and Schnitzler, 1997). For 
schematic representation of this pathway please refer to figure 1.1. 
This circuitry highlights the PnC as the sensorimotor interface of the ASR (Lingenhohl and 
Friauf, 1994). This area consolidates sensory information and transforms it into an adaptive 
behavioural output. The PnC does not only receive sensory projections, however. It also receives 
afferents from higher brain areas which can serve to modulate the startle response, making the 
ASR a plastic response (for review see Koch, 1999).  As discussed previously, the ASR is subject to 
both enhancement and attenuation. 
 
Figure 1.1 The Primary Startle Pathway 
When a sound is detected by the ear it activates the auditory pathway. If the sound is 
sufficiently loud, this will cause excitation of the giant neurons in the PnC, which directly 
 
 
  7 
 
 
innervate motor neurons of the spinal cord, eliciting a startle response. Adapted from (Simons-
Weidenmaier et al., 2006). 
1.2 An Introduction to Sensory Filtering: Habituation 
Habituation is a modulation of information processing and is a form of non-associative 
learning. It refers to the progressive decrease of a behavioural response following repeated 
exposure to the behaviour-inducing stimuli. Virtually any behaviour can be subject to 
habituation. This review will focus on habituation of reflexes, like the ASR, and habituation of 
motivated behaviors, like locomotion.  
Habituation of the ASR is denoted by the decrease in startle amplitude after repeated 
presentation of a loud, intense sound. In some organisms, such as C. Elegans it is a decrease in 
startle probability and not magnitude. In mammals, this decrement is most commonly negatively 
exponential and  eventually, with continued exposure, reaches an asymptotic level of stable 
response magnitude (Rankin et al., 2009). If the stimulus is re-introduced after a prolonged 
period of absence, the organism will respond highly again, but this response will not be quite as 
great when it was presented for the first time (Thompson and Spencer, 1966). 
This process of habituation is considered an adaptive form of learning. It is separated from 
simple muscle or receptor fatigue by displaying 10 core characteristics (for review see Rankin et 
al., 2009). Most critically, these include that habituation is stimulus specific, subject to 
spontaneous recovery, and lasts longer when it is induced by lower frequency stimulation (Best 
et al., 2005; Rankin, 2009). Habituation is adaptive as the unconditioned stimulus, the loud noise, 
contains no biologically relevant information. By lessening responding, the organism prevents 
useless expenditure of energy and attention (Koch, 1999). 
 
 
  8 
 
 
1.2.1 There are Two Types of Habituation: Short and Long-Term  
There are two forms of habituation, short-term and long-term. Short-term habituation 
refers to the decrease in startle magnitude that occurs when a loud sound is presented 
repeatedly within a short time span. Typically in a lab setting, short-term habituation occurs 
across trials within a single testing session. However, long-term habituation refers to the 
attenuation of startle that occurs across multiple testing sessions, or days.  
A debate exists about whether short-term and long-term habituation are mediated by the 
same processes.  Traditionally, it was thought that short-term habituation is non-associative, 
whereas long-term habituation was an associative learning process that involves retrieval 
mechanisms (Davis, 1970; Wagner, 1981; Sanderson and Bannerman, 2011). However, recent 
studies have suggested that long-term habituation is also non-associative (Pilz et al., 2014). 
Despite both being non-associative, the neuronal underpinnings of these processes are 
very different. The mechanism underlying short-term habituation occurs directly within the 
startle pathway. It is largely hypothesized to be due to presynaptic depression, mediated by BK 
channels, between the secondary auditory afferent neurons and the giant neurons of the PnC 
(Weber et al., 2002; Simons-Weidenmaier et al., 2006; Typlt et al., 2013).  
Much less is known about the mediation of long-term habituation of startle. Studies have 
implicated multiple brain structures. De-cerebrated rats show intact short-term but severely 
disrupted long-term habituation, providing evidence for involvement of the cortex (Leaton et al., 
1985). While this was re-affirmed by Groves et al. (1974), they also noted that lesions to the 
posterior aspect of the mesencephalic reticular formation also resulted in an absence of long-
term habituation.  However, this was accompanied by a large reduction in startle magnitude as 
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well, making interpretation of the results difficult. Other studies demonstrated that the 
cerebellar vermis was critical (Timmann et al., 1998), as lesions to this area cause disruptions in 
long-term habituation (Leaton and Supple, 1986). Clearly, a greater understanding of the 
mechanisms and structures underlying long-term habituation is needed. 
1.2.2 Habituation and Sensitization: The Dual Process Theory 
The most prominent theory of habituation was proposed by Groves and Thompson (1970) 
termed the dual process theory. Although this theory is applicable to the habituation of all 
behaviours, for ease it will be discussed using habituation of the ASR as an example. Groves and 
Thompson suggested that following repeated exposure to a stimulus, behavioural outcome is 
dependent on two opposing processes: habituation and sensitization.  Behaviourally, 
sensitization is the opposite of habituation, an enhancement of response magnitude (Koch, 
1999). 
Groves and Thompson hypothesized that habituation occurs within the stimulus-
response pathway (which in this case would be the primary startle pathway), and that 
sensitization occurs in a separate “state” pathway (see also Poon and Schmid, 2012). Repeated 
exposure to a startling stimulus simultaneously activates both sensitization and habituation 
pathways. The input of these pathways is integrated at some point of the startle pathway, a likely 
candidate would be the PnC (Lingenhohl and Friauf, 1994), and the behavioural output equals 
the summative activity of these opposing processes. 
The balance between sensitization and habituation is not only detectable on the resulting 
startle amplitude. The onset latency of the startle response itself is thought to reflect a state of 
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sensitization. In general, startle amplitude is negatively correlated with startle latency. However, 
in studies with testing parameters promoting habituation, startle latency decreases with startle 
amplitude. This is thought to be a reflection of a parallel increase in sensitization that impacts 
latency rather than the startle amplitude (Pilz and Schnitzler, 1996). 
The neuronal underpinnings of the pathway of startle sensitization have not been well 
established. Furthermore, within the literature it is hard to distinguish if any manipulations that 
result in an increased startle reactivity in general can be classified as a mechanism of 
sensitization.  Fear-potentiation of startle, where an aversive-conditioned stimulus is presented 
before a startling sound, has been well studied, but it is unclear if these mechanisms reflect the 
same type of plasticity required for general (non-associative) sensitization of the startle response. 
Regardless, sensitization of the startle response can be induced with electrical stimulation of the 
amygdala, an effect that was  most reliably induced when stimulation sites targeted the ventral 
amygdalofugal pathway, which projects to lower brainstem nuclei (Rosen and Davis, 1988). 
 Although the amygdala has direct projections to the startle-mediating PnC, it appears 
that startle sensitization is relayed through intermediary nuclei. Potential relay sites include the 
periaqueductal grey area, substania nigra, deep mesencephalic nucleus, laterodorsal tegmental 
(LDT) or pedunculopontine tegmental nucleus (PPT; Hitchcock and Davis, 1986; Yeomans and 
Pollard, 1993; Fendt et al., 1994; Krase et al., 1994; Frankland et al., 1995; Frankland and 
Yeomans, 1995). Interestingly, electrical stimulation at certain potential relay centers (e.g. the 
PPT) can induce startle-like responses (Yeomans and Pollard, 1993). 
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The neuropeptide Substance P has also been strongly linked to unconditioned 
sensitization of startle (Krase et al., 1994). Interestingly, Kungel et al. (1994) found that Substance 
P innervation of the PnC mainly came from the PPT and LDT, and not the amygdala. They also 
observed that Substance P’s ability to increase excitability of PnC neurons was increased with the 
co-administration of a cholinergic agonist. A subset of cholinergic midbrain neurons, including 
those in the PPT, are known to co-express Substance P markers (Standaert et al., 1986). 
Additionally, a rat line with hypocholinergia (Flinders Resistant Line) showed a decreased startle 
response magnitude, as well as sensitization of startle to tones (Markou et al., 1994). Taken 
together, this may suggest that cholinergic PPT function could be involved in sensitization of the 
startle response. However, a more widely accepted view of cholinergic-midbrain function has 
been that these neurons inhibit, or decrease, startle and that this is a mechanism for prepulse 
inhibition, as discussed in section 1.3.4 and 1.4.3.  
1.2.3 Comparing Habituation of Reflexive vs. Non-Reflexive Behaviours 
Previously, we discussed habituation in terms of the ASR, but habituation is not limited to 
just reflexive behaviours: it is applicable to all behaviours. Incremental attenuation of non-
reflexive behaviours, in the literature referred to as emitted or motivated behaviours, are also 
important processes to understand. Research on habituation of non-reflexive behaviours can 
focus on everything from habituation of food foraging, aggression, to exploratory behaviour. 
Here, we focus on the latter, which is reflected in the habituation of locomotion in a new 
environment. 
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Habituation of locomotor behaviour generally displays the same features as habituation 
of reflexive behaviours. Both behaviours show short-term (intra-session) and long-term (inter-
session) habituation. Overall, the principles discussed in section 1.2.1 can also extend to emitted 
behaviours. The most important shared feature is that habituation of non-reflexive behaviours is 
also not due to muscle or receptor fatigue (Rankin et al., 2009). Additionally, Muller and 
colleagues (1994) also defined decreases of locomotion within a testing session to reflect 
adaptation and decreases across sessions to reflect both adaptation and a memory for the 
environment. Groves and Thompson’s dual process theory of habituation is also applicable to 
locomotor behaviour as Welker (1957) found that the motivational state of an animal can greatly 
alter habituation of locomotion. Therefore, both reflexive and non-reflexive habituation is 
subject to the same behavioural principles; however the underlying physiological mechanisms 
are thought to be very different.  
This idea is best illustrated in a study by Williams, Hamilton and Carlton (1975). They 
examined both habituation of the ASR and locomotion. They observed that the two processes 
were ontogenetically dissociable. Habituation of locomotion differs according to age. Habituation 
of locomotion was not present in rodents younger than 13 days, but was present in older rodents, 
whereas habituation of the startle response was present as early as 13 days of age. This suggested 
that the two processes are actually mediated by distinct physiological mechanisms.  
1.2.4 Habituation of the ASR and Acetylcholine 
One of the first general theories of habituation was proposed by Carlton (1968). This 
theory stated that acetylcholine (ACh) was the neurotransmitter which mediated all inhibitory 
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processes, including habituation. Later studies, however, have greatly refuted this idea. There 
has been little evidence to suggest that ACh has a role in short term habituation of the ASR. In 
fact, most research has concluded that ACh is not involved in habituation of reflexes (Hughes, 
1984). Across a variety of species, and developmental stages, anticholinergics have had no effect 
of the short-term habituation of the startle response (Williams et al., 1975; Brown, 1976).  
Interestingly, none of these studies investigated long-term habituation. This is surprising 
as ACh innervates the entire brain, and is well poised to regulate a global process like long-term 
habituation. In part this could be because chronic manipulation of the cholinergic system was not 
available at the time these studies were performed, and it is likely that studying long-term 
habituation would require chronic rather than transient alterations. The cerebellar vermis, one 
of the structures linked to long-term habituation does receive cholinergic input from the lateral 
reticular nuclei (Barmack et al., 1992a; Barmack et al., 1992b).  Furthermore, the mesencephalic 
reticular formation that has also been linked to long-term habituation, houses two cholinergic 
cell groups, the LDT and PPT. Despite this, no current study has looked at long-term habituation 
of the startle response and the role of ACh. This will be one of the goals of this thesis. 
1.2.5 Habituation of Locomotor Behaviour and Acetylcholine 
As previously discussed, there is little evidence to suggest that ACh is involved in 
habituation of the ASR, but there is much more evidence to suggest that ACh is very important 
for habituation of locomotor behaviour. The differential role that ACh plays in the habituation of 
locomotor behaviour compared to the ASR once again reiterates that the primary physiological 
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mechanisms of underlying these processes are distinct, as evidenced by different ontogenetic 
and cholinergic regulation.   
There are many studies that have sought to understand the role of cholinergic function in 
habituation of locomotion. General septal cholinergic lesions by 192 IgG-saporin produced 
deficits in short-term habituation, but it also produced a decrease in overall locomotor behaviour 
compared to controls (Lamprea et al., 2003). Other studies have used in vivo microdialysis to 
monitor the profile of ACh release during open field tasks. In the hippocampus, it was observed 
that when rats are exposed to novel environments, extracellular ACh levels increased and that 
this is correlated with increased locomotor and exploratory behaviour (Ikegami, 1994; Thiel et 
al., 1998; Giovannini et al., 2001). This could suggest that ACh is important for encoding 
memories about new environments, or that it is somehow inducing increased motor activity. 
Theil and colleagues (1998) provide evidence against the later argument. They re-exposed 
animals to the same environment the following day and found that ACh levels increased again, 
but that locomotor behaviour decreased compared to the first exposure. In summary, evidence 
suggests that ACh has a role in the process of both short- and long-term habituation of 
locomotion whether through memory formation or arousal. Regardless, the cellular 
mechanism(s) and the potential cholinergic receptor subtypes involved remain elusive. 
1.2.5  Habituation of Locomotor Behaviour and Cholinergic Receptors 
ACh binds to two distinct receptor types: nicotinic and muscarinic receptors. Muscarinic 
receptors are metabotropic; there are 5 types of muscarinic receptors (M1-M5) all of which are 
G-protein coupled receptors. Activation of M1, M3, and M5 leads to decreased K+ conductance 
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thereby increasing neuronal excitability, whereas M2 and M4 activation leads to increased K+ and 
decreased Ca+ conductance causing inhibition. 
Green and Summerfield (1977) provided the first evidence of muscarinic receptor 
involvement in habituation of locomotor behaviour. They administered the muscarinic 
antagonist scopolamine and found that both short-term and long-term habituation were 
disrupted (Ukai et al., 1994; Brodkin, 1999). 
More recently Schildein and colleagues (2002) investigated the role of nicotinic receptors 
in open field habituation. They found that local infusions of nicotine into the nucleus accumbens, 
right after exposure to an open field task, improved long-term habituation. Fittingly, they also 
observed that a general nicotinic antagonist, mecamylamine, disrupted this. If nicotine was given 
5 hours after exposure to the open field, then again, they found disruptions in long-term 
habituation. This suggested that nicotinic receptors play an important, time dependant role in 
early consolidation phases of long-term habituation. While this provides an interesting basis for 
the role of the nucleus accumbens nicotinic receptors in habituation learning, questions remain 
about what specific nicotinic receptors are involved, and if there is a role for these receptors 
outside of the nucleus accumbens in short-term habituation of locomotor or other behaviours, 
as well as in the encoding processes of long-term habituation. Thus one of the goals of this thesis 
will be to understand what role the α7-nAChR specifically is playing in short and long-term 
habituation of locomotor behaviour and of the ASR.  
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1.3 An Introduction to Sensorimotor Gating: Prepulse Inhibition  
Prepulse inhibition (PPI) was first described by Sechenov  in 1863 (Sechenov, 1863). Like 
habituation, it is a pre-attentive mechanism which can reduce the cognitive burden of sensory 
information. However, unlike habituation, PPI of the startle response is not a learned behaviour 
(Koch, 1999); it occurs on the first trial. It can improve across days of repeated testing, known as 
PPI learning (Plappert et al., 2006, Typlt et al., 2013), or be enhanced (or disrupted) through 
associative conditioning of the prepulse  (Li et al., 2009). Another critical distinction between PPI 
and habituation is that PPI reflects a direct gating of a motor response, in this case the startle 
response.  
PPI occurs when the presentation of a weak pre-stimulus reduces the behavioural 
response to a strong startling stimulus, the pulse (Peak, 1939; Hoffman and Fleshler, 1963). The 
strength of this inhibition can vary and is partly dependent on the latency between the pulse and 
prepulse, termed the interstimulus interval or ISI (Jones and Shannon, 2000a; Bosch and Schmid, 
2008). PPI occurs at ISIs ranging between 10-1000 ms.  A prepulse can be of the same sensory 
modality as the startle pulse or PPI can be cross-modal. Current theories suggest that the 
processing of the prepulse inhibits processing of the pulse, resulting in decreased startle (for 
schematic representation see to figure 1.2).  
The adaptive value of gating neural circuits is proposed to be the prevention of distractive 
interference during concurrent neural activation, thereby acting as a protective processing 
mechanism. Essentially, this prevents sensory information from flooding our brain and usurping 
finite attentional capacities (Braff et al., 1992; Koch and Schnitzler, 1997; Wynn et al., 2004). 
Another prominent theory regarding the adaptive function of PPI is that the prepulse facilitates 
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orienting responses such as approach eye-saccades by activating neurons in the Superior 
Colliculus while simultaneously inhibiting startle-mediating neurons in the brainstem. This is 
thought to coordinate approach behaviours. By visually orienting to a stimulus and inhibiting eye 
closure (that accompanies the startle response), PPI can be thought of as a very early form of 
response selection (Yeomans, 2012).  
 
Figure 1.2 Prepulse Inhibition 
When a loud, intense acoustic stimulus is presented it induces a robust startle response. If a less 
intense stimulus is presented, in this case termed the prepulse, it will not induce a startle 
response. If a prepulse precedes a pulse by 10-1000 ms, this will greatly reduce the magnitude of 
the startle reflex compared to when the pulse is presented alone. This attenuation of the startle 
magnitude is referred to as prepulse inhibition (adapted from Koch, 1999) 
1.3.1 Prepulse Inhibition vs. Prepulse Facilitation 
The presence of a prepulse prior to a startling pulse does not always inhibit the ASR. 
Prepulse Facilitation (PPF) describes the situation when the presence of a prepulse increases 
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startle magnitude, compared to when the startling sound is presented alone. Whether PPF or PPI 
is induced seems to be best predicted by ISI and prepulse type. Very short (>10-15 ms) or very 
long (<1000 ms) ISIs tend to be the most effective at inducing PPF. While both discrete and 
continuous prepulses (duration lasting throughout the entire ISI) can induce PPF, continuous 
prepulses tend to be the most effective –especially at longer ISIs (Graham, 1975; Hsieh et al., 
2006).  
One feature of both PPF and PPI  is that they are disrupted in Schizophrenia (Wynn et al., 
2004); however they are thought to be separate, independent processes. They display different 
time courses, different sensitivity to prepulse saliency, and are modulated differentially by 
background sound and Gamma-aminobutyric acid (GABA) agonism (Graham, 1975; Ison et al., 
1997). They also have opposing effects on the response latency of startle: PPI tends to increase 
response latency, whereas PPF decreases it (Ison et al., 1973).  
The mechanisms and function of PPF have remained elusive.  PPF is not due to temporal 
summation of the prepulse and the startling pulse (Ison et al., 1997). One theory suggests that in 
PPF the prepulse generally increases arousal, resulting in an increase in startle (Graham, 1975; 
Reijmers and Peeters, 1994), however there is evidence as well to suggest this may not be the 
case (Ison et al., 1997). For example, several studies suggest that PPF reflects an orienting or 
attentional mechanism by which a prepulse stimulus leads to an enhanced startle response 
(Hazlett et al., 1998; Wynn et al., 2004). Confusingly, PPI has also been suggested to reflect and 
orienting response (Yeomans, 2012). How two independent and opposing processes may reflect 
the same orienting response is unclear. One possibility is that they may reflect different aspects, 
or timing, of the orienting response.  
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Akin to the dual process theory for habituation, at ISIs close to the border of PPI and PPF, 
the behavioural output is thought to be balanced between opposing PPF and PPI processes 
(Reijmers and Peeters, 1994; Ison et al., 1997). Despite the fact that the mechanisms and 
functions of PPF are largely unknown, because PPF represents a phenomenon that is the 
behavioural opposite of PPI, it is critical to be aware of the effects this process may have on 
studies of PPI.   
1.3.2 The Neural Circuitry of Prepulse Inhibition 
The neuroanatomical circuitry of PPI clearly illustrates its function as a neural gating 
mechanism. PPI occurs due to the manner in which PPI-mediating structures impinge upon the 
primary startle pathway. When the pre-pulse is first detected by the ear it excites the Cochlear 
Root neurons (apart from the ascending hearing pathway, which is not discussed here). It is at 
this point where the signal is divergently processed through the primary startle pathway as well 
as by a parallel PPI pathway (see figure 1.3). Within the PPI pathway the signal is transmitted to 
the inferior and the superior colliculi. Neurons of these nuclei induce activation of the PPT 
(Kandler and Herbert, 1991). It is supposed that the superior colliculus (SC) integrates and 
transmits information from all sensory modalities, whereas the inferior colliculus (IC) transmits 
strictly auditory information to the PPT (Semba and Fibiger, 1992; Fendt et al., 2001). Once 
activated the PPT is thought to release ACh within the PnC (Koch et al., 1993; Swerdlow and 
Geyer, 1993). This is the site of imposition that is hypothesized to be critical for PPI of startle. The 
PPT cholinergic input inhibits startle mediating giant neurons of the PnC (Fendt and Koch, 1999; 
Bosch and Schmid, 2006), which translates into less activation of the spinal motoneurons 
resulting in a decreased startle response. This is the major hypothesized mechanism underlying 
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PPI. New evidence has suggested that there is an additional fast PPI circuit that involves 
cholinergic projections from the ventral nucleus of the trapezoid body onto cochlear root 
neurons (Gomez-Nieto et al., 2008; Gomez-Nieto et al., 2014).  
It is important to note that the prepulse and pulse are processed in the exact same 
manner. Due to the ISI, it is thought that the presumed cholinergic inhibition of giant neurons is 
still in effect when the startle pulse is being processed. Due to this residual inhibition, the PnC is 
unable to activate the spinal motoneurons as strongly as if the pulse was presented alone. The 
efficacy of this inhibition is dependent on the duration of the ISI (Jones and Shannon, 2000a; 
Bosch and Schmid, 2008). Different paths within the PPI circuitry may reflect differential circuits, 
neurotransmitter systems, and receptors being activated during PPI and playing different roles 
at different ISIs (Yeomans et al., 2010). 
The previously described circuitry is located within the brainstem, however many higher 
brain structures have also been linked to PPI. These include the hippocampus, amygdala, medial 
prefrontal cortex, ventral striatum, ventral pallidum, substantia nigra, the ventral tegmental area 
and the nucleus accumbens, (for review see Koch, 1999). These areas act to modulate PPI via 
direct, or indirect, projections to the PPT. Figure 1.2.4 illustrates how the PPT is able to act as an 
integration point for top-down control of PPI. One example for this top-down modulation is the 
enhancement of PPI in rats and humans by increased attention to the prepulse (Li et al., 2009)  
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Figure 1.3 The Neural Circuitry of Prepulse Inhibition 
This figure displays a simplified neuroanatomical summary of known PPI circuitry.  The primary 
startle circuit is shown in red.  The darker grey highlights the structures important for the 
mediation of PPI, and the lighter grey displays structures that modulate PPI. This diagram 
illustrates the PPT as the interface for PPI modulation by these higher brain regions. Shown in 
blue is a fast circuit of PPI suggested by Gomez-Nieto et al. (2014). Both the pulse and prepulse 
are processed through these pathways in the same manner, but due to the latency between each 
stimulus, residual (presumed) acetylcholine from the PPT is still inhibiting the PnC during 
processing of the pulse. This causes a decreased startle response.  
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1.3.3 Neurotransmitters Involved in Prepulse Inhibition 
It was the findings of Koch, Kungel and Herbert (1993) alongside Swerdlow and Geyer 
(1993), that lead to the principle cholinergic hypothesis of PPI.  Both these studies induced 
general lesions of the PPT, and observed a substantial deficit in PPI. While these seminal studies 
provided an essential foundation for the field, the methodology was too limited to determine 
PPT cholinergic input as the singular mediator of PPI. Firstly, the PPT is a heterogeneous structure 
in terms of neurotransmitter release (Wang and Morales, 2009). Secondly, recent papers have 
demonstrated that other neurotransmitters play an important role in PPI. Differential modulation 
of PPI according to the ISI is a prime example of this. Yeomans and colleagues (2010) suggested 
that ACh transmission mediates PPI at medium to long ISIs (100-1000 ms), but that at shorter ISIs 
(1-10 ms) GABA is involved. GABAA antagonism disrupted PPI at short ISIs, whereas GABAB 
antagonism disrupted PPI at longer ISIs, suggesting that GABA transmission may be an additional 
mediator of PPI.  
While the field has largely hypothesized that GABA and ACh mediate PPI, other 
neurotransmitters can modulate PPI at different levels of the neuron circuitry as well. Serotonin 
modulation has been shown in the hippocampus (Adams and van den Buuse, 2011) and raphe 
nuclei (Fletcher et al., 2001); whereas dopamine transmission has been heavily implicated in the 
medial prefrontal cortex (Ellenbroek et al., 1996; Zhang et al., 2000) and striatum (Zhang et al., 
2000). Removal of a single neurotransmitter system does not completely ablate PPI. When 
examining the PPI literature it becomes apparent that even this pre-attentive behaviour is 
sensitive to changes in the transmission of different neurotransmitters across many different 
areas of the brain. 
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1.3.4. Prepulse Inhibition and Acetylcholine  
Although PPI is a complex process that is modulated by many neurotransmitter systems, 
literature within this field has particularly focussed on PPI regulation by ACh. The strongest 
evidence that ACh is a primary mediator of PPI stems from pharmacology studies. For example, 
Fendt and Koch (1999)  found that cholinergic antagonism within the startle-mediating PnC 
disrupted PPI, and that general cholinergic agonism enhanced PPI. A choline-free diet also causes 
drastic reductions in PPI which can be restored by re-introducing a general cholinergic agonist, 
arecoline, back into the rodent’s diet (Wu et al., 1993). Manipulations of the cholinergic system 
have been well documented to alter PPI, but the cholinergic receptors responsible (discussed 
below), and the source of cholinergic modulation (discussed in section 1.4.3) remains to be 
determined.  
1.3.4.1 Muscarinic Receptors and Prepulse Inhibition 
Systemic muscarinic antagonism using scopolamine disrupted PPI at ISIs of 100 and 300 
ms; ISIs of 30 ms or less were unaffected (Jones and Shannon, 2000a). At the cellular level, Bosch 
and Schmid (2006) found that muscarinic antagonism prevented cholinergic inhibition of the PnC 
giant neurons in vitro. Furthermore, they found that muscarinic M2 and M4 subtype-preferring 
antagonists mediated this effect. This suggests that the inhibitory, presumably presynaptic M2 
and M4 receptors are responsible for the muscarinic component of PPI. However, Bosch and 
Schmid (2006) did note that the most effective inhibition occurs when general cholinergic 
agonism is used, suggesting a complementary role of nicotinic receptors.   
A lot of emphasis has been placed on understanding how ACh may influence PPI at the 
level of the PnC. This cholinergic input is assumed to arise from the PPT, and will be discussed 
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more thoroughly in section 1.4.3. Recently, a novel, ‘fast PPI circuit’ has been proposed (see 
figure 1.3), whereby a cholinergic projection from the ventral nucleus of the trapezoid body sends 
inhibitory cholinergic projections to the cochlear root nucleus (Gomez-Nieto et al., 2014). What 
receptor types may underlie this inhibition is currently unknown. 
 There also have been a few studies that have looked at cholinergic modulation of PPI by 
higher brain structures. Microinfusion of cholinergic agonists into the CA1 and dentate gyrus of 
the hippocampus disrupted PPI as well as generally reduced startle reactivity. This could be 
rescued by muscarinic antagonism, suggesting that muscarinic receptors in the hippocampus play 
a role in modulating PPI (Caine et al., 1992). 
1.3.4.2 Nicotinic Receptors and Prepulse Inhibition 
Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels.  They 
are can be found within the peripheral and central nervous system. Once activated by 
endogenous ACh, or an agonist, the channel opens to allow passive flow of positively charged 
ions through the cell membrane. According to electrochemical gradients this causes an influx of 
Na+ and Ca+, and an efflux of K+ and overall excitation of the membrane. These channels are 
composed of a variety of potential subunits. In vertebrates there are 17 known nAChR subunits 
(α1-10, β1-β4, γ, δ, and ε) and channel composition differs according to the location of the 
nAChR.  General nicotinic agonism, via nicotine, is well known to enhance PPI in human and 
rodent models (Acri, 1994; Acri et al., 1995; Kumari et al., 1997; Guan et al., 1999).  
The most common nAChR expressed in the brain are the α7 and the α4β2 subtypes (Ripoll 
et al., 2004) and both have been suggested to play a role in PPI. It seems that only α4β2 nAChR 
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are expressed in PnC giant neurons however, as local, but not systemic α4β2 agonism could 
improve PPI. In contrast, systemic, but not local, α7 nAChR agonism improved PPI; this suggests 
that α4β2 nAChRs directly alter startle, whereas there is a modulatory role for α7 nAChR outside 
the primary startle pathway (Pinnock et al., 2015).  
1.3.4.3 A Closer Look at Prepulse Inhibition and the α7 Nicotinic Receptor 
This section will take an in depth view of the role the α7 nAChR plays in sensorimotor 
gating. The α7 nAChR is a homomeric channel, with 5 identical α7 subunits composing the core 
of the channel (Paterson and Nordberg, 2000). The α7-nAChR rapidly becomes up-regulated and 
desensitized (Couturier et al., 1990; Fenster et al., 1997) in the persistent presence of ACh (or 
agonist), and has  a lower affinity for ACh than other nAChRs (Hajos and Rogers, 2010). Distinctly, 
the α7 receptor is more permeable to Ca+ than other nAChRs, particularly α4β2-nAChRs (Seguela 
et al., 1993). The α7-nAChRs transiently amplifies Ca+ signalling by “Ca+-induced Ca+-release” via 
calcium stores in the endoplasmic reticulum and activation of voltage gated calcium channels 
(Dajas-Bailador et al., 2002). This signalling pathway is activated by α7-nAChRs at post- and pre-
synaptic sites and has been linked to long-term plasticity processes such as modulation of 
neurotransmitter release, regulation of postsynaptic excitability, and long-term potentiation, (for 
review see Dajas-Bailador and Wonnacott, 2004). This cellular mechanism clearly illustrates how 
the α7-nAChR is poised to play an important role in cognition. 
There are several different lines of evidence to suggest that that the α7-nAChR is involved 
in PPI. For example, one of the main behavioural hallmarks of schizophrenia is a deficit in 
sensorimotor gating. Subsets of schizophrenic patients have abnormalities in the CHRNΑ7 gene, 
which encodes the α7-nAChR. These abnormalities, particularly the dinucleotide polymorphism 
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in the intron 2 region, have been correlated with deficits in inhibitory gating mechanisms 
(Freedman et al., 1997; Leonard et al., 2002).  
Furthermore, the brains of schizophrenic patients typically have abnormally low levels of 
α7-nAChRs in the medial prefrontal cortex and hippocampus (Freedman et al., 1995; Guan et al., 
1999), both of which are implicated in the neural circuitry of top-down modulation of PPI (see 
figure 1.3). A DBA/2 mouse model of schizophrenia also correlated a decrease in α7-nAChRs in 
the hippocampus with the strength of gating deficits (Stevens et al., 1996). Selective agonism of 
the α7-nAChR restored this mouse model’s PPI deficit (Simosky et al., 2001) and can restore many 
other types of PPI deficits as well (O'Neill et al., 2003; Dunlop et al., 2009; Wallace et al., 2011). 
Despite this strong line of pharmacological evidence that the α7-nAChR is an important 
modulator of PPI, recent studies have shown that α7-nAChR KO mice have normal PPI of the 
acoustic startle response (Paylor et al., 1998; Young et al., 2011). However, other studies have 
shown auditory gating deficits in heterozygous α7(-/+) KO mice, as assessed by in vivo evoked 
potential recordings in the hippocampus (Adams et al., 2008). In summary, the current literature 
suggests that the α7-nAChR is a modulator, rather than a mediator, of PPI, which will be further 
studied as one aim of this thesis.  
1.4 The Pedunculopontine Tegmental Nucleus (PPT) 
The PPT, alongside with the parabigeminal (PBG) and LDT nuclei compose the cholinergic 
cell groups of the midbrain. The LDT and PPT are very similar in structure and connectivity, 
however, this review will focus on the PPT. 
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The PPT is a heterogeneous structure in terms of neurotransmitter release. In addition to 
ACh, GABA (Lavoie and Parent, 1994b), and glutamate (Clements and Grant, 1990) 
immunoreactivity has been observed in the PPT. There has been debate if these 
neurotransmitters are co-released or not. This may be in part due to species differences, but in 
the rodent it appears these neurotransmitters are released independently (Wang and Morales, 
2009); however, see (Clements et al., 1991; Lavoie and Parent, 1994b).  
A special note regarding the cholinergic neurons of the PPT is that they also release nitric 
oxide as the all choline acetyltransferase (ChAT) positive neurons co-stain for the nitric oxide 
marker, β-nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase (Vincent et al., 
1986; Lavoie and Parent, 1994b). Around 30% of these cholinergic neurons also express 
substance P markers, corticotropin-releasing factor and gastrin-releasing peptide 
immunoreactivity (Standaert et al., 1986; Vincent et al., 1986). 
1.4.1 Connectivity of the PPT 
There are two distinct cholinergic regions within the PPT: the pars dissipatus, which 
encapsulates the rostral PPT and has sparse ACh neurons; and the pars compactus, which is 
densely packed with cholinergic neurons and denotes the caudal aspect of the PPT (Martinez-
Gonzalez et al., 2011). The anterior vs. posterior PPT receive different input and project to 
different regions of the brain.  
The rostral PPT receives inhibitory GABAergic input from the substania nigra and global 
pallidus (Granata and Kitai, 1991; Florio et al., 2007). It is also highly innervated by the 
subthalamic nucleus and ventral tegmental area, and deep cerebellar nuclei (Semba and Fibiger, 
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1992). The PPT receives the majority of its cortical input from the primary auditory and medial 
prefrontal cortex (Semba and Fibiger, 1992; Schofield and Motts, 2009). The nucleus basalis, LDT 
and contralateral PPT seem to innervate the entirety of the PPT. The caudal PPT receives the 
majority of the incoming sensory input from the ipsilateral SC and IC, as well as ventral cochlear 
nucleus, principle sensory trigeminal nucleus, and the superior olivary complex (Semba and 
Fibiger, 1992).  
The projections of the cholinergic PPT are diffusely spread through the brain. They can 
also be dissociated topographically. The anterior PPT innervates the dorsolateral striatum, 
substania nigra (pars compacta), global pallidus, and nucleus basalis (Semba and Fibiger, 1992; 
Lavoie and Parent, 1994a; Dautan et al., 2014), whereas the caudal PPT preferentially innervates 
the dorsal striatum and nucleus accumbens, IC, SC, ventral tegmental area, nucleus pontis oralis, 
reticular pontine formation, PnC, and thalamus (Semba et al., 1990; Koch et al., 1993; Lavoie and 
Parent, 1994a; Garcia-Rill et al., 2001; Dautan et al., 2014). Interestingly, the same cholinergic 
neurons innervate both the PnC and thalamus (Semba et al., 1990). 
1.4.2 Function of the PPT 
The PPT has been implicated in a number of different behavioural and cognitive function. 
As rostral vs. caudal regions display a distinct pattern of afferent and efferent connectivity, it is 
no surprise that there is a topographical hypothesis in the functioning of the PPT (see Martinez-
Gonzalez et al., 2011; Gut and Winn, 2016 for more detail). However, this review will focus on 
the general hypothesized function of the PPT as a whole.  
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Cholinergic projections from the PPT to the thalamus encompass an arm of the ascending 
reticular activating system which mediates wakefulness and sleep transitions (Walter, 2014). 
Cholinergic PPT neurons are activated during rapid eye movement (REM) sleep (Hobson et al., 
1975) and optogenetic activation of these neurons is sufficient to induce REM sleep (Van Dort et 
al., 2015). It is thought these cholinergic neurons drive state-transitions by producing transient 
responses to sensory events (Petzold et al., 2015). While induction of REM sleep might be 
mediated by projections to the nucleus pontis oralis (Nguyen et al., 2013), the cholinergic PPT is 
well poised to influence arousal and cortical processing through its connections.  
It is suggested that the PPT has a greater influence on cognitive control than previously 
thought. Historically the PPT was highly implicated in motor control, specifically locomotion. 
However, after extensive review of animal studies following PPT lesions (that generally show no 
gross motor impairments), Gut and Winn (2016) suggest that the PPT can be more appropriately 
thought as a part of a lower-level action selection process. Due to its rapid detection of sensory 
information, and output to striatal and thalamic inputs, Gut and Winn predict the PPT prevents 
impulsive and inappropriate responding. Accordingly, a recent study found that while rats with 
selective cholinergic lesions of the PPT showed little impairment in a 5-choice serial reaction time 
task, the only notable difference in their behaviour was a tendency towards more impulsive 
responding (Cyr et al., 2015).  
Expanding this idea further, the PPT may also play a role in associating the outcome of 
actions with outcomes or environment. The PPT is well known to be implicated in reward-based 
learning as lesions to this area disrupt morphine-induced (Olmstead and Franklin, 1993) and 
nicotine-induced  conditioned place preference (Laviolette et al., 2002).  Modulation of PPT 
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activity can differentially influence the activity of the ventral tegmental area (Pan and Hyland, 
2005; Xiao et al., 2016), particularly when associated with a sensory cue (Pan and Hyland, 2005). 
This may suggest that the PPT can execute basic action selection and associate this with reward. 
Fittingly, recent studies have shown that neuronal activity in mouse PPT reflects both action and 
outcome in a decision-making task (Thompson and Felsen, 2013) indicating that the PPT’s role in 
action-selection could adapt with experience. 
1.4.3 The Cholinergic Midbrain and its Role in Sensorimotor Gating 
The idea that the PPT may mediate early action selection fits excellently with its 
hypothesized role in PPI. As stated, PPI has also been suggested to be an early form of action 
selection, mainly though promoting orienting responses (eye saccades) while inhibiting startle 
and eye-closure (Yeomans, 2012). The execution of these functions is predicted to be mediated 
via the PPT. It sends cholinergic projections to the SC which can influence eye saccades 
(Kobayashi et al., 2002), and as discussed, it is known to innervate and inhibit the startle 
mediating brainstem (Koch et al., 1993; Bosch and Schmid, 2008). 
The longstanding hypothesis that the mechanism underlying PPI stems from cholinergic 
inhibition of startle-mediating neurons via the PPT has been supported by a large body of 
evidence. As previously discussed this primarily comes from a seminal study by Koch, Kungel and 
Herbert (1993), where they lesioned the PPT and saw a disruption in PPI but no difference in 
baseline startle magnitude. They inferred this was mediated by diminished cholinergic input from 
the PPT, as they observed 35% decrease in ChAT immunoreactivity in the PPT. Similar findings 
were reported by Swerdlow and Geyer (1993) using electrolytic lesions, however they also 
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reported an increase in startle magnitude (when no prepulse was present). Fittingly, 
microinfusions of cholinergic agonists into the PnC enhanced PPI, and muscarinic antagonism 
disrupted it (Fendt and Koch, 1999). The idea that this cholinergic modulation stemmed from the 
PPT was further supported by in vitro stimulation of PPT projections and sensory afferents to the 
PnC which caused  a delayed inhibition of synaptic transmission (Bosch and Schmid, 2008). 
Together, the evidence strongly supports that the cholinergic cells of PPT mediate PPI. 
However, a recent study by MacLaren and colleagues (2014) had the unique advantage 
to selectively lesion the cholinergic cells of the PPT using a urotensin II diptheria toxin fusion 
protein. Following this, they found no disruption in PPI, but profoundly reduced baseline startle 
magnitudes. When they completed a general lesion of the PPT, they could re-affirm past studies 
showing disruptions in PPI. Additionally, a mouse with a conditional knock-out of cholinergic 
transmission in the midbrain (LDT, PPT and PGB) displayed improved PPI compared to wildtype 
mice, with no change in baseline startle magnitude (Machold, 2013). These studies represent 
some of the first evidence to suggest that it is not the cholinergic cells of the PPT that are critical 
for PPI. However, it is impossible to rule out compensatory mechanisms that accompany lesion 
techniques or knock-out models (for review see Barbaric et al., 2007; Otchy et al., 2015). 
Although in vitro patch clamp studies in the rodent have shown that cholinergic agonism 
can inhibit synaptic signals in startle-mediating giant neurons of the PnC fitting with cholinergic 
midbrain mediation of PPI (Bosch and Schmid, 2006, 2008); in vitro recordings of unidentified 
PnC neurons in the cat following electrical stimulation of the PPT caused excitatory prolonged 
responses (a train of action potentials lasting greater than 12 ms following stimulation). This 
could be blocked by administration of scopolamine, a muscarinic antagonist, and induced using 
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carbachol, a general ACh agonist (Homma et al., 2002). Interestingly, this prolonged 
responsiveness seems similar to that observed during in vivo recordings of PnC neurons following 
application of Substance P. Furthermore, as previously discussed, activity in PnC neurons in 
response to to acoustic stimulation was also enhanced by cholinergic agonism in rats (Kungel et 
al., 1994). This suggests that ACh may have an excitatory influence on startle mediating neurons. 
How this influences the output of the PnC (and ultimately behaviour) remains unanswered. In 
light of this recent evidence, it is clear that the midbrain cholinergic hypothesis of PPI may need 
to be re-evaluated, specifically using techniques that can manipulate neuronal activity with 
improved cell-type and temporal specificity.  
1.5 Rationale and Hypothesis 
In this thesis, I aimed to understand the differential role ACh may play in sensorimotor 
gating and the sensory filtering of reflexive vs. non-reflexive behaviours. Based on the literature 
review above, my overall hypothesis is that ACh is critical for sensorimotor gating of the ASR, and 
habituation of locomotor behaviour. It seems to play no role in the short-term habituation of the 
ASR, however, ACh’s role within long-term habituation of the ASR has been largely unexplored. 
Understanding the role of ACh in sensory filtering and sensorimotor gating is important for 
several reasons. Firstly, these processes are disrupted in a number of psychiatric illnesses and 
better treatment options may result from understanding the underlying pharmacological 
mechanisms related to these processes. Secondly, sensory filtering and sensorimotor gating are 
thought to act as proxy measures for an individual’s efficiency of information processing and/or 
methods for reducing cognitive burden. Uncovering the subtle differences in modulation of these 
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processes will help us not only to better understand the processes themselves, but how they 
relate to higher-cognitive function. 
My aim was to re-define the role of cholinergic modulation of sensory filtering and 
sensorimotor gating. Next, we aimed to refine this by investigating what cholinergic receptor is 
critical for modulation of these processes, as well as what nucleus was providing the necessary 
cholinergic input.  
Chapter 2 defines the role of ACh on PPI and habituation of the ASR using transgenic mice 
with a reduced cholinergic tone. Hypothesis: I hypothesize that ACh is the primary mediator of 
prepulse inhibition, but plays no role in habituation of the acoustic startle reflex. Mice with 
deficient cholinergic tone mice will show a disruption on PPI, but intact habituation. 
Chapter 3 uncovers the receptors mediating cholinergic modulation of sensorimotor 
gating mechanisms. Specifically, I investigated the α7-nAChR’s role, using an α7-nAChR knock-
out mouse model. Hypothesis A: I hypothesized that the α7-nAChR is involved in PPI of startle, 
and predict these mice will have a deficit in PPI. Additionally, I hypothesized that this receptor is 
necessary for nicotine-induced enhancement of PPI, but not involved in the short-term or long-
term habituation of startle. Hypothesis B: If deficits in pre-attentive cognitive mechanisms like 
sensorimotor gating were observed, I predicted these deficits would lead to disruptions in higher 
cognitive function, such as working memory in spatial tasks (e.g. the Barnes Maze). 
In Chapter 4 I aimed to evaluate the role of cholinergic PPT neurons in sensorimotor 
gating using designer receptors exclusively activated by designer drugs (DREADDs) and 
optogenetics. Using these complementary techniques I both transiently inhibited (DREADDs) and 
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activated (optogenetics) cholinergic cells specifically in the PPT to elucidate the role of this 
nucleus. Hypothesis: Based on findings from Chapter 2, I hypothesized that pulsatile cholinergic 
release from the PPT is responsible for the cholinergic modulation of PPI. I predicted that by using 
DREADDs to selectively inhibit these cells, I would observe a reduction in PPI. Using the opposite 
approach, I predicted that optogenetic stimulation of cholinergic PPT neurons would induce PPI 
(in place of an auditory prepulse) prior to a startling stimulus. 
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2. Chapter 2 
 
 
VAChT KD Mice Show Normal Prepulse Inhibition but Disrupted Long-term 
Habituation 
 
 
 
 
 
 
 
 
 
 
 
 
Sections 2.1-2.5 were published previously, see Schmid S, Azzopardi E, De Jaeger X, Prado MA, 
Prado VF (2011) VAChT knock-down mice show normal prepulse inhibition but disrupted long-
term habituation. Genes Brain Behav 10:457-464. 
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2.1 Introduction 
The neurotransmitter acetylcholine (ACh) plays an important role in both the central and 
peripheral nervous system. Disruptions in the central cholinergic system has been associated 
with different human disorders, including Alzheimer’s disease (Felder et al., 2001; Mesulam, 
2004), and Schizophrenia (Felder et al., 2001; Barak, 2009). One hallmark in Schizophrenia is 
impaired prepulse inhibition (PPI) of the acoustic startle response. Prepulse inhibition is a 
measure of sensorimotor gating, referring to the inhibition of the startle response to a sudden 
intense auditory stimulus (pulse) because of prior presentation of a sub-threshold stimulus 
(prepulse). This reflects the ability to suppress sensory information from processing and 
conscious awareness. It has been used as an assay and endophenotype of sensorimotor gating 
deficits exhibited by patients with Schizophrenia.  
Prepulse inhibition can pharmacologically be disrupted by systemic injections of 
cholinergic muscarinic antagonists (as reviewed by Jones and Shannon, 2000a; Barak, 2009), 
whereas systemic nicotine has been shown to enhance PPI in Schizophrenic patients and healthy 
humans (Kumari et al., 2001, 2002; Postma et al., 2006; Kumari et al., 2008), as well as in different 
animal models (Acri et al., 1994; Curzon et al., 1994). Prepulse inhibition of the startle response 
has been proposed to be at least partly mediated by inhibitory cholinergic projections from the 
laterodorsal tegmental (LDT) and pedunculopontine tegmental nucleus (PPT) to the startle-
mediating neurons in the pons (Koch, 1993; Bosch and Schmid, 2006, 2008). Besides its 
descending inhibition to the caudal pontine reticular nucleus (PnC), the PPT projects to higher 
brain structures, including the Thalamus, Substantia Nigra and Ventral Tegmental Area (Steriade 
et al., 1990; Yeomans, 1995; Blaha et al., 1996; Fendt et al., 2001). It is suggested that these 
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cholinergic PPT projections may be responsible for cortical activation and eliciting approach 
behaviours, while inhibiting avoidance behaviours like startle through the descending projections 
(Fendt et al., 2001).  
Habituation is another form of sensory filtering that is disrupted in Schizophrenia and 
delayed in patients suffering from Autism Spectrum Disorders. Short-term habituation (STH) 
describes the decline of a behavioural response (e.g. startle) to repeated presentation of the 
same stimulus within a testing session, whereas long-term habituation (LTH) describes the 
decline of the first (or the average) response over consecutive testing sessions. Habituation is a 
basic form of non-associative learning. Although STH of startle occurs within the primary startle 
pathway (Davis et al., 1982a; Schmid et al., 2010), LTH is disrupted by lesions outside of this 
pathway, for example in the cerebellar vermis (Leaton and Supple, 1986, 1991). Yet, there is little 
indication for a role of ACh in habituation of startle (Hughes, 1984). 
 Habituation and PPI deficits have been associated with cognitive symptoms in neural 
disorders. The cholinergic system plays a major role in cognitive function and drugs facilitating 
cholinergic transmission have been developed as cognitive enhancers. Efficient synaptic release 
of ACh depends on its transport into synaptic vesicles by vesicular ACh transporter (VAChT; Prado 
et al., 2006; de Castro et al., 2009). Homozygous VAChT knock-down mice (VAChT KDHOM) with a 
65% reduced immunoreactivity for VAChT in the brain show decreased ability to refill synaptic 
vesicles (Prado et al., 2006; de Castro et al., 2009). Homozygous VAChT KD mice have a reduced 
capability to sustain ACh release and the injection of the cholinesterase inhibitor galantamine 
has previously shown to reverse motor and memory deficits in mutant mice (Prado et al., 2006; 
de Castro et al., 2009). Homozygous VAChT KD mice are therefore an excellent model to study 
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the consequences of disruptions in central cholinergic function. We studied the effect of VAChT 
KD on basic cognitive processes such as STH and LTH as well as PPI of startle. 
2.2 Methods 
2.2.1 Subjects 
For this experiment we used a mutant mouse line which had the vesicular acetylcholine 
transporter protein knocked-down (VAChT KDHOM). Generation and genotyping of the mice has 
been described before (Prado et al., 2006; de Castro et al., 2009).  The mice were generated by 
targeting the 5’ untranslated region of the VAChT gene for homologous recombination by 
inserting a TK-Neo resistance cassette 1.5 kb downstream from the VAChT stop codon. The 
placement of this cassette interrupts VAChT expression in cholinergic neurons of the central 
nervous system, but leaves somatomotor cholinergic neurons relatively intact. These mice had a 
mixed 129/terSV x C57BL/6J background. Mice were back-crossed for at least three generations 
(N3). Ten different breeding pairs of heterozygous mice were bred to generate wild-type (WT) 
and homozygous KD littermates. Only male WT and KD animals were used in this study. They 
were housed in groups of 3-4 in a temperature controlled room a with 12 hour light–dark cycle. 
Food and water were available ad libitium. All testing occurred during the light phase while the 
animals were between 2-5 months of age. Animals were cared for according to the ethical 
guidelines of the University of Western Ontario Animal Use Subcommittee and Canadian Council 
on Animal Care (CCAC). 
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2.2.2 Drugs 
In an attempt to rescue cholinergic function, galantamine (1 mg/kg, intraperitoneal (IP)), 
an acetylcholine-esterase inhibitor, was administered to both WT and KD animals. Galantamine 
was dissolved in sterile saline (0.9% NaCl) to a dilution of 1 mg/ml. Both genotypes were also 
given saline as a control. Injections were given either before testing (WT n=14: n=7 saline, n=7 
galantamine. KD n=37, n=18 saline, n=19 galantamine) or after (KD saline n=9, galantamine n=10) 
in order to elucidate the effects of ACh during encoding and retrieval or consolidation processes.  
2.2.3 Startle Testing 
Mice were randomly assigned to a sound-proofed startle box (Med Associates, St Albans, 
VT, USA) in which they consistently underwent all behavioural testing. For an overall schematic 
representation of the behavioural protocol see figure 2.1.  
Mice were acclimated to the startle box for 5 minutes/day for 3 days with background 
noise (65 dB SPL white noise). On the final day of acclimation animals also underwent an 
input/output (I/O) test. For this test animals are placed in their respective holders and placed in 
the startle box. Testing began with an acclimation phase (5 min, 65 dB white noise) which  was 
followed by the presentation of  white noise bursts (20 ms duration) starting at 65 dB SPL and 
increasing to 120 dB SPL (increasing by 5 dB SPL with each trial for a total of 12 trials; 15 seconds 
between trials).  
The I/O test allowed us to ensure our animals have normal hearing ability as well as 
assessing the animal’s individual startle reflex magnitude.  Rodents fall within a spectrum 
between high and low startle reactivity much like humans (Hutchison et al., 1997; Schwegler et 
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al., 1997). The I/O function assessed where the mice fall in this spectrum and according to this 
we determined a gain setting. This gain amplified the signal from the movement sensitive 
platform to the digitizer, allowing for a more a more accurate reading. If the signal was too low, 
the transducer (which converted the amount of movement-induced displacement into an 
electrical signal) may not have been sensitive enough to detect changes, specifically decreases, 
in startle magnitude.  We increased the output so that each animal responded within the optimal 
range, making the data more stable between animals and improved measurement accuracy. 
Using this method we did not have to separate data into low and high startling reactivity as 
previous studies have done (see Hutchison et al., 1997) which can make analysis complicated. 
We prescribed high startling mice a gain of 1, medium startling 2-3, and low startling 4 (refer to 
figure 1.2).  This gain was kept constant for each animal over every day of testing. We factored 
out the gain (by dividing the amplitude of the startle by the gain factor) when analyzing baseline 
startle amplitudes, to reduce confounding of results. 
Once I/O testing was completed, the animals began the experimental protocol. Animals 
were tested once daily for 5 days. The protocol consisted of a 5 minute acclimation phase (65 dB 
SPL white noise) and two blocks of trials (see figure 2.1). Block one was used to assess habituation 
and block two was used to assess PPI.   
The first block consisted of 30 pulse-alone trials. A startle pulse was a 105 dB SPL (20 ms 
duration) burst of white noise. The intertrial interval (ITI) was 15 sec. This pulse was chosen based 
on data from the I/O test as it was the first to induce the maximal startle amplitude (see figure 
2.2). Using a higher startle pulse could risk hearing damage.  Following the pulse the resulting 
startle magnitude was recorded digitally using Med Associate software. The magnitude reflected 
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the amount of displacement, induced by the startle, of the movement sensitive platform placed 
at the bottom of the startle box. 
The second block of trials was a mix of 60 prepulse and 10 pulse-alone trials. The pulse-
alone trials, which were exactly the same as described in block one, measured baseline startle 
magnitude. The prepulse trials consisted of a 85 dB SPL (4 ms duration) prepulse with an 
interstimulus interval (ISI) of either 6, 12, 50, 100, 200 or 250 ms. This created 6 types of prepulse 
trials, and 10 trials of each type.  All trials were presented in a pseudo-randomized manner to 
ensure an accurate baseline startle measurement. Startle magnitudes, recorded digitally in the 
same manner as described previously, were compared between pulse-alone trials and prepulse 
trials. 
When galantamine (1 mg/kg, intraperitoneal) was administered either pre or post testing 
(see figure 2.1), mice only completed block one of testing as only habituation was necessary. 
Presenting a stimulus too many times can cause sensitization to that stimulus, which would 
confound our results (Plappert et al., 1999). Therefore for this part of the study, all long-term 
habituation results were derived during a separate testing session where just the acclimation 
phase and block one were presented.  If an animal was re-used for injection testing, sessions 
were separated by a minimum of 2 weeks.  
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Figure 2.1 A Graphic Representation of Sensory Filtering and Sensorimotor Gating Testing 
This represents one day of testing. This testing is repeated for every day, for 5 days. Block I 
assesses habituation, and block II assesses PPI. All trials in block II appear in a pseudo-randomized 
order.  Only the habituation rescue experiments contained injections, which occurred either 
directly before or directly after testing (Intertrial interval: ITI, interstimulus interval: ISI). 
 
2.2.3.1 Data Analysis for Startle Testing 
To analyze PPI and habituation data, unpaired or paired Student’s t tests or two-way 
repeated measures analysis of variance (ANOVAs) were used. To assess if VAChT KDHOM animals 
displayed differences in STH, all responses from block one were normalized by dividing them by 
the average of the first three responses. We analyzed this using a two way ANOVA (trial number 
x genotype). This was done for everyday of testing and then averaged across days. For LTH the 
first three trials of block one were averaged for each day of testing. These averages were 
combined across animals and then plotted (across days) for visualization. We also normalized all 
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data points to the average of the first 3 trials on day 1, and plotted values across days. To 
statistically analyse long-term habituation (LTH) we used a two-way ANOVA (day x genotype). For 
rescue experiments, for each genotype, we analyzed LTH using a two-way ANOVA (day x drug 
type).  
In our studies, PPI was expressed as percent of baseline startle. This means that the 
responses from the prepulse trials of block two were divided by the average of the pulse alone 
trials of block two (baseline startle). This was then multiplied by 100 to give a percent 
([startle/baseline startle] x 100). We determined percent of startle for each trial type, for each 
day. We then performed a two-way ANOVA (genotype x day) to determine if PPI improved across 
days of testing.  We then averaged PPI values across days and performed a two way ANOVA (trial 
type x genotype).  
We assessed baseline startle, to ensure startle ability between genotypes was equal, by 
using the pulse-alone trials of block two. This was the optimal measurement as startle responses 
within block one are not stable due to habituation. Criteria for significance for all statistical tests 
was p<0.05. 
2.3 Results 
2.3.1 Both Genotypes Have the Same Startle Reactivity 
Fourteen WT and 12 VAChT KDHOM mice were tested for their startle response amplitude 
with increasing startle stimulus intensities from 65 to 120 dB SPL white noise in 5 dB SPL steps. 
All startle boxes were calibrated to box 1 in order to allow for a direct comparison of startle 
amplitudes. As shown in figure 2.2a,b, the absolute startle response amplitude differed 
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substantially between individual mice with high, intermediate and low startling mice in both 
genotypes. A two-way repeated measures ANOVA (genotype x sound intensity) showed no effect 
of the genotype on startle response amplitudes (F(1,311)= 0.08, p=0.78), however there was a 
significant effect of the sound intensity (F(11,301)= 17.21, p<0.0001), but no interaction of the two 
factors (F(1,311)= 0.9, p=0.33). Although high startling mice overshot the scale, low startling mice 
barely raised the signal above the noise level, making it difficult to quantify startle attenuation 
by PPI or habituation, which illustrates the necessity of gains for appropriate startle magnitude 
detection. The average startle amplitude of the final three startle trials from this test was also 
used to further compare absolute startle responses amplitudes between genotypes. A two-tailed 
independent Student’s t-test indicated no difference in baseline startle magnitude amplitudes 
between genotypes (t24=0.7, p>0.05). 
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Figure 2.2 Individual Input/Output Functions of VAChT KDHOM Mice Compared to Wild-type 
After three acclimation sessions, animals were exposed to 65 dB SPL background noise and 
increasing startle stimulus intensities from 65 to 120 dB SPL. No difference in startle response 
amplitudes between genotypes was observed. Both WT (a) and KD mice (b) reached maximum 
startle amplitude at around 105 dB SPL; however, there was considerable variability in the 
maximum startle responses between individuals within both the groups. Although some mice 
overshot our range of measurement, others barely raised the signal above noise level. In 
subsequent experiments, gain factors for the measured motor response were adjusted according 
to the following scheme: mice that overshot were measured with a gain of 1.0, intermediate mice 
were measured with the default gain of 2 and low startling mice were measured with a gain of 4. 
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2.3.2 Prepulse Inhibition of the Acoustic Startle Response is Normal in VAChT KDHOM Mice  
Prepulse inhibition of startle was tested across ISIs. As shown in figure 2.3, VAChT KDHOM 
mice and their WT littermates did not differ in their ability to suppress startle stimuli that were 
preceded by a prepulse as we could detect no influence of genotype (F(1,58)= 0.82, p=0.78). 
Prepulse inhibition differed across ISIs (F(5,58)=11.5, p<0.001), but this was unaffected by genotype 
as there was no interaction between genotype and ISI (F(5,58)=0.8, p=0.84).  
Both groups inhibited their startle by around 70% at ISIs between 5 and 50 ms, with a 
maximum PPI of 75% at 50 ms ISI. Prepulse inhibition slightly decreased in both the groups at ISIs 
of 100 ms (66% for WT and 67% for KD) and 250 ms (50% WT and 54% KD). Overall, this suggests 
that PPI is unaffected by the knockdown of VAChT.  
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Figure 2.3 Prepulse Inhibition is Unaltered by VAChT Knock Down 
Startle response amplitudes to acoustic startle stimulus alone trials were compared with startle 
amplitudes when startle stimuli were preceded by an acoustic prepulse. This prepulse occurred 
at different interstimulus time intervals (ISI), as indicated. The average startle amplitude of each 
animal to startle stimulus alone trials was set to 100% and all other responses are expressed as 
percentage of it. Both genotypes, the VAChT KDHOM mice (KD) as well as their WT littermates, 
showed up to a 75% reduction of startle by the prepulse with no difference between groups 
(n=16/genotype).  
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2.3.3 Short-Term Habituation is Unaffected by VAChT KD, but Long-Term is Impaired 
All animals were habituated to startle stimuli during block I prior to testing PPI. As shown 
in figure 2.4a, both groups of animals habituated to 70–75% of their initial startle amplitude 
(measured as the average of the first two responses) within each testing session. An ANOVA 
showed a significant main effect of trial number (F(29,270)= 2.98, p<0.001), with no interaction of 
genotype and trial number (F(20,270)= 0.75, p=0.82), which confirmed no effect of genotype on 
STH.  
We tested for LTH by analyzing the average of the first three startle responses over the 5 
days of testing. As shown in figure 2.4b initial startle responses declined over the course of 5 days 
to around half of the amplitudes on day 1 in WT mice. In contrast, VAChT KDHOM mice did not 
show any LTH across sessions. The ANOVA showed a significant interaction between the factors 
genotype and day (F(4,145)= 2.52, p=0.045).This effect is summarized in figure 2.4c. This figure 
displays the course of both STH and LTH over five consecutive days of testing in both genotypes. 
Both genotypes still showed STH, but only the WT mice showed LTH as the mutant mice startled 
to the same extent at the beginning of each test session. 
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Figure 2.4 Short-Term Habituation is Normal in VAChT KDHOM Mice, but Long-Term is Impaired 
 (a) Short-term habituation in VAChT KDHOM mice was similar to that of their WT littermates. The 
startle response amplitude of each mouse was normalized to the average of its first three startle 
responses. (b) The long-term habituation of VAChT KDHOM and WT mice. The averages of the first 
three startle responses of each day were calculated for each mouse and then averaged within 
genotypes. Startle response magnitude declined over days in WT animals, but not in VAChT KD 
mice. (c) The course of STH and LTH over 5 days. For more clarity, six consecutive startle 
responses of an animal were always averaged (blocks of six, for a total of five blocks). The data 
of each animal was then normalized to the value of the first block (=100%). The graph shows that 
both genotypes show STH at every day, but whereas the overall startle amplitudes decline in WT 
animals over the 5 days, startle amplitudes remain at the same level in VAChT KDHOM mice, 
indicating a lack of LTH (n=16/genotype). 
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2.3.4 Rescuing the Long-Term Habituation Deficit 
Next, we tested if we could rescue LTH by increasing cholinergic tone using galantamine 
injections (1 mg/kg IP) prior to experiments. For this experiment, half of the WT and VAChT KDHOM 
mice were injected with saline and half with galantamine before the gain setting I/O test (WT 
n=14, VAChT KDHOM n=37). A two-way ANOVA (genotype x drug) was performed on the average 
of the final three startle responses of the gain setting test (equal gains for all groups). It did not 
detect any difference between genotypes (F(1,13)= 0.03, p=0.86) or drug (F(1,13)= 3.93, p=0.06) or 
interaction between these factors (F(1,13)= 2.74, p=0.11). In order to further exclude the possibility 
that galantamine injections caused a general increase of startle responses, 16 WT and 16 
VAChTKDHOM mice were injected with saline after 2 days acclimation to the boxes and startle was 
tested. On the next day, they received a galantamine injection prior to testing startle amplitude 
(figure 5a). A paired t-test showed no difference in baseline startle amplitudes between saline 
and galantamine injections in WT (t15=1.2, p=0.12) or VAChTKDHOM mice (t15=0.9, p=0.19). 
For the rescue experiment, we injected animals with galanthamine or saline prior to 
testing for 5 days. In WT animals, a repeated measure ANOVA (injection x trial OR day) showed 
that there was no effect of injection group on STH. We found no interaction between drug and 
trial (F(29,390)= 1.08, p=0.35, figure 2.5b), and no effect of repeated galantamine injection over 5 
days on LTH (F(4,66)= 1.54, p=0.2, figure 2.5c). We noted that both injection groups display less 
STH and LTH than in the previous experiment without injections. This is probably due to the 
aversive nature of the injection procedure itself (compare figure 5b,c with figure 4a–c).  
In VAChT KDHOM mice, a repeated measure ANOVA (injection x trial OR day) showed there 
was also no effect of injection on STH (F(29,270)= 0.70, p=0.87, figure 2.5b). However, pre-testing 
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galantamine-injected VAChTKDHOM mice displayed a decline of their average startle responses 
between days, whereas saline-injected animals did not show any LTH, confirming the lack of LTH 
in VAChTKDHOM mice in a second cohort of mice (figure 2.5d). The ANOVA confirmed this as there 
was a trend towards a significant interaction between drug and day (F(4,22)= 1.33, p=0.054). 
Unpaired Student’s t-tests confirmed no difference between injection groups at days 1 (t35=0.9, 
p=0.39), 2 (t35=1.75, p=0.08) and 4 (t35=1.68, p=0.08), but a significant difference between 
injection groups at days 3 (t35=2.6, p=0.01) and 5 (t35=2.4, p=0.02).  
In order to test whether the acetylcholine-esterase inhibitor had to be present during 
learning/retrieval, or if it was sufficient when present during the consolidation phase following 
learning, we repeated the rescue experiment with the VAChT KDHOM mice, but administered 
galantamine (or saline) immediately after the behavioural testing. As expected, STH in this group 
of animals was not affected by the type of injections and animals showed STH comparable to 
non-injected animals (figure 2.6a, compare figure 2.4a). As revealed by a repeated measures 
ANOVA (day x drug) galantamine failed to rescue LTH when injected immediately after the 
behavioural testing session (F(1,159)= 0.43, p=0.79), as shown in figure 2.6b,c. 
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Figure 2.5 Rescue of LTH by Pre-Test Injections of Galantamine 
 (a) Control experiments were performed which tested the effect of galantamine (gal) vs. saline 
(sal) on baseline startle responses. Sixteen WT and 16 VAChT KDHOM mice were exposed to 
acclimation and block I (habituation) in two subsequent days, with sal injection on day 1 and gal 
injection on day 2. The first three startle responses of each animal after saline were compared 
with the first three responses after galantamine on the subsequent day. There was no effect of 
drug type on baseline startle amplitude in either genotype. (b) The STH to 30 startle stimuli in 
WT (n=23) and VAChT KDHOM mice (n=27) injected with gal or sal. For each mouse, the startle 
response amplitude of each trial was normalized to the average of its first three startle responses. 
Short-term habituation was overlaid by initial sensitization in both genotypes (compare with 
figure 4a), probably due to the aversive nature of injections. No difference between genotypes 
or injection group was detected. (c) The LTH of WT mice following 5 days of sal or gal treatment 
prior to behavioural testing. The average of the first three startle amplitudes of each day were 
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calculated for each mouse and then averaged within treatment. No differences between injection 
groups could be detected at any of the 5 days (n=7/group). Finally, (d) displays the LTH of VAChT 
KDHOM mice following 5 days of sal or gal injections prior to behavioural testing. Homozygous 
VAChT KD mice that were injected with gal (n=19) show a decline of their startle responses mainly 
after day 1. Animals injected with sal (n=18) did not show LTH, confirming the previous results. 
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Figure 2.6 Post-Test Injections of Galantamine Did Not Rescue LTH 
Animals were injected with 1 mg/kg of galantamine (gal) immediately after behavioural testing. 
(a) The STH to 30 startle stimuli in VAChT KDHOM mice injected by gal and in control VAChT KDHOM 
mice injected by saline (sal). For each mouse, the startle responses for all 5 days were normalized 
to the average of its first two startle responses. Both injection groups show intact STH. (b) The 
LTH of sal- and gal-injected mutant mice. The averages of the first three startle responses of each 
day were calculated for each mouse and averaged within treatment. Both groups of animals show 
the same level of startle amplitudes over the 5 days. (c) The course of STH and LTH over 5 days. 
For more clarity, six consecutive startle responses of an animal were averaged (blocks of six, for 
a total of 5 blocks). The data of each animal was then normalized to the value of the first block 
(=100%). Both groups of animals show STH, but no LTH, over 5 days (KDHOM mice sal n=9, KDHOM 
mice gal n=10).  
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2.4 Discussion 
Homozygous VAChT knock-down mice had a 65% reduced expression of the VAChT 
protein resulting in reduced cholinergic neurotransmission. It has been shown previously that 
these mice have a decreased ability to maintain physical activity. This impairment was most 
evident during tasks where prolonged muscle contraction was required, such as in the rotarod or 
wire hang tests. Heterozygous VAChT KDHOM mice with a 40% reduction of VAChT 
immunoreactivity display slower motor learning than their WT controls and impaired object and 
social recognition, however their motor function, olfaction and spatial memory are mainly 
unperturbed (Prado et al., 2006; de Castro et al., 2009). In this study, we found that VAChT KDHOM 
mice have normal PPI and STH of startle, but disrupted LTH. Surprisingly, our data indicates that 
VAChT KDHOM mice do not exhibit lower startle responses than their WT littermates, as assessed 
by comparison of the I/O function (figure 2.2). Small differences between genotypes, however, 
would be very difficult to detect, given the huge variability of startle responses between animals 
of the same genotype. It still seems safe to state that the previously reported motor deficits of 
the VAChT KDHOM mice did not have a major impact on our results. A short startle response every 
15-20 seconds may not be sufficient to deplete cholinergic synaptic vesicles. Indeed, the 
previously reported motor deficits were specific for prolonged motor activity, whereas initial 
synaptic release and release probability have been shown to be normal in these mice (Prado et 
al., 2006). 
2.4.1 Prepulse inhibition 
The inhibitory effect of a prepulse on the startle reflex is largely assumed to occur via 
cholinergic PPT projections to the PnC, but descending limbic cortico–striato–pallido–pontine 
 
 
  66 
 
 
circuitry is also known to regulate pontine inhibitory tone. This regulation determines the degree 
to which the prepulse can inhibit the subsequent startle response. The cholinergic system closely 
interacts with dopaminergic systems in the striatum; therefore, it is not clear to what extent 
cholinergic drugs affect the PPI circuitry directly as opposed to PPI modulation through 
alterations in the signaling of other neurotransmitter systems, including dopamine. The 
expression of normal PPI in VAChT KDHOM mice was surprising given the large body of evidence 
for an important role of cholinergic modulation of PPI and the reported effects of systemic 
cholinergic drugs.  
We tested PPI at different ISIs between prepulse and startle stimuli, since it has been 
hypothesized that different neurotransmitter systems mediate PPI at different time scales (Jones 
and Shannon, 2000a, b; Fendt et al., 2001; Jones et al., 2005; Yeomans et al., 2010). We chose 
the prepulse intensity that yielded maximum PPI without causing a startle reaction itself (85 dB 
SPL). We varied the ISI from the commonly used 100 ms to 30 and 50 ms, which are the ISIs 
yielding maximum PPI in mice, plus a very short and a long ISI, in order to ensure that we did not 
miss any cholinergic contribution. There was no PPI deficiency at any ISI. However, as with the 
lack of an effect on baseline startle reactivity, we cannot exclude the possibility that although 
cholinergic transmission was reduced in the mutant mice, it still may have been sufficient for PPI 
signaling in response to a short prepulse every 15-20 seconds. Furthermore, other 
neurotransmitter systems contributing to PPI, such as GABA (Kodsi and Swerdlow, 1995; Fendt, 
1999; Yeomans et al., 2010), could be upregulated and compensate for the lack of cholinergic 
transmission in these mice. The unperturbed PPI in the mutant mice therefore cannot lead to the 
assumption that ACh plays no role in mediating and modulating PPI.  
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2.4.2 Habituation 
Short-term habituation of startle is assumed to occur within the glutamatergic primary 
startle pathway. More specifically, the glutamatergic synaptic terminals of sensory afferent fibers 
projecting on the startle-mediating giant neurons in the PnC are assumed to undergo synaptic 
depression during STH (Weber et al., 2002; Simons-Weidenmaier et al., 2006; Schmid et al., 
2010). The role of cholinergic modulation in habituation has been investigated in the past and it 
is assumed that STH to external stimuli is not directly modulated by cholinergic 
neurotransmission (Hughes, 1984), which is in accordance with our results. The disruption of STH 
in both treatment groups in the rescue experiment with pre-test injections is likely because of 
the aversive procedure of IP injections immediately prior to behavioural testing. Aversive stimuli 
can cause sensitization and fear-potentiation of startle that  could override the habituation 
process (Groves and Thompson, 1970). The fact that STH was normal in both groups in the post-
test injection rescue experiment supports this conclusion.  
Galantamine injections did not enhance baseline startle responses. Although it prolongs 
the effect of ACh, it might not affect the initial startle response amplitude, but rather the 
duration. Most importantly, pre-test galantamine injections seem to restore LTH in VAChT KDHOM 
mice, although the ANOVA failed to show a clear significance with p values just slightly above 
0.05. A paired t-test confirmed a significant difference in startle amplitudes between 
galantamine- and saline-injected VAChT KDHOM mice for days 3 and 5. The rescue experiment was 
difficult to perform, as the injection procedure itself leads to sensitization, which opposed 
habituation in the following startle test (compare STH and LTH in figures 4 and 5), and decreasing 
the differences between WT and VAChTKDHOM mice in terms of habituation. Disruptions in LTH 
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could be rescued only by pre-test injections of galantamine, when galantamine was present 
during acquisition and expression of LTH. Unfortunately, unlike in many other learning 
paradigms, acquisition and expression of learning are difficult to separate in LTH experiments. 
Galantamine did not restore LTH when present during the consolidation phase only (post-test 
injections).  
Little is known about mechanisms underlying LTH of startle. Long-term habituation can 
be disrupted by lesions of the cerebellar vermis (Leaton and Supple, 1986, 1991). Thus it is an 
extrinsic modulation of startle that employs cellular substrates different from the ones that 
mediate startle and STH. There is evidence for a cholinergic innervation of the cerebellum 
(Jaarsma et al., 1997), but its connection to the vermis or to LTH is unclear. Although the 
cerebellar vermis is important for LTH, the cholinergic PPT projections to the PnC might be a 
downstream effector mediating the inhibition of startle during LTH. An increase of the cholinergic 
tone in this projection could mediate LTH. Interestingly, the first injection of galantamine seemed 
to induce maximum LTH, as opposed to the gradual startle decline during normal LTH. This would 
be expected if galantamine strongly enhanced cholinergic activity as opposed to a gradual 
increase in cholinergic tone during LTH. A tonic cholinergic function would also be more 
vulnerable to reduced cholinergic neurotransmission in VAChT KDHOM mice, as opposed to a 
transient cholinergic activation during PPI. 
 Interestingly, the lack of LTH to startle stimuli in VAChTKDHOM mice is paralleled by a lack 
of habituation to a juvenile intruder in these mice (Prado et al., 2006). Moreover, mutant mice 
showed a deficit in object recognition, which could also be explained by a lack of habituation to 
the recently explored object. It will be crucial to gain more information about the respective 
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underlying circuitry and mechanisms in order to elucidate in what way these disruptions are 
connected to each other. Future studies should seek to include comparisons of reflexive 
behaviour, like startle, versus non reflexive behaviours like locomotion and exploratory 
behaviour.  
In conclusion, although PPI and STH were not impaired, the unexpected disruption of LTH 
in VAChT KDHOM mice gives us valuable insights into both cognitive functions of cholinergic 
neurotransmission and mechanisms underlying LTH of startle. Future experiments may want to 
address whether the LTH deficit is specifically mediated by the cholinergic dysfunction in the 
midbrain (i.e. PPT) or by higher brain areas modulated by the basal forebrain cholinergic cell 
groups, using brain region selective regional knockouts for VAChT. 
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2.6 Link between Chapter 2 and Chapter 3 
 
To re-define the role of ACh in sensory filtering and sensorimotor gating of the ASR, we 
used a transgenic mouse model with a 65% reduction in VAChT (which loads ACh into secretory 
vesicles). In these mice secretory vesicles are not re-filled efficiently and therefore the 
sustained release of ACh is reduced. Using these mice, we were able to discover the important 
and novel role of ACh in the mediation of long-term habituation which previous studies were 
unable to determine, mainly due to the methodological considerations. The transgenic mice 
had normal PPI, which was surprising given the litany of pharmacological studies linking ACh to 
PPI. Therefore, we suggested that transient release may be relatively intact in this transgenic 
mouse model, and that this type of cholinergic transmission is critical for PPI; whereas 
prolonged release mediates LTH. 
Our next step was to uncover what cholinergic receptor is involved in the mediation of 
LTH and PPI. As our observed LTH deficit was rescued by galanthamine, a cholinergic agonist 
and positive allosteric modulator of nicotinic receptors, we specifically chose to investigate the 
role of the α7-nAChR. This receptor has also been linked to gating deficits in schizophrenic 
populations, is abundant within several areas of the sensory filtering and sensorimotor gating 
pathways, and has been strongly implicated in learning and memory.  
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3. Chapter 3 
 
 
 
Sensorimotor Gating and Spatial Learning in α7-Nicotinic Receptor Knockout 
Mice 
 
 
 
 
 
 
 
 
 
 
 
 
Sections 3.1-3.5 were published previously, see: Azzopardi, E., Typlt, M., Jenkins, B. & Schmid, S. 
(2013). Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. Genes, 
Brain and Behavior, 12: 414–423.  
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3.1 Introduction 
Sensorimotor gating refers to the ability of the brain to implicitly filter unnecessary 
sensory information, preserving its limited neuronal capacity for the processing of salient 
information. Prepulse inhibition (PPI) and habituation of the acoustic startle response represent 
two different behavioural measures of sensory filtering (Braff et al., 1978). Prepulse inhibition 
(PPI) occurs when the presentation of a sensory stimulus (prepulse) reduces the behavioural 
response to a strong startling stimulus (pulse). Theoretical expositions suggest that the 
processing of the prepulse actively inhibits the processing of the pulse, resulting in decreased 
responsiveness (for review see Koch et al., 1999). The startle response can also be used to assess 
habituation of a reflexive behaviour. Habituation is defined as the progressive decrease in 
response amplitude following repeated exposure to the stimulus. There are two forms of 
habituation: short-term and long-term, which refer to the attenuation of responding within a 
testing session or across multiple testing sessions, respectively. 
 Nicotine is well known to enhance PPI (Acri, 1994; Acri et al., 1994; Faraday et al., 1999; 
Ingram et al., 2005), but the responsible nicotinic receptor subtype is unknown. Pharmacological 
studies have suggested a role of α7-nicotinic acetylcholine receptors (nAChRs). Positive 
modulation of α7-nAChRs improves auditory gating in the DBA/2 mouse model of Schizophrenia 
(Simosky et al., 2001), and rescues apomorphine and MK801-induced PPI deficits in rats (Dunlop 
et al., 2009; Wallace et al., 2011). Surprisingly, previous studies using α7-nAChR knockout (KO) 
mice have shown that these mice have normal PPI (Paylor et al., 1998; Young et al., 2011). This 
discrepancy with drug studies may be due in part to methodological considerations, as another 
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study observed a deficit in auditory P50 gating in heterozygous α7-nAChR KO mice (Adams et al., 
2008).  
In terms of habituation, a study by Williams et al. (1975) has shown that habituation of 
reflexive behaviours, like startle, is mediated by separate mechanisms to those of habituation of 
motivated behaviours, such as exploratory behaviour and spontaneous locomotion. 
Pharmacological studies have suggested that acetylcholine (ACh) is very important for short- and 
long- term habituation of locomotion (Ikegami, 1994; Thiel et al., 1998; Giovannini et al., 2001). 
In particular, it has been shown that nicotinic receptors in the Nucleus Accumbens play an 
important role in early consolidation phases of long-term habituation of locomotion (Schildein et 
al., 2002). In contrast, reflexive behaviours historically have been suggested to be independent 
of ACh (Brown, 1976; Hughes, 1984). Indeed, there is no evidence to suggest that nicotinic 
receptors are involved in short-term habituation of startle (Brown, 1976; Hughes, 1984; Paylor 
et al., 1998). However, a recent study by Schmid et al. (2011) linked ACh to long-term habituation 
of startle, as mice with a general knock-down of the Vesicular Acetylcholine Transporter show 
clear long-term habituation deficits. 
In this study, we therefore sought to evaluate the sensory filtering capacities of α7-nAChR 
KO mice using PPI, short- and long-term habituation of both startle and locomotion. We also 
treated animals with nicotine prior to testing in order to determine whether the enhancement 
of PPI is dependent on α7-nAChRs. Finally, we performed a spatial learning task in order to test 
whether sensorimotor gating deficits correlate with impairments in higher cognitive function. 
Recently, Singer et al. (2013) have demonstrated that in CB57BL/6 mice, PPI correlated with 
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working memory performance in the Morris water maze. We sought to reaffirm and expand on 
this correlation using the Barnes maze, which also emphasizes spatial learning and memory. 
3.2 Methods 
The order of testing was as follows: startle testing, locomotor box, Barnes maze and 
elevated plus maze for all animals. 
3.2.1 Subjects 
We used a commercially available mutant mouse line (B6.129S7Chrna7, stock no. 003232; 
Jackson Laboratories, Bar Harbour, ME, USA) that has a null mutation in the Chrna7tm1Bay gene, 
which encodes the α7-nAChR protein. The KO was produced by a deletion of the last three exons 
(8–10) of the Chrna7 gene. The strain originated on a mixed129/SvEv and C57BL/6 background 
and has been backcrossed to the C57BL/6J line for at least eight (N8) generations. Control mice 
were age-matched wild-type (WT) C57BL/6J counterparts. Animals were cared for according to 
the ethical guidelines of the University of Western Ontario Animal Use Subcommittee and 
Canadian Council on Animal Care (CCAC). Mice were group housed, with a 12-h light–dark cycle 
with ad libitum food and water. Testing occurred at age 6–14 weeks during the light phase. For 
most tests, 18 male KO and WT mice (C57BL/6J from Jackson Laboratories) were used. Long-term 
habituation of startle and locomotor testing were tested with a separate batch of mice of both 
sexes (WT: n=21, 16 males/5 females; KO: n=14, 9 males/5 females). 
3.2.2 Testing of the Acoustic Startle Response 
All startle testing was completed using Med Associates sound-proofed startle boxes and 
associated software (Startle Reflex Version 5.95, St Albans, VT, USA). Figure 3.1 shows a 
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schematic representation of behavioural protocol. Animals were acclimated to the startle box for 
5 min/day for 3 days with background noise (65 dB SPL, white noise). All testing sessions began 
with an acclimation phase (5 min, 65 dB SPL, white noise). On the final day of acclimation, animals 
also underwent an input/output (I/O) test to determine an appropriate gain setting for each 
individual animal (figure 3.2). An I/O function began with stimulation at 65 dB SPL (20-ms 
duration) and increased in 5 dB SPL steps to 120 dB SPL (for details see Schmid et al., 2011; 
Valsamis and Schmid, 2011). Once the gain was set it was kept constant throughout the 
remainder of the experiment. 
 For the next 5 days, the animals were tested once daily with the following behavioural 
protocol. Mice of each genotype (n=18/group, male) underwent PPI and short-term habituation 
testing. The protocol consisted of two blocks of trials (figure 3.1). Block I assessed habituation by 
presenting 33 trials of the startle pulse (20 ms white noise at 105 dB SPL and 15 s inter-trial 
interval, ITI). Block II assessed PPI. There were five different trial conditions (10/condition) for a 
total of 50 trials. All trials were presented in a pseudo-randomized order. The trial conditions 
were as follows: startle pulse alone trials (to determine baseline) and combinations of commonly 
accepted prepulses (75 or 85 dB SPL; 4 ms) at two different interstimulus intervals (ISIs; 30 or 100 
ms). Separate animals were used for long-term habituation experiments (WT: n=21, 16 males/5 
females; KO: n=14, 9 males/5 females). To examine long-term habituation, we employed the 
same acclimation schedule, but removed block II to prevent over presentation of startle stimuli, 
which can induce sensitization (Plappert et al., 1999). 
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Figure 3.1 Testing of the Acoustic Startle Response 
As shown in the graph, animals underwent 3 days of acclimation to startle boxes and background 
noise and an I/O function was measured on the third day. Next, they completed five subsequent 
testing days, where they were exposed to a 5-min acclimation period, a first block with 33 startle 
stimuli alone for measuring short-term habituation, and a second block with 50 trials, 10 trials 
each of startle stimuli alone, and any combination of 75 or 85 dB SPL prepulses, administered 30 
or 100 ms before the startle pulse. Asterisks indicate the first three startle responses and squares 
indicate the last three responses in block I that were used to calculate the amount of short-term 
habituation in each animal. The dots indicate the first three startle responses on day 5 that were 
used along with the first three responses on day 1 (asterisks) to calculate the amount of long-
term habituation. Please note that block II was omitted for testing long-term habituation as 
displayed in figure 3.5b,d, and a shortened program was used for testing the effects of nicotine 
injections (see section 3.2.2.1).  
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3.2.2.1 Nicotine Administration and Acoustic Startle Testing 
To test the effect of nicotine on PPI, we used a shorter protocol to account for the drug’s 
short half-life in mice blood plasma. Block I was reduced to 3 trials and block II to 30 trials (three 
different trial conditions, 10 trials per condition): startle pulse alone and 75 or 85 dB SPL prepulse 
(both with 30 ms ISI). Both WT (n=20, male) and KO (n=18, male) mice were given a single 
subcutaneous injection of either nicotine (1 mg/kg free base nicotine, nicotine hydrogen tartrate 
salt, Sigma Chemical Co., St. Louis, MO, USA, dissolved in phosphate-buffered saline, 0.9% NaCl) 
or saline immediately before behavioural testing. Each mouse was administered both treatments 
on separate days. We allotted a 2-day recovery period between treatments and the order of 
nicotine/saline administration was randomized and counterbalanced across genotypes. 
3.2.2.2 Data and Statistical Analysis of Sensory Filtering and Sensorimotor Gating of the ASR 
Startle magnitude was calculated as the maximal displacement of the movement-
sensitive platform induced by the startle reflex following the startle pulse (arbitrary units). To 
detect differences in baseline startle between genotypes, we examined the I/O function, where 
all animals had the same gain factor, as well as initial startle values (average of the first three 
trials) on day 1 of testing for the group tested on long-term habituation. We used a two-way 
repeated measure analysis of variance (ANOVA) (genotype × sound level) for the I/O function and 
an unpaired Student’s t-test for the latter group.  
To analyse short-term habituation of startle, we calculated short-term habituation ratios 
(average of trials 28–30/average of first 3 trials; see figure 3.1, stimuli marked with squares and 
asterisks, respectively), and compared them using an unpaired Student’s t test. To analyse long-
term habituation, we normalized all data points to the average of the first three trials on day 1 
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for each individual mouse. We then used a three-way repeated measures ANOVA (day × 
genotype × sex) and post hoc unpaired Student’s t -tests. We also calculated a long-term 
habituation ratio (average of first five trials on day 5/average of first five trials on day 1; 
corresponding to stimuli marked with asterisks and dots in figure 3.1), and compared ratios 
between genotypes using an unpaired Student’s t-test.  
The PPI was expressed as percent of prepulse inhibition (%PPI=[1−{startle magnitude with 
prepulse/baseline startle without prepulse}×100). We determined the average %PPI for each 
prepulse type and performed two-way ANOVA (trial type × genotype). We also calculated 
averages for each trial type per day and performed a two-way repeated measures ANOVA 
(genotype × day) in order to determine if PPI changed across days. When nicotine was 
administered, we performed a three-way repeated measures ANOVA (drug × genotype × 
prepulse) to determine changes in %PPI with drug treatment.  Additionally, we subtracted PPI 
with nicotine administration from PPI with saline (%PPI nicotine−%PPI saline) for each animal, 
and used a one sample t-test to determine if the difference significantly differed from zero. To 
determine the effect of nicotine on baseline, we again subtracted baseline startle with saline 
treatment from baseline with nicotine and compared between genotypes with an unpaired t -
test. 
3.2.3 Locomotor Testing 
We used locomotor behaviour to assess habituation of non-reflexive behaviours. To 
examine short-term habituation of locomotor behaviour mice (WT: n=6 males, KO: n=12 males) 
were placed in a locomotor box (Versamax, Columbia, OH, USA) to freely explore for 2h. Distance, 
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rearing, rest time and time spent in each quadrant of the box were measured. Data values were 
totalled and parsed into 5-min blocks, and a two-way repeated measures ANOVA (blocks of time 
× genotype) was performed to assess short-term habituation of locomotion. 
 Long-term habituation of locomotor behaviour was tested in separate mice (WT: n=15, 
10 males/5 females; KO: n=13, 8 males/5 females), once daily for 15 min for 5 consecutive days. 
The values of the first 5-min block were analysed using a three-way repeated measures ANOVA 
(day × genotype × sex). Short-term habituation data were analysed in raw values, but for long-
term habituation data was also normalized (activity/activity of first 5 min on day 1). This was for 
graphical representation and to reduce individual variability in locomotor behaviour as suggested 
by Thiel et al. (1998). 
3.2.4 The Barnes Maze 
The Barnes maze is designed to test spatial learning and memory in rodents. The protocol 
used for this test has been previously described by Sunyer et al. (2007). Mice (n=10/genotype, 
male) completed four trials per day on days 1–4 to ensure acquisition of the task. Trials were 
considered completed when a mouse entered the target hole, or when 3 min had passed. The 
inter-trial interval between testing was on average 20 min. On days 5 and 12 of testing, the 
animals completed probe trials to assess short- and long-term spatial memory, with the target 
hole covered to prevent entrance. Mice were given a single 90-second trial to freely explore the 
apparatus on probe days.  
For all days, holes investigated by mice were tracked by ANY-Maze software (Version 4.82, 
Stoelting, Wood Dale, IL, USA). Investigation was defined as when a mouse hovered over a hole 
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with their nose (i.e. nose poke). The distance, latency to approach and enter target, as well as 
errors was tracked. In addition, on probe trial days, we measured the location of errors (based 
on distance to target). We defined two types of errors: a primary error was defined as any time 
the mouse investigated a hole that was not the target, and a secondary error was defined as the 
first instance a mouse investigated a non-target hole after investigating the target hole. Total 
errors were the sum of primary and secondary errors. 
3.2.4.1 Data and Statistical Analysis of the Barnes Maze  
 Performance on days 1–4 showed how well the animals were able to learn the task. The 
values for each of the measures (distance, latency, or errors) examined were averaged over all 
four trials/day, in order to give us average performance for each day.  Each measure was analysed 
using a two-way repeated measures ANOVA (day × genotype). For performance on day 1 only, a 
separate analysis was completed where latency to approach target was analysed by trial using a 
two-way repeated measures ANOVA (genotype × trial). This aimed to assess working memory 
performance, based on improvement across trials. Analysis of only day 1 was appropriate for this 
measure, to remove memory of the task as a potential confound. Performance on days 5 and 12 
showed how well animals were able to recall the task in their short- or long-term spatial memory, 
respectively. To analyse this, separate two-way repeated measures ANOVAs were performed 
(hole × genotype). 
3.2.5 Elevated Plus Maze 
Both WT (n=14, male) and KO (n=14, male) mice were placed in the centre of the elevated 
plus maze. The apparatus contained four arms: two covered and two uncovered. Animals had 5 
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min to freely explore the maze. The number of entries, latency to enter and time spent in closed 
and open arms were digitally recorded by ANYMaze software (Version 4.82, Stoelting). Unpaired 
Student’s t-tests were then used to determine differences between genotypes. 
3.3 Results 
3.3.1 α7-nACHR KO Mice Have Normal Startle Reactivity  
Critical to our study was the ability of α7-nAChR KO mice to startle normally. We found 
that startle I/O functions did not differ between genotypes (F(11,,403)=3.0, p=0.1; n=18/genotype: 
figure 3.2). Furthermore, baseline startle in block I (average of first three trials on day 1) and in 
block II (pulse-alone trials) did not differ between the genotypes (t34=1.5, p=0.14; t34=0.52, p=0.6, 
respectively). 
 
  
 
 
  85 
 
 
 
 
 
Figure 3.2 α7-nAChR KO Mice Have Normal Startle Reactivity 
Representative I/O functions of startle response amplitudes for different startle stimulus 
intensities. Both genotypes display natural variability of startle magnitudes with very high and 
very low startling animals within each group. Based on startle amplitude (low, intermediate or 
high), a gain was prescribed as indicated in the figure (see also Methods). This allowed for 
accurate signal detection and prevented floor effects in low startling mice. The I/O function of (a) 
WT and (b) KO did not differ statistically. The solid black line indicates the average across all 
animals of the group (n=18/genotype, all male. Not all mice shown here for clarity). 
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3.3.2 Prepulse Inhibition is Mildly Impaired in α7-nAChR KO Mice 
Eighteen male WT and KO animals underwent PPI testing. We observed a mild, but 
consistent impairment of PPI in α7-nAChR KO mice. In WT mice, when a 75 dB SPL prepulse 
preceded the startle pulse, startle was reduced by about 52.1% and 52.2% at the ISIs of 30 and 
100 ms, respectively; whereas in KOs startle was only reduced by 38.5% and 37.2%, respectively. 
Therefore, PPI was significantly reduced in KO mice compared to WT (F(1,34)=6.87, p=0.02, figure 
3.3a) with a 75 dB SPL prepulse regardless of ISI. In all groups, PPI was stable across days of testing 
as there was no main effect of day at either ISI (30 ms ISI F(4,175)=0.27, p=0.9; 100 ms F(4,175)=1.0, 
p=0.4) or interaction between day and genotype (30 ms F(4,700)=0.87, p=0.59; 100 ms F(4,700)=0.27, 
p=0.9).  
When a higher prepulse level of 85 dB SPL was used we did not observe any PPI 
differences between genotypes. In WT animals, startle was suppressed by 49% and 62.3% at 30 
and 100 ms ISIs, respectively, and in KO mice by 44% and 53.8%, respectively. While there is still 
a trend of impaired PPI in KO, this failed to reach statistical significance (F(1,34)=1.5, p=0.32, figure 
3.3b). There was also no main effect of day (30 ms F(4,175)=2.2, p=0.08; 100 ms F(4,175)=0.48, p=0.8) 
or day by genotype interaction (30 ms F(4,700)=1.9, p=0.11; 100 ms F(4,700)=0.38, p>0.82). 
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Figure 3.3 α7-nAChR KO Mice Have a Mild Impairment of PPI 
 (a) α7-nAChR KO mice were unable to suppress startle as effectively as WT across ISIs using a 75 
dB SPL prepulse. (b) When an 85 dB SPL prepulse was used, α7-nAChR KO mice displayed the 
same ability as WT type to suppress startle across ISIs (n =18/genotype, male). 
 
3.3.3 The α7-nAChR is Critical for Nicotine-Induced Enhancement of PPI 
Many previous studies have shown that acute, systemic nicotine improved PPI; we 
wanted to investigate the role of the α7-nAChR in this enhancement. We injected WT (n =20, 
male) and α7-nAChR KO mice (n =18, male) with saline and nicotine (1 mg/kg, figure 3.4) before 
PPI testing with both prepulse intensities and an ISI of 30 ms. We performed a three-way ANOVA 
(drug × genotype × prepulse) and confirmed an impairment of PPI in KO mice at both prepulse 
intensities (F(1,36)=5.5, p=0.025). The ANOVA did not detect a main effect of nicotine treatment 
(F(1,36)=0.6, p=0.43) or interaction between genotype, drug, and prepulse (F(1,36)=1.1, p=0.3). 
However, we did see that the drug tended to act differently according to the prepulse level, but 
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the drug by prepulse interaction just failed to reach significance (F(1,36)=4.05, p=0.052). Generally, 
at the 75 dB SPL prepulse, we saw no effect of nicotine; PPI of WT mice was 45.2% with saline 
and 47% with nicotine administration. A similar trend was observed in the KO mice. When KO 
mice were administered saline, PPI was 34.6%, and when given nicotine it was 35.3% (figure 
3.4a). At the higher prepulse of 85 dB SPL however, nicotine seemed to improve PPI in WT mice. 
When WT mice were administered saline, PPI was 43.6%, and when given nicotine it increased 
to 55.6%, whereas in the KO mice PPI was similar in both conditions: PPI with saline was 27.6% 
and with nicotine it was 30%. When we looked at the individually normalized changes in PPI, we 
found a significant improvement of PPI in WT (t17=2.43, p=0.03), but not in KO animals (t17=0.34, 
p=0.73, figure 3.4b). Two WT mice were eliminated from this analysis as outliers (±3 standard 
deviations from mean).  
Nicotine also enhanced baseline startle amplitudes compared with saline treatment in 
WT animals (t17=2.4, p=0.03), but not in KO mice (t17=0.43, p=0.67). Once again, however, this 
effect was strongest when the data was analysed for individual changes in each mouse between 
saline and nicotine conditions. The WT mice showed an increased baseline startle when given 
nicotine, whereas KO mice showed no changes (mean change around 0, figure 4.4c). Changes in 
baseline startle were significantly different between genotypes (t34=2.05, p=0.048). 
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Figure 3.4 Nicotine-Induced Enhancement of PPI and Startle Magnitude is Absent in α7-
nAChR KO Mice 
(a) We reconfirmed that KO mice have impaired PPI compared with WT in both drug conditions 
and prepulses. Nicotine tends to enhance PPI at the 85 dB SPL prepulse in WT mice. We do not 
see enhancement at lower prepulse levels as PPI is generally weaker and more variable with a 75 
dB SPL prepulse. (b) There was a significant effect of nicotine at 85 dB SPL prepulse on changes 
of PPI in WT, but not in KO mice. The asterisk denotes that the change in PPI (PPI nicotine−PPI 
saline) between drug conditions is significantly different from zero in WT but not KO mice. (c) The 
change in baseline (BL) startle amplitude between treatment conditions (nicotine baseline−saline 
baseline) is displayed for both genotypes. Nicotine enhanced baseline startle in WT animals, but 
not in α7-nAChR KO mice (n =18/genotype, male). 
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3.3.4 The Habituation of Reflexive and Non-Reflexive Behaviours is Unaltered in α7-nAChR KO 
Mice 
We examined short- and long-term habituation of the startle response in male WT and 
α7-nAChR KO mice over 5 days of testing. Wild-type mice (n=18, male) show a progressive 
decrease in startle amplitude within a testing session, on average they reduced responding by 
about 27% by the end of block I (short-term habituation ratio=0.73). In KO mice (n=18, male) 
responses also decreased by about 23% (short-term habituation ratio=0.77). 
The short-term habituation ratios between genotypes did not differ (t34=1.7, p=0.1, figure 
3.5a,b). We used a separate batch of animals to examine long-term habituation of startle with a 
shortened behavioural program in order to avoid overexposure. In WT mice (n=21, 16 males/5 
females) average startle response decreased to 92%, and in KO mice (n=14, 9 males/5 females) 
to 91% within 5 days. These long-term habituation ratios did not significantly differ (F(1,31)=1.6, 
p=0.22), neither was there any interaction between sex and genotype (F(1,31)=0.6, p=0.46). When 
startle was normalized to day 1 of testing, the ANOVA revealed that startle significantly changed 
across days (F(4,31)=21, p<0.001). There was no effect of sex (F(1,31)=0.16, p=0.67) or genotype 
(F(1,31)=0.01, p=0.79), or sex by genotype by day interaction (F(4,28)=0.4, p=0.57; figure 3.5b).  
Habituation of reflexive behaviours like the startle response is mediated by mechanisms 
distinct from habituation of non-reflexive, or motivated, behaviours like locomotion (that reflects 
exploratory behaviour). Therefore, we also examined short-term habituation of locomotion in 
WT (n=9, male) and α7-nAChR KO (n =12, male) mice. There was a significant decrease of distance 
travelled within the 2 h test session (F(23,529)=9.9, p<0.001) with no effect of genotype (F(1,23)=0.3, 
p=0.87) or interaction between genotype and time (F(23,529)=1.26, p=0.2, figure 3.5c). Rearing 
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activity also significantly decreased within a test session (F(23,506)=4.6, p<0.001), with no 
significant time by genotype interaction (F(23,506)=1.0, p=0.49). For rearing analysis, one KO animal 
was eliminated as it never reared. Rest time tended to increase across time, but this failed to 
reach significance (F(23,529)=1.3, p=0.14), with no interaction between time and genotype 
(F(23,529)=1.2, p=0.22).  
While the above data suggests that α7-nAChR KO mice have normal short-term 
habituation of locomotor behaviour, we did observe one difference between genotypes: KO mice 
spent significantly less time in the centre of the open field throughout testing compared with WT 
(t23=1.82, p=0.04). They also tend to travel less in the centre, although this failed to reach 
significance (t23=1.67, p=0.11).  
To examine long-term habituation of locomotor behaviour, we used separate mice (WT: 
n=16, 9 males/5 females; KO: n=13, 8 males/5 females) and tested them in the locomotor box 
across 5days. We found that there was no difference in activity between genotypes (F(1,25)=2.7, 
p=0.11) or sex (F(1,25)=0.5, p=0.51). With normalized data (to day 1 of each animal) we found that 
the distance travelled significantly decreased across days (F(4,100)=5.3, p=0.017), with no main 
effect of genotype (F(1,25)=3.25, p>0.05), sex (F(1,25)=0.8, p=0.37) or interaction of day, sex , and 
genotype (F(4,100)=0.7, p=0.41). This shows that both genotypes had normal long-term habituation 
of locomotor behaviour, see figure 3.5d. 
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Figure 3.5 Habituation of Startle and Locomotion is Unaltered in α7-nAChR KO Mice 
(a) Short-term habituation ratios for the startle response did not differ between genotypes. (b) 
Short- and long-term habituation of startle at days 1 and 5. In both genotypes startle amplitudes 
progressively decrease within a testing session and across testing sessions to a comparable 
degree. (c) Both genotypes show significant short-term habituation of locomotor behaviour, with 
activity greatly attenuated by the end of testing. (d) Both WT and KO mice decreased locomotor 
activity across days, displaying normal long-term habituation of locomotion (WT n=21, 16 
males/5 females; KO n=14, 9 males/5 females). Overall, this suggests that the α7-nAChR was not 
critical for these behaviours. 
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3.3.5 α7-nAChR KO Mice Have No Impairments of Spatial Learning and Memory 
To date, discrepancies exist whether α7-nAChR KO mice have normal or impaired spatial 
learning and memory, and spatial memory performance has been linked to PPI performance 
(Singer et al., 2013). Therefore, we tested male WT and α7-nAChR KO mice in the Barnes maze 
(n=10/genotype, male) in order to reassess spatial learning. 
When we analysed the latency to approach target, we observed a main effect of day, 
which suggested that learning occurred across days (F(5,114)=18.9, p<0.001). We found no main 
effect of genotype (F(1,114)=0.1, p=0.78) or interaction between day and genotype (F(5,570)=0.4, 
p=0.86), which indicates that both genotypes performed similarly (figure 3.6a). Furthermore, we 
observed normal activity levels as both genotypes travelled the same distance across days 
(F(5,114)=2.6, p=0.14). While there was no difference in the number of primary errors made by 
genotypes (F(5,114)=4.4, p=0.07), KO mice tended to make significantly less total and secondary 
errors (F(5,114)=5.1, p=0.036; F(5,114)=17.6, p=0.015, respectively). Consequently, they also took 
significantly less time to enter the target (as opposed to approach it) than WT mice (F(3,76)=10.2, 
p=0.005), despite both genotypes improvement across days of testing (F(3,76)=5.1, p=0.003). 
Additionally, as Singer et al. (2013) found the strongest correlation between PPI and spatial 
working memory; we also examined improvements on day 1 across trials. Both genotypes 
considerably improved across trials (F(3,54)=6.53, p=0.001) with no difference between genotypes 
(F(1,18)=0.09, p=0.78, figure 3.6b).  
We found a significant preference for the target hole on days 5 (F(19,380)=39, p<0.001) and 
12 (F(19,380)=23.3, p<0.001) with no main effect of genotype (F(1,18)=0.01, p=0.93; F(1,18)=1.1, 
p=0.32, days 5 and 12, respectively, figure 3.6c,d). Furthermore, latency to approach the target 
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did not differ between genotypes on days 5 or 12 as there was no effect of day (F(1,18)=0.18, 
p=0.68),genotype (F(1,18)=0.12, p=0.73) or interaction between day and genotype (F(1,18)=0.14, 
p=0.71), which shows that α7-nAChR KO mice have normal retention of spatial tasks. 
 
 
Figure 3.6 α7-nAChR KO Mice Have Normal Spatial Learning and Memory 
 (a) α7-nAChR mice show normal acquisition of a spatial task, as both genotypes significantly 
improved performance on training days 1–4. Unchanged performance on days 5 and 12 suggests 
that both genotypes accurately remembered the task. (b) The analysis of spatial working memory 
during the first training sessions within day 1. Both genotypes show similar times to approach 
the target on day 1. (c) Number of nose pokes on the different holes on the maze. Both WT and 
α7-nAChR KO mice show a preference for the target holes on day 5 and (d) day 12, suggesting 
that α7-nAChR KO mice have normal short- and long-term spatial memory (n=10/genotype, 
male). 
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3.3.6 Elevated Plus Maze Testing in α7-nAChR KO Mice 
The fact that α7-nAChR KO mice spent less time in the centre of the locomotor box and 
seem to have an increased drive to enter the target drop box in the Barnes maze may be 
indicative of an increased level of anxiety in these mice. Therefore, we decided to directly assess 
anxiety using the elevated plus maze (n=14/genotype, all male). We found that total distance 
travelled (WT=17.0 ± 0.8 m, KO=16.5 ± 1 .0 m; t26=0.3, p=0.76), latency to enter the open arm 
(WT=4.5 ± 1.9 s, KO=4.9 ± 2.6 s; t24=0.3, p=0.87) and number of entries into closed (WT=28.0 ± 
1.3, KO=27.4 ± 2.1; t26=0.25, p=0.80) or open arms (WT=16.1 ± 1.2, KO=15.4 ± 1.1; t26=0.5, p=0.63) 
did not differ between genotypes. However, we did find that KO animals spent more time in 
closed vs. open arms compared with WT (WT=152 ± 14.9 s, KO=199.1 ± 8.0 s; t24=2.8, p=0.001), 
which suggests that they are more anxious than their WT littermates. 
3.4 Discussion 
The aim of this study was to understand the role of α7nAChR in sensory filtering and 
sensorimotor gating mechanisms and how they relate to higher cognition. 
3.4.1 Prepulse Inhibition 
 We observed that α7-nAChR KO mice had a mild, but consistent and significant 
impairment of PPI. The KO mice consistently show reduced PPI at the 75 dB SPL prepulse, 
regardless of ISI. At the higher prepulse level of 85 dB SPL, PPI differences failed to reach 
significance in one of two groups. Generally, PPI is more robust at higher prepulse levels, and so 
we suggest that this impairment is mild and therefore most apparent when PPI is not at its 
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maximum. As pharmacological data suggest that α7-nAChR plays a very important role in PPI, our 
observation of a mild deficit may in part be due to compensation by other nicotinic receptors in 
our KO model. Supportive of this idea, Adams et al. (2008) observed P50 auditory gating deficits 
only in heterozygous KO mice.  
Our observed PPI deficit does not match with the results of previous α7-nAChR KO mice 
studies. Both Paylor et al. (1998) and Young et al. (2011) observed normal PPI in KO mice. Both 
studies also used a α7-nAChR subunit null mutation, generated in a mixed 129/SvEv C57BL/6J 
line that were backcrossed onto the C57BL/6J strain for at least six generations. As our line 
(purchased from Jackson Laboratories) matches this background, genetic differences are unlikely 
to account for our observed results. The explanation for the discrepancy might lie in the 
differences between experimental protocols. Prepulse levels and ISIs were the same in all studies; 
however, both Paylor et al. (1998) and Young et al. (2011) used male and female mice, and found 
a main effect of sex on PPI and baseline startle. This might have increased the variability of their 
data and thereby occluded a mild PPI deficit. Reduced variability by only using male mice makes 
our experiment more apt to detect this deficit in PPI.  
Additionally, in past studies, animals may not have been sufficiently habituated to the 
startle stimulus prior to PPI testing. Without sufficient prior exposure to startle stimuli alone, 
short-term habituation interferes with PPI measurements, especially with the first trials, thereby 
further increasing the variability. Finally, Young et al. (2011) did not normalize PPI measurements 
for each mouse, which greatly increases the inherent variability between mice (see figure 3.2). In 
fact, they show a higher average baseline startle magnitude in KO mice compared with WT, but 
the same startle response magnitude when a prepulse is present, which may have reflected a 
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disruption of PPI in KO mice had normalized PPI been calculated for each animal. Additionally, 
studies have shown that differences in baseline startle also influence PPI, particularly when data 
is not normalized (Csomor et al., 2008). 
3.4.2 Nicotine-Induced Enhancement of PPI  
Apart from the fact that α7-nAChRs play a minor role in PPI, we also observed that they 
are critical for nicotine-induced enhancement of startle amplitude and PPI. Although the overall 
ANOVA failed to yield a significant effect of nicotine, we did observe a slight, but significant 
enhancement of PPI with nicotine when %PPI was normalized to reflect changes from the saline 
condition (%PPI nicotine−%PPI saline), which is in accordance with the previous studies (Gould et 
al., 2005). The ANOVA likely failed to reach significance because of the high number of factors 
involved in the analysis and because of a ceiling effect, as WT mice were already performing well 
with saline administration. By reducing variability, via normalizing to the saline condition, this 
effect was strengthened and able to achieve significance.  
Where this nicotine effect is mediated is not fully understood yet. Nicotine may simply 
amplify the contribution of the α7-nAChR to PPI, thereby causing PPI enhancement. Startle-
mediating neurons of the Caudal Pontine Reticular Nucleus (PnC) receive cholinergic input from 
the midbrain that is assumed to mediate PPI (Fendt and Koch, 1999; Bosch and Schmid, 2006, 
2008). Potentially, α7-nAChRs in the PnC could directly modulate baseline startle effects and 
possibly even PPI. Alternatively, many PPI-modulating brain areas are known to express α7-
nAChRs, including the Prefrontal Cortex, Hippocampus, Ventral Tegmental Area and Nucleus 
Accumbens (Gotti et al., 1997; Paterson and Nordberg, 2000). Future studies should seek to 
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understand where this effect is occurring through localized injections of α7-nAChR agonists and 
antagonists.  
Studies estimate that smoking rates in Schizophrenic populations are two to four times 
greater when compared with the normal population (Hughes et al., 1986; Leonard et al., 2000). 
In both healthy and Schizophrenic patients, PPI improved after smoking (Kumari et al., 1997; 
Kumari et al., 2001), which may indicate that Schizophrenics are smoking as a form of self-
medication (Kumari and Postma, 2005). Our study indicates that the α7-nAChRs are at least 
partially mediating aspects of the initial beneficial effects of nicotine. It is important to note, 
however, that we only provide evidence that α7-nAChRs are critical for acute effects of nicotine. 
Chronic nicotine is known to alter nicotinic responses and receptor levels; therefore, the situation 
may be different in smokers. 
3.4.3 Habituation of Reflexive and Non-Reflexive Behaviours 
In accordance with previous literature, we did not find that the α7-nAChR was involved in 
short- or long-term habituation of the startle response. A recent study by Schmid et al. (2011) 
showed that the neurotransmitter acetylcholine was involved in long-term habituation of startle, 
but we did not find any influence of the α7-nAChR on long-term habituation, which suggests that 
the effect is mediated by other cholinergic receptors.  
Furthermore, we did not find any evidence that the α7-nAChR is involved in short- or long-
term habituation of locomotor behaviour. Previous studies suggested that nAChRs were 
important for the consolidation of long-term habituation of locomotion (Schildein et al., 2002). 
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Again, our study indicates that a different nicotinic receptor subtype might be responsible for the 
previously reported effects. 
Overall, we found that the α7-nAChRs are not necessary for habituation of reflexive or 
non-reflexive behaviours, although, as with all constitutive KO mice, compensation by the 
knockout model cannot be ruled out. 
3.4.4 Spatial Learning and Higher Cognition 
We tested whether deficits in sensory filtering and sensorimotor gating correlate with 
deficits in higher cognitive processes, especially in spatial working memory tasks, as previously 
shown (Erwin et al., 1998; Singer et al., 2013). Studies of spatial learning and memory in the α7-
nAChR KO mouse have been inconclusive in the past (Paylor et al., 1998; Curzon et al., 2006; 
Fernandes et al., 2006). In accordance with the findings of Paylor et al. (1998), we found normal 
spatial learning and memory in α7-nAChR KO mice. This was rather surprising as the α7-nAChR is 
known to be highly expressed in the Hippocampus (Freedman et al., 1995; Guan et al., 1999). 
Again, there may be compensation by other nicotinic receptors in our KO model as Curzon et al. 
(2006) found that a deficit in spatial learning existed in an inducible KO model. However, a recent 
study by Winterer et al. (2013) also failed to show improvements in P50 sensory gating in 
schizophrenic patients using an α7-nAChR positive allosteric modulator, which implied that the 
role of α7-nAChR in higher cognition is still unclear.  
We found mildly impaired PPI in α7-nAChR KO mice but normal spatial learning and 
memory, and so did not observe the hypothesized correlation between sensorimotor gating 
deficits and higher cognitive function. The difference between our and Singer et al.’s (2013) 
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findings could be due to task differences as their protocol emphasized spatial working memory. 
We assessed improvement of performance on day 1 to examine working memory, but found no 
differences between genotypes. Conversely, recent data suggests that impaired attention is 
central in the cognitive deficits observed in α7-nAChR KO mice (Young et al., 2007); therefore, 
the observed PPI deficit might correlate better with disruptions in attentional-based tasks. 
3.4.5 Anxiety 
Interestingly, we found that KO mice were significantly faster to enter the target during 
Barnes maze testing, despite no genotype differences in latency to approach target. Accordingly, 
we also observed that KOs were significantly less likely to make secondary errors. During 
locomotor testing KO mice spent less time in the centre of the locomotor box. Accumulating this 
evidence, we suggest that an increased level of anxiety in α7-nAChR KO mice may explain these 
findings. Increased anxiety would make the mice more motivated to enter the target in the 
Barnes maze instead of exploring other holes, as well as stay closer to the walls in the locomotor 
box. In the elevated plus maze test, however, most parameters were similar between genotypes, 
except the time spent in closed vs. open arms. This finding suggests that α7-nAChR KO mice may 
be slightly more anxious. It should be noted that we also ran light/dark box testing on a separate 
batch of animals (data not shown), but increased anxiety could not be reconfirmed.  
Other studies have noted no changes in anxiety compared to wildtype mice (Paylor et al., 
1998; Fernandes et al., 2006); however, one study observed that α7-nAChR mice had longer 
freezing times during conditioning tasks, which correlates with heightened anxiety (Davis and 
Gould, 2007). Additionally, a recent study by Pandya and Yakel (2013) found that in rats, high 
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doses of an α7-nAChR agonist (10mg/kg, PNU-282987) had anxiogenic effects during open field 
testing that could be rescued by serotonin (5-HT1a) antagonism. Clearly, the role of α7-nAChR in 
anxiety needs further elucidation. 
3.4.6 Conclusions 
In summary, we have shown that α7-nAChRs play a (small) role in PPI, and are critical to 
nicotine-induced enhancement of both PPI and startle magnitude. We did not find any evidence 
to suggest that this receptor is involved in habituation of reflexive or non-reflexive behaviours. 
We also found that α7-nAChR KO mice had normal spatial learning and memory, consistent with 
most previous studies, and that they may have had slightly heightened anxiety. Future studies 
will seek to understand the mechanisms underlying the α7-nAChR effects on startle and PPI. 
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3.6 Link between Chapter 3 and 4 
Our last study suggested that the α7-nAChR has a minor role in the mediation of PPI, but 
no role in the LTH of the ASR. Our first study (Chapter 2) also uncovered no major deficits in PPI 
in mice with deficient cholinergic tone. Together, our evidence seems to suggest that perhaps 
ACh is not a major contributor to PPI, in contrast to what has been traditionally assumed. 
However, as both our models used congenital and chronic manipulations of cholinergic activity, 
it is hard to rule out what role compensatory mechanisms may have played. 
Historically the PPT has been hypothesized to provide the cholinergic input necessary 
for PPI. The PPT is a heterogeneous structure, composed of glutamatergic, GABAergic and 
cholinergic neurons. Deficits in PPI have been reliably induced after non cell-type specific 
lesions of the PPT, but this deficit was attributed to the loss of cholinergic cells. As our previous 
chapters have only seen a mild link between PPI and ACh, we wanted to re-evaluate the role of 
the cholinergic neurons in the PPT in PPI. To do so, we used optogenetics and DREADDs, which 
both specifically targeted only cholinergic neurons of the PPT. Furthermore, we were able to 
transiently manipulate the activity of cholinergic PPT neurons, reducing the impact of 
compensation. 
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4. Chapter 4 
 
 
 
Cholinergic Midbrain Neurons Modulate Startle Magnitude, but Not Prepulse 
Inhibition 
 
 
  
 
 
  107 
 
 
4.1 Introduction 
We are constantly bombarded with incoming sensory information from our five senses 
that our brain needs to process. How we process sensory information is critical for our daily 
functioning. Appropriate reduction of sensory information reaching conscious awareness and 
removal of behavioural responding to unnecessary sensory information is therefore highly 
adaptive. An inability to filter inundating sensory information can overwhelm our cognitive 
capabilities. Deficits in sensory filtering and sensorimotor gating occurs in many mental illnesses, 
including schizophrenia, obsessive compulsive disorder, and autism spectrum disorders (Braff 
and Geyer, 1990; Ornitz et al., 1993; Wynn et al., 2004; Hoenig et al., 2005). Examples of sensory 
filtering processes include habituation and prepulse inhibition (PPI), both can be studied in 
humans and pre-clinical animal models using the acoustic startle response (ASR).  
Habituation is defined as the progressive decrease in startle magnitude after repeated 
exposure to the startle-inducing sound. This reduces the cognitive and motor burden of repetitive 
sensory information (Koch, 1999). Habituation can occur within a day (short-term habituation) 
or across days (long-term habituation). Sensitization is the opposite of habituation; it reflects the 
increase in behavioural responding after repeated exposure and is mediated through an 
independent mechanism (Groves and Thompson, 1970).  In any case, it is important to keep in 
mind that an individual’s behavioural output is always the sum of these influences; therefore, 
they cannot be studied independently.  
PPI occurs when the presentation of a sensory stimulus (prepulse) prior to a startle-
inducing sound reduces the magnitude of the startle response compared to when that same 
startling sound is presented alone. This is termed sensorimotor gating and it is thought to protect 
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ongoing neuronal processing from distractive interference by the secondary stimulus (Koch, 
1999). Alternatively, the prepulse is predicted to coordinate approach behaviours by facilitating 
orienting responses such as eye-saccades through activation of neurons in the superior colliculus 
while simultaneously inhibiting startle-mediating neurons in the brainstem. In this way, PPI can 
thought of as a very early form of response selection (Yeomans, 2012).  
The timing between the prepulse and startle pulse, termed the interstimulus interval (ISI) 
can greatly impact the amount PPI (Yeomans et al., 2010). The behavioural opposite of PPI is 
paired pulse facilitation (PPF), where the presentation of a pulse prior to a startling sound 
enhances startle magnitude. PPI generally occurs at ISIs of 20-1000 ms, whereas PPF occurs at 
short (>10 ms) or very long ISIs of more than 1 second (Ison et al., 1973; Graham, 1975; Ison et 
al., 1997). There is evidence to suggest that PPF opposes PPI by an independent mechanism to 
determine behavioural output in a manner similar to habituation and sensitization (Ison et al., 
1973). However this may only be the case at ISIs that border the induction of PPI or PPF (around 
10 ms). 
PPI and habituation both lead to an attentuation of sensory signals, but they are thought 
to be mediated by very different brain mechanisms. Also, habituation of reflexive compared to 
non-reflexive behaviours has been observed to be differentially regulated (Williams et al., 1975; 
Hughes, 1984). Prepulse inhibition of the ASR has been very reliably shown to be impacted by 
manipulations of ACh (Fendt and Koch, 1999; Hohnadel et al., 2007; Yeomans et al., 2010; 
Pinnock et al., 2015); whereas cholinergic manipulations have been shown to differentially 
regulate habituation of reflexive (ASR) versus non-reflexive (locomotor) behaviours (Hughes, 
1984; Thiel et al., 1998; Schildein et al., 2002).  While there appears to be no role of ACh in the 
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short-term habituation of the ASR (Hughes, 1984), recent evidence suggested it may be 
important for long-term habituation of the ASR (Schmid et al., 2011).  Regarding non-reflexive 
habituation, ACh has been linked to both long- (Thiel et al., 1998) and short-term habituation 
(Lamprea et al., 2003). Understanding the source of this cholinergic modulation as well as the 
receptors involved may help uncover more about this differential regulation on habituation.  
It has been a long-standing hypothesis within the field that the pedunculopontine 
tegmental nucleus (PPT) provides cholinergic inhibition onto startle-mediating neurons of the 
brainstem, more specifically the giant neurons of the caudal pontine reticular formation (PnC) 
(Koch et al., 1993; Swerdlow and Geyer, 1993; Fendt and Koch, 1999; Bosch and Schmid, 2006, 
2008). This cholinergic inhibition is the hypothesized mechanism underlying PPI; there has been 
no suggestion that it has any role in the habituation of the ASR or locomotion, but this has been 
largely untested. 
Recent evidence has challenged the cholinergic midbrain hypothesis of PPI. For example, 
a conditional knock-out of cholinergic function in the midbrain (including the PPT, laterodorsal 
tegmental (LDT) and parabigeminal nucleus (PGB)) caused mice to have improved PPI (Machold, 
2013).  Additionally, a study by MacLaren et al. (2014) was the first to selectively lesion the 
cholinergic cells of the PPT and examine sensorimotor gating. Specific lesions of cholinergic PPT 
neurons profoundly reduced startle magnitude, but left PPI intact. Similar to previous studies 
which originally provided the foundation for this hypothesis (Koch et al., 1993; Swerdlow and 
Geyer, 1993), they found that non-specific lesions to the PPT still reliably induced PPI deficits. 
Their observed reduction in startle magnitude was counter-intuitive to the hypothesized 
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inhibitory role of cholinergic neurons and their mediation of PPI, however earlier studies also 
suggested that these neurons may modulate startle magnitude.  
Stimulation of the ventral amygdalofugal pathway and ventral midbrain at sites that 
included (but were not limited to) the PPT have been shown to enhance, or even induce, startle-
like responses (Yeomans and Pollard, 1993). Furthermore, electrical stimulation of PPT neurons 
caused prolonged excitation of PnC neurons in the cat (Garcia-Rill et al., 2001; Homma et al., 
2002), and substance P-induced excitation of giant neurons was augmented by cholinergic 
agonism (Kungel et al., 1994). This is particularly interesting as substance P has been strongly 
linked to sensitization of startle (Krase et al., 1994), and is known to be co-expressed by a subset 
of cholinergic neurons in the PPT which directly innervated the PnC (Kungel et al., 1994).    
Together, these studies suggest that the cholinergic midbrain hypothesis of PPI and 
cholinergic inhibition of startle in general, may need to be re-examined. With the advent of new 
technologies, namely chemogenetic and optogenetic approaches, we aimed to revisit the impact 
of PPT cholinergic projections to the startle pathway with improved cell-type and temporal 
resolution that was previously unachievable. We specifically wanted to test the impact of 
cholinergic PPT activity on PPI and habituation of both the ASR and locomotion.  
4.2 Methods 
This chapter is composed of 3 parts with overlapping but distinct methodology. Firstly, 
we verified the phenotype of our transgenic rat line (discussed below) to ensure it was an 
appropriate model for sensory filtering and sensorimotor gating testing. We then used this line 
to inhibit (section 4.2.3) or activate (section 4.2.4) cholinergic PPT neurons during behavioural 
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tasks. For each experimental approach we completed ASR testing, as well as a positive 
behavioural control task, conditioned place preference. In cholinergic inhibition studies, we also 
examined the habituation of locomotor behaviour. Finally, we completed immunohistochemistry 
and/or electrophysiology as proof of functional neuronal inhibition or activation. 
4.2.1 Subjects 
For this study we used a hemizygous transgenic rat line (Long Evans-Tg(Chat-Cre)5.1Deis, 
RRRC#00658. Rat Resource & Research Center, Columbia, MO, USA). This rat line has a bacterial 
artificial chromosome (BAC, RP23-246B12) randomly inserted into its genome. This BAC contains 
the mouse ChAT gene with a Cre insertion before the ATG of the ChAT promoter. This strain is 
estimated to carry six copies of the transgene (Witten et al., 2011) and was maintained by 
breeding a carrier male with a wild-type (WT) Long Evans female. This model allowed us to 
achieve cell-type specificity by using viral vectors dependent on Cre recombinase for expression 
in order to create either an optogenetic or chemogenetic model of the cholinergic system 
depending on the Cre-dependent viral vector employed.   
Animals were genotyped at age 4-6 weeks via tissue punches taken from the ear and 
performing polymerase chain reaction (PCR).  Procedure and primers are described by Witten et 
al., (2011). Briefly, we used the Extract-N-Amp Tissue PCR Kit (Sigma Aldrich, Oakville, Ont, CAN) 
for Cre detection with the primers Cre-F: AAGAACCTGATGGACATGTTCAGGGATCG and Cre-R: 
CCACCGTCAGTACGTGAGATATCTTTAACC. 
Animals were cared for according to the ethical guidelines of the University of Western 
Ontario Animal Use Subcommittee and Canadian Council on Animal Care (CCAC). For the first 8-
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10 weeks of age, animals were group housed. Following surgery, animals were individually 
housed. Rats were given ad libitum food and water, and maintained on a 12 h light-dark cycle. All 
testing occurred during the light phase.  
4.2.2 Validation of Transgenic Model 
Our first aim was to ensure our transgenic rat model was appropriate for sensory filtering 
and sensorimotor gating testing. For this validation both sexes were used and compared with WT 
littermates as controls (WT n=16, 8 male, 8 female; Cre-ChAT n=16, 7 male, 9 female).  
4.2.2.1 Testing of the Acoustic Startle Response 
Testing of the ASR was completed in an enclosed sound attenuated startle box from MED 
Associates (MED-ASR-PRO1, St Albans, VT, USA). Transgenic and WT animals were placed into 
small transparent tubes (25 cm x 12 cm) mounted on a movement sensitive platform. A 
piezoelectric transducer mounted below the platform converted the vertical displacement of the 
platform induced by a startle response into a voltage signal. Startle amplitude was determined 
using the amplitude of the largest positive and negative peaks of the signal measured in a 300 
ms window after the presentation of the acoustic stimulus. Determination of the amplitude was 
done by MED Associates’ software (Startle Reflex version 6.0, MED Associates, Inc. St Albans, VT, 
USA) 
 For a schematic representation of ASR testing, see figure 4.1. Testing began with 
acclimatization to the startle box for 5 minutes every day, for 3 days. During this acclimation, and 
throughout each test session, there was a 65 dB SPL white-noise background sound. Every testing 
session began with a 5 min acclimation period. On day 3 rats were tested on an input/output 
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(I/O) function which assessed startle reactivity. This test began with the presentation of a 65 dB 
SPL white noise (20 ms) and increased to 120 dB SPL, in 5 dB SPL steps at an intertrial interval 
(ITI) of 20 s. Startle reactivity determined the setting of the gain of the movement sensitive 
platform (for detail see Valsamis and Schmid, 2011). This gain amplified the signal from the 
platform in order to ensure animals startled within a detectable range. Once an animal’s gain was 
determined, it was kept constant throughout the remaining days of testing. The I/O was 
completed at a gain of 1 for all animals. Following the I/O, experimental testing began.  
Experimental testing consisted of two blocks of trials. Block I was used to assess short-
term habituation and block two was used to assess PPI. The STH block consisted of 30 startle-
alone trials (20 ms white noise, 105 dB SPL, 30 s ITI). The PPI block consisted of 7 different trial 
types (10 trials/condition, total=70 trials, pseudorandomized order). The trial conditions were as 
follows: startle pulse-alone trials (for comparison of startle amplitude with prepulse) and 
combinations of two different prepulses (75 or 85 dB SPL white noise; 4 ms) at three different 
interstimulus intervals (ISIs; 15, 30 or 100 ms). The ITI for this block varied between 15-25 ms. 
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Figure 4.1 Schematic Representation of Startle Testing 
Animals were acclimated to the startle chambers three times (indicated by the grey box in the 
diagram). Animals then completed an input/output function to assess startle reactivity (blue 
box). During this, animals were presented with increasingly louder auditory stimuli (indicated by 
the black bars) and the resulting startle magnitude was recorded. Following this, ASR testing 
began (purple box). Animals began testing with a 5 min re-acclimation to the box. The first block 
of testing assessed habituation. Identical startle-pulses were presented repeatedly and startle 
magnitude was recorded. Short-term habituation ratios were calculated by using the average of 
the final five trials (denoted by dots) divided by the first two startle responses in Block I (denoted 
by asterisks). Block II assessed PPI which contained a mix of trial types as we used 2 prepulse 
intensities (75 or 86 dB SPL) and a variety of interstimulus intervals (ISI; 15, 30 or 100 ms). 
Pseudorandomly placed within this block were 10 startle-alone trials, which were used for 
quantification of PPI.  
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4.2.2.2 Statistical Analysis for Habituation and PPI  
To analyse the majority of data, we used an analysis of variance (ANOVA). For all statistical 
analysis included in this chapter, whenever this test was performed, Levene’s Test of Equality of 
Error Variance or Mauchley’s Test of Sphericity (repeated measures ANOVA only) was examined. 
If Levene’s Test was violated, an equivalent non-parametric ANOVA was run. In the case of a 
repeated measures ANOVA, if sphericity was violated, corrections were applied based on the 
epsilon value (if ε<0.75 the Greenhouse-Geisser correction was applied, or if ε>0.75 the Huynh-
Feldt correction was used). If post-hoc tests were necessary, we used student t-tests with 
Bonferroni corrections. For all analyses included in this chapter, outliers were removed. Outliers 
were defined as any data point that was outside the range of ±3 standard deviations from the 
mean (calculated using all animals). Finally, criterion for significance was α=0.05. 
With regards to ASR testing, in order to detect differences in startle reactivity and startle 
magnitude between genotypes, we examined the I/O function (where all animals had the same 
gain factor). We used a three-way repeated measure ANOVA (genotype × sex × sound level) for 
the I/O function. To analyse short-term habituation of startle, we calculated STH ratios by dividing 
the average of trials 25-30 by the average of trials 1-2 for each animal; see figure 4.1, (stimuli 
marked with squares and asterisks respectively) and compared them using a two-way ANOVA 
(genotype × sex). 
Prepulse Inhibition was expressed as percent of prepulse inhibition: %PPI= (1− [startle 
magnitude with prepulse/baseline startle without prepulse] × 100). This indicated the amount 
that startle was inhibited, as a percentage of the baseline response. We determined the average 
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%PPI for each prepulse type and performed four-way ANOVA (prepulse dB SPL × ISI × genotype 
× sex). 
4.2.2.3 Testing of Locomotor Behaviour 
We tested the locomotor behaviour of transgenic and WT littermates. To ensure that 
there was no gross motor impairments in the transgenic model. Rats were placed into a 45 x 45 
cm box with 2 adjacent opaque walls and 2 adjacent translucent walls. This occluded the rat’s 
ability to observe other animals during testing.  The animals were able to freely explore the box 
for 20 min while they were tracked using a webcam and ANYmaze software (Version 4.99, 
Stoelting, Wood Dale, IL, USA). Distance travelled and time spent in the center (6x6 cm centered 
square) and surrounding perimeter was recorded. The distance each rat travelled and time spent 
in the center and perimeter of the box were totalled across the 20 min of testing. Additionally, 
the data for each animal was averaged in to 5 min blocks (total of 4 blocks) in order to assess the 
changes in locomotor behaviour across time. 
To assess short-term habituation of locomotor behaviour a three-way repeated measures 
ANOVA (genotype × sex × time) was performed. The total distance travelled was analysed using 
a two-way ANOVA (genotype × sex) and the time spent in the center or perimeter was analysed 
separately from distance using a repeated measures three-way ANOVA (genotype × sex × area). 
4.2.3 Inhibition of Cholinergic PPT Neurons 
To inhibit cholinergic neurons of the PPT we induced expression of the designer receptor 
exclusively activated by designer drugs (DREADD) protein hM4Di, a modified muscarinic receptor, 
using Cre-dependant viruses in our transgenic (Cre-ChAT) rat model.  This receptor is activated 
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by the biologically inert ligand clozapine N-oxide (CNO). Activation of the hM4Di protein 
hyperpolarizes neurons through G-protein activation of inward rectifying potassium channels 
(Armbruster et al., 2007) as well as by inhibiting presynaptic neurotransmitter release (Stachniak 
et al., 2014) 
We performed sensory filtering and sensorimotor gating assessment of the ASR (hM4Di 
n=12/group, 7 male, 5 female) or exploratory behaviour (n=6/group, males only) following PPT 
cholinergic inhibition. As a positive behavioural control paradigm, we added assessment of 
morphine-induced conditioned place preference (CPP; n=6/group, males only). To verify 
inhibition of cholinergic PPT neurons we completed immunohistochemisty in addition to in vitro 
patch clamp (single neuron analysis) and in vivo (multi-unit analysis) electrophysiology. 
4.2.3.1 Surgical Procedure 
For viral injections into the PPT, animals (aged 10-14 weeks) were induced with a 5% 
isoflurane and 95% oxygen for induction, and maintained with a 2% isoflurane and 98% oxygen 
combination. A subcutaneous injection of meloxicam (1 mg/kg) and intramuscular injection of 
Baytril (10 mg/kg) were administered before surgery and as needed 7 days post-surgery for pain 
management. Blunt-ended ear bars and a snout mask were used to secure the head in the 
stereotaxic frame. A midline incision was made in the skin on top of the head, and bilateral bore 
holes were drilled at the following co-ordinates from bregma: ± 2.0mm medial/laterally, -7.2mm 
ventrally and either -7.6 (weight 300g) or 7.8mm (weight <400g) caudally. (Paxinos and Watson, 
2005). We injected 1 µl/side of virus solution (rAAV8-hSyn-DIO-hDM4(Gi)-mCherry, 5.3*10e12 
vg/ml, Lot: AV4680b. UNC Vector Core, Chapel Hill, NC, USA; or its control rAAV8-hSyn-DIO-
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mcherry, 3.8*10e12 vg/ml, Lot: AV4680b. UNC Vector Core, Chapel Hill, NC, USA) at a rate of 
0.1µl/min using a blunt end 1.0 µl Hamilton syringe (Model 7001 KH SYR, Knurled Hub NDL, 25 
gauge, 2.75 in, point style 3; Hamilton, Reno, NV, USA). The syringe rested for 1 min prior to 
injection and 7 minutes post before retraction. Silk suture was used to close the wound and rats 
were given a 21 day recovery period to promote maximal expression of the DREADD (or control) 
protein before testing began. 
4.2.3.2 Behavioural Testing With DREADDs 
After a 21 day recovery period animals started acclimatization to the startle boxes, 
underwent I/O testing, and behavioural testing began. Animals were administered an 
intraperitoneal (IP) injection of the DREADD ligand CNO (10 mg/kg in 18% Dimethyl Sulfoxide 
(DMSO), Toronto Research Chemicals, Toronto, ON, CAN) or vehicle (18% DMSO, in saline) 20 
min prior to testing. Each animal underwent at least 4 days of testing (2 CNO, 2 vehicle). Order 
of drug administration was randomized and counterbalanced across groups.  
Experimental parameters of startle testing were identical to that depicted in figure 4.1, 
with the exception of a variable ITI (15-25ms) in the habituation block. For a schematic 
representation of the timeline and testing see figure 4.2. With respect to %PPI, STH ratios and 
startle reactivity, data was analyzed identically to that described above. Statistical analysis was 
also similar to that described previously however it now replaced genotype with virus type and 
included the variable of drug type (CNO vs. vehicle) in ANOVAs (e.g. virus type × drug × sex × 
prepulse dB SPL × ISI).  
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Once animals completed startle testing a subset of males (n=6/group), were given a 5 
minute rest period in their home-cages before being placed in locomotor boxes (refer to figure 
4.2). Administration of CNO was given prior to startle testing which lasted an estimated 30 
minutes. In mice, the half-life of CNO is an estimated 1.5 hours (Guettier et al., 2009) but 
behavioural effects in rats have been shown to persist much longer (Mahler et al., 2014; 
Wirtshafter and Stratford, 2016), therefore cholinergic PPT inhibition was still in effect during 
locomotor testing. Experimental parameters were identical to those discussed previously, see 
section 4.2.2.3. Data analysis was similar to that described above, however,   genotype was 
replaced with virus type and included the variable of drug type (CNO vs. Vehicle) in ANOVAs (e.g. 
virus type × drug × time). 
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Figure 4.2 Behavioural Testing During DREADD Inhibition of Cholinergic PPT Neurons 
Prior to testing, animals received bilateral infusions of a Cre-dependent virus (hM4Di or mCherry 
control) into the PPT. 21 days later, behavioural assessment began. Animals were first acclimated 
to the startle chamber three times (5 min, grey box). Their startle reactivity was then assessed 
using an input/output function. After this, habituation and PPI of the ASR was tested. This testing 
was roughly the same as described in figure 4.1, except there was a variable ITI of 15-25 s during 
ASR testing. Additionally, testing was preceded with either a systemic injection of CNO (10 mg/kg 
in 18% DMSO) or vehicle (18% DMSO) 20 min prior to testing. Following ASR testing there was a 
5 min rest in their home cages before animals completed locomotor testing. 
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4.2.3.3 Conditioned Place Preference (Positive Behaviour Control)  
A subset of males (n=6/group) underwent an unbiased, counterbalanced, conditioned 
place preference (CPP) procedure, as described previously (Ahmad et al., 2013). Briefly, saline 
vehicle or morphine injections (5 mg/kg IP, administered immediately prior to placement in the 
chamber) were paired with one of two environments that differed in color (black or white), 
texture (smooth floor or textured with woodchip bedding), and smell (2% acetic acid or no added 
scent). As reported previously, rats display no baseline preference for either of these two 
environments (Laviolette and van der Kooy, 2003). Animals received alternating exposure to the 
morphine-paired and saline-paired environment for a total of 3 exposures per environment (1 
session/day). Drug assignment to environment type was counterbalanced. Thirty minutes prior 
to the morphine or saline injection, all animals were administered CNO (10 mg/kg in 18% DMSO, 
IP).  
Three days after the conditioning phase ended, animals were tested for a place 
preference (with no injections prior to testing). They were able to freely explore a test chamber 
for 10 min. The test chamber consisted of two compartments with environments identical to 
those used in conditioning on either end with a small neutral gray zone separating them. Testing 
began when the animal was placed in this neutral zone and the distance travelled and time spent 
in each compartment was recorded and tracked using a webcam and ANYmaze software (Version 
4.99, Stoelting, Wood Dale, IL, USA). For each animal, CPP behavior was expressed by plotting 
the time spent in each compartment and using an individually calculated place preference score 
(time in morphine paired environment/time in saline).  
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            Time spent in each chamber during the test day was analyzed using a repeated measures 
ANOVA (environment × virus). The preference score was analysed using a one-sample t-test. As 
no preference would have a score of 1, we used a one-tailed t-test for each group to determine 
if this score significantly differed from no preference.  
4.2.3.4 Immunohistochemistry 
Animals were euthanized by IP injections of an overdose of sodium pentobarbital 
(Euthanyl: Bimeda-MTC Animal Health Inc. Cambridge, ON, CAN) and transcardially perfused with 
saline followed by 4% paraformaldehyde. The brains were harvested and stored in 30% sucrose 
until sliced into 40 µm slices using a freezing microtome (KS34S, Thermo Fischer Scientific, 
Waltham, MA, USA). Slices were divided into 4 parallel series and stored at -20˚C in cryo-
protectant solution (30% sucrose, 30% ethylene glycol, and 5% of 0.01% sodium azide in 0.1M 
phosphate buffer (PB)). 
Prior to free-floating immunohistochemistry being performed, as well as in between all 
incubations with antibodies, all slices were thoroughly rinsed in 0.1M PB. Antibodies were 
delivered in a 0.1M PB and 0.1% bovine serum albumin (BSA) solution. Slices were pre-treated 
with a 1% H2O2 in 0.1M PB (Caledon Laboratories Ltd., Georgetown, ON, CAN) for 10 min then 
blocked for 1 hour in a 0.1M PB plus 0.4% Triton X-100 and 0.1% BSA (Fisher Scientific, Hampton, 
NH, USA) solution before incubation with primary antibodies. Next, tissue was incubated 
overnight with an anti-mCherry antibody (1:25000, rabbit, polyclonal; ab167453 Abcam, Toronto, 
ON, CAN). The mCherry antibody was amplified, first by incubating tissue with a goat anti-mouse 
biotinylated secondary antibody (1 h, 1:500; Vector Laboratories, CA, USA), followed by avidin-
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biotin complex solution (1h, 1:500; Vectastain Elite ABC Kit, Vector Laboratories, Burlington, CA, 
USA). Finally, slices were treated with 3,3′-diaminobenzidine tetrahydrochloride (DAB) solution 
(0.04% H2O2, 0.2mg/ml DAB; Sigma-Aldrich, Oakville, ON, CAN).  
To label cholinergic neurons, slices were then incubated in β nicotinamide adenine 
dinucleotide phosphate (NADPh) solution (0.3% Triton-X, 0.1 mg/ml nitroblue tetrazolium, 1 
mg/ml β NADPh, Sigma-Aldrich, ON, Canada) and rinsed. Tissue was then mounted onto 
positively-charged glass slides and cover-slipped.  
The tissue was imaged using a bright field Nikon DS-Qi2 microscope (Nikon, NY, USA) and 
associated NIS-Elements AR software. Images were taken at 2 and 20x objectives. 
4.2.3.4.1 Co-expression of mCherry and the Cholinergic Marker NADPh 
Images were taken for each animal between post-surgery days 26-35. For each animal, a 
representative image was taken at the injection site as well as one posterior and anterior to the 
site at 20x magnification. The number of blue (NADPh), brown (mCherry), and blue and brown 
(co-expressed) cells were counted manually by two individuals. Cell counts were tracked using 
ImageJ software using the Fiji cell counter plugin (Schindelin et al., 2012; Schneider et al., 2012). 
The inter-rater reliability was calculated using a two-way mixed effects model intra-class 
correlation (ICC) and was revealed to be strong (ICC: 0.93). Once counted, an average of the two 
cell counts was used for reporting and analysis. This method has been adapted from Pitchers et 
al., (2010). 
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4.2.3.5 In Vitro Patch Clamp Electrophysiology 
In a separate group of animals, 0.3 µl of AAV virus containing mCherry (n=2) or hM4Di 
(n=4) were injected bilaterally into PPT of 5 week old transgenic Cre-ChAT rats. Rats were 
anesthetized with isoflurane 21-26 days after surgery and their brains were extracted. Brains 
were cut into 300 µm coronal slices using a vibrating-blade microtome (HM 650V, Thermo 
Fischer Scientific, Waltham, MA, USA) in ice-cold carbogen-equilibrated solution containing (in 
mM): 2.5 KCl, 10 MgS04, 1.25 NaH2PO4, 24 NaHCO3, 0.5 CaCl2-2H2O, 11 Glucose, and 234 
Sucrose. Slices containing the PPT (Bregma -7.20 mm to -8.10 mm) were then incubated at 32°C 
for 1 hour in artificial cerebrospinal fluid (ASCF) containing (in mM): 124 NaCl, 3 KCl, 3 MgS04, 
1.25 NaH2PO4, 26 NaHCO3, 1 CaCl2-2H2O and 10 Glucose. 
4.2.3.5.1 Patch Clamp Recordings 
Electrophysiological experiments were performed at room temperature and the protocol 
was similar to that of previous studies (Zaman et al., 2011; Zaman et al., 2014). In K+-based whole-
cell current clamp mode, the spontaneous firing properties of PPT mCherry-positive neurons 
were recorded in ASCF bubbled with carbogen.  
Cholinergic neurons expressing the Cre-dependent viral marker, mCherry, were visualized 
using an upright microscope (Zeiss Axioskop, Germany), equipped with an EMCCD camera (Evolve 
512, Photometric, Tuscon, AZ). Recording electrodes were pulled on a P-97 Puller (Sutter 
Instrument, Novato, CA, USA) from fabricated borosilicate glass capillaries (1B150F-4, OD;1.50 
mm, ID;0.84 mm, World Precision Instruments, Sarasota, FL, USA) and had 4–6 MΩ tip resistance 
when filled with an intracellular solution containing (in mM): 140 K-gluconate, 10 KCl, 1 MgCl2, 
10 HEPES, 0.02 EGTA, 3 Mg-ATP, and 0.5 Na-GTP, pH adjusted to 7.35, 290–300 mosm/l.  
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Slices were treated with 5 µM CNO (in 0.1% DMSO) for 10 minutes in recording chamber. 
The spontaneous activity before and after the CNO treatment was recorded in PPT neurons at -
50 mV holding potential. Signals were sampled at 10 kHz, amplified with Axopatch 200B, digitized 
with Digidata-1550 and analyzed using pClamp10.4 (all Axon Instruments, Molecular Devices, 
Sunnyvale, CA, USA).  
To analyse the spontaneous firing frequency of mCherry-positive PPT neurons pre- and 
post-CNO treatment, we performed a two way repeated measures ANOVA (virus type × drug).  
4.2.3.6 In Vivo Electrophysiology 
A total of 9 animals were used to assess the efficacy of hM4Di-induced inhibition in vivo 
(hM4Di n=4, 2F, 2M mCherry n=5, 3F 2M). Animals were anesthetized using an initial dose of 
ketamine (80 mg/kg IP) and xylazine (5 mg/kg), and supplemental doses were given 
intramuscularly as needed.  The rat’s head was fixed in a stereotaxic frame using blunt ear bars 
and a headpost was attached to the skull with acrylic dental cement. A stainless steel screw was 
inserted into the right frontal skull bone to serve as an anchor for the headpost and electrical 
ground. A craniotomy (2 x 2 mm; 5-8 mm posterior to bregma) was performed in the left frontal 
skull bone to expose the brain. At the end of the surgical procedure, the right ear bar was 
removed to allow free-field auditory stimulation during the electrophysiological recordings in the 
contralateral PPT. 
4.2.3.6.1 In vivo Recordings 
Extracellular electrophysiological signals were collected using a 32-channel electrode 
array which consisted of a single shank with 32 equally-spaced recording sites, spanning 0.25 mm 
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in length (A1x32-Poly3-10mm-25s-177-A32; NeuroNexus Technologies, Ann Arbor, MI). The 
electrode array was connected to a high-impedance headstage (NN32AC, Tucker Davis 
Technologies (TDT), FL, USA), and the neuronal activity was pre-amplified and digitized (two 
RA16SD Medusa preamps, TDT). It was then sent to a RZ5 processing module. For each of the 32 
channels, the neuronal activity was digitally sampled at 25 kHz and bandpass filtered online at 
300 – 3000 Hz using a voltage threshold for spike detection of three standard deviations above 
the noise floor.  
To record, the electrode was inserted in the brain 7.6-7.8 mm posterior from bregma and 
2.0 mm medially from bregma. Using a hydraulic microdrive (FHC, ME, USA), the electrode array 
was lowered until all 32 recording sites were within the PPT (estimated depth of 7.2-7.7 mm from 
the skull). The depth of penetration was determined by probing the auditory responsiveness of 
brain regions and mapping their progressive changes with increasing depth. Once the electrode 
was determined to be in the PPT, it settled for 1 hour before conducting recordings. The electrode 
was coated with DiI to verify placement. 
In each subject, an audio stimulation paradigm was performed before and 20 min post an 
administration of CNO (10 mg/kg in 18% DMSO, IP via a butterfly catheter inserted prior to the 
rat being placed in the stereotactic frame).  To assess auditory-evoked responses in the PPT, 
computer-triggered auditory stimuli were presented using a RZ6 processing module (TDT, 100 
kHz sampling rate) and custom Matlab software. Auditory stimuli consisted of noise bursts (1-32 
kHz; 50 ms duration) from a speaker (MF1; TDT) positioned 10 cm above the surface of the 
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stereotaxic frame and 10 cm from the base of the right pinna on a 30 degree angle from midline 
in the contralateral space. Auditory stimuli were 85 dB SPL (4 ms, white noise bursts). 
4.2.3.6.2 Offline Sorting and Statistical Analysis 
To analyse multi-unit data, custom scripts in Matlab were used to generate rasters and 
Peri-Stimulus Time Histograms (PSTH). The average spontaneous activity of a multi-unit cluster 
was determined using the average firing rate within the final 100 ms of each trial. Auditory 
responsiveness was determined as the average firing rate across trials within a 2-12 ms window 
of time after the auditory stimulus onset. For representative rastor plots and PSTHs, see 
supplemental figure A.2.  We defined a multi-unit cluster to as responsive to an auditory stimulus 
if it displayed a significantly increased firing rate during auditory stimulation compared to 
spontaneous activity, as determined using paired t-test.  
Multi-unit activity of spontaneous and auditory-evoked activity was compared prior to 
CNO administration to 20 min post CNO administration. The average percent change in 
spontaneous and auditory-evoked firing rate was calculated for each multi-unit cluster (e.g. 
%Change= Activity pre-CNO/Activity post-CNO x 100%). This was then averaged for each animal 
and within each virus type. For each animal, we also determined the proportion of multi-units 
who’s activity decreased (%Change <0) and averaged this within groups. Both these measures 
were compared between groups using an unpaired Student’s t-test. 
4.2.3.6.3 Immunohistochemisty and Imaging 
Immunohistochemistry was performed to verify electrode placement and virus 
expression similarly to described in section 4.2.3.4, however because the electrode was coated 
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with a fluorescent marker, DiI, we used a fluorescent secondary antibody for mCherry 
fluorescently (Alexa-594, donkey anti-rabbit, 1:500 Thermo-Fischer Scientific Waltham, MA, 
USA).  
Images were acquired using a Leica LSM 800 (Zeiss, Germany) confocal microscope and 
associated Zen software (Zeiss, Germany) using 10x magnification. Images were scanned using 
the 546 nm laser line and collected wavelengths included 550-700 nm.   
4.2.4  Optogenetic Activation of Cholinergic PPT Neurons 
To activate cholinergic neurons of the PPT we induced expression of the optogenetic 
protein, a modified Channel Rhodopsin 2 (ChR2(H134R)) using Cre-dependent viruses in our 
transgenic (Chat-Cre) rat model.  The light-gated ChR2(H134R) ion channel is activated maximally 
by blue light (465 nm), and once opened cations freely enter the cell according to electrochemical 
gradients. The ChR2(H134R) opsin has been modified to conduct a larger current compared to 
ChR2 when activated, although it displays slightly slower protein kinetics (Fenno et al., 2011). 
We completed sensorimotor gating assessment of the ASR paired with photostimulation 
of the PPT (ChR2(H134R) n=7, 1M 6F YFP n=6, 1M 5F). The same animals also completed 
optogenetically-induced CPP testing as a positive behavioural control. To further verify that our 
photostimulation paradigm was effective in activating cholinergic neurons in the PPT, animals 
received photostimulation 60-90 min prior to perfusion, and c-FOS expression was analysed. 
4.2.4.1 Surgical Procedure 
To induce expression of the light-sensitive channel ChR2(H134R) we bilaterally injected 
the Cre dependant rAAV5-EF1α-DIO-hChR2(H134R)-eYFP (4.3*10e12 vg/ml, Lot:AV4313p. UNC 
 
 
  129 
 
 
Vector Core, Chapel Hill, NC, USA) or its control rAAV5-EF1α-DIO-eYFP (4.9*10e12 vg/ml, 
Lot:AV4836c. UNC Vector Core, Chapel Hill, NC, USA). Viruses were aliquoted and stored at -80 
°C. For more details regarding surgical procedure and coordinates see section 4.2.3.1.   
We injected 1.0 µl of virus per side, at a rate of 0.1µl/min. The syringe rested for 7 min 
before retracting. Bilateral fiber-optic cannulae (7.2 mm, 400/430 µm core, NA 0.48; Doric 
Lenses, Franquet, QC, CAN) were then lowered into the same location where viral injections had 
taken place. Once in place, they were secured using acrylic dental cement. Three jeweler’s screws 
were placed in the skull to improve security of the implants (2 bilaterally over the parietal skull 
bones and 1 on the left frontal skull bone). Silk suture was used to close the wound and rats were 
given a 28 day recovery period to promote maximal expression of ChR2(H134R) before testing.  
4.2.4.2 Optogenetic Stimulation During Sensorimotor Gating Assessment  
28 days post-surgery animals began ASR testing (ChR2(H134R) n=7, 1M 6F; YFP n=6, 1M 
5F). First, they were acclimated to a modified startle chamber: the startle platform and speakers 
were identical to that explained in the previous section, however animals were tested in a clear, 
rectangular holding chamber (w: 25 cm, h: 30 cm), placed in a partially enclosed box. This ensured 
the rat was comfortably tethered to the Light Emitting Diode (LED; housed with a fiber-optic 
rotary joint: FRJ 1x1, Doric Lenses, Franquet, QC, CAN), which was suspended on top of the box. 
The LED was connected to the animal using a branching opto-patchcord (400/430 µm core, 0.48 
NA, Doric Lenses, Franquet, QC, CAN).  
Prior to testing, animals were acclimated to the tether procedure. Animals were tethered 
two times (15 min) while freely exploring their home cages. During their first exposure to the 
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startle chambers, animals were not tethered (15 min), however for the following 3 acclimation 
procedures they were tethered to the LED but received no photostimulation. Since tethering 
required the use of a larger holding chamber during startle testing, the acclimation procedure 
was lengthened to 15 min to reduce movement artifacts during testing.  
An I/O function identical to that described previously (section 4.2.2.1) was done to 
determine startle reactivity. Once testing began, it was composed of three blocks of trials (figure 
4.3). The first block consisted of 20 habituation trials (105 dB SPL white noise, 20 ms duration), 
with a variable ITI of 20-60 s. This was to ensure startle magnitude was relatively stable before 
optogenetic manipulations.  
The second block was to determine the effects of PPT cholinergic optogenetic stimulation 
on baseline startle. It consisted of 15 trials (105 dB SPL white noise, 20 ms duration) with a fixed 
ITI of 60 s. The first 5 trials were startle-alone trials. The next 10 startle stimuli were presented 
with concurrent optogenetic stimulation (photostimulation duration: 60 ms, see below section 
4.2.4.2.1 for details, triggered 1 ms prior to startle pulse, duration: 20 ms). To determine the 
impact of concurrent photostimulation on startle we normalized trials with photostimulation to 
the average 3 trials that preceded photostimulation for each individual rat. Additionally, we 
averaged trials with photostimulation and those without and divided these values to create an 
individualized total ratio (Stim Ratio: avg with stim/avg without). This was compared between 
groups using a one-way ANOVA.  
Block III assessed auditory PPI and optogenetically-induced PPI. The first trial consisted of 
an auditory prepulse (85 dB SPL, 4 ms) with an ISI of 15, 30, 100 or 200 ms. In the following trial 
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blue light was delivered to the PPT (causing activation of these cells) instead of the auditory 
prepulse. These trial types were termed Opto-induced PPI. Prepulse inhibition was analysed using 
a three way ANOVA (virus type × prepulse type × ISI).   
4.2.4.2.1 Photostimulation 
Optogenetic stimulation was triggered by a 28V signal from the Med Associates boxes, 
which was transformed using a converter (SG231, Med Associates Inc.) into a TTL-pulse. This TTL-
pulse triggered a waveform generator (DG1022, Rigol Technologies, OR, USA) which was used to 
modulate light stimulation. The waveform generator triggered the LED driver (LED RV 1Ch 1000 
Single LED, Doric Lenses, Franquet, QC, CAN), which controlled the LED light fiber. 
Light stimulation was delivered using a blue LED (465 nm, FRJ 1x1, Doric Lenses, Franquet, 
QC, CAN), CAN)  at 50 Hz (3 pulses of 15 ms of light, 5 ms rest), 10 Hz (3 pulses of 15 ms, 85 ms 
rest), or 1 Hz (15 ms pulse). Light illumination varied from 21-24.7 mW. Optical power was 
measured using an energy meter console (PM100D paired with photodiode sensor S120C, 
Thorlabs Inc., NJ, USA).  
In a subset of experimental animals (n=3, 1 male, 2 female), testing was re-run with 
unilateral stimulation of the anatomical left PPT, or low-light stimulation of 1-4 mW/side (data 
reported in appendix A). There was a minimum of 2 days separating testing. Data analysis was 
similar to that explained previously, but we introduced the photostimulation (frequency or 
laterality) and into the ANOVA (virus type × stimulation × ISI). 
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4.2.4.2.2 Drugs  
All animals were re-tested with the 50 Hz photostimulation as described above, but 
received an IP injection of mecamylamine hydrochloride (3 mg/kg) or saline, 7 days apart, prior 
to testing. During startle testing, the acclimation was shortened to 7 min to account for the half-
life of mecamylamine (1.2 hours, Debruyne et al., 2003). Short-term habituation curves, ratios 
and PPI were calculated as described above (section 4.2.2.2). To analyze PPI however, a separate 
repeated measures ANOVA (virus × drug × ISI) was performed for photostimulation as a prepulse 
and auditory PPI.  
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Figure 4.3 Schematic of Sensorimotor Gating Testing Paired with Optogenetic Stimulation 
Animals were acclimated to the startle chamber three times (indicated by the grey box). 
Animals then completed an input/output function to assess startle reactivity (blue box) where 
animals were presented with increasingly louder auditory stimuli (indicated by the black bars) 
and the resulting startle magnitude was recorded. Animals began testing with a 5 min re-
acclimation to the box. Block I habituated the animal so that startle reached a stable level of 
responding. Block II assessed the role of cholinergic release from the PPT on startle magnitude. 
Photostimulation of the PPT coincided with the presentation of a startle pulse. 
Photostimulation is represented by the blue bar. In the final block of testing (block III), some 
prepulses were replaced by photostimulation to optogenetically-induce PPI. Prior to a startle-
pulse, animals were presented with an auditory prepulse OR photostimulation. 
Pseudorandomly placed within this block were 10 startle alone trials to determine baseline 
startle amplitudes. 
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4.3.2.3 Opto-Induced CPP 
The same rats were used as in startle experiments above (n=7, 1 male, 6 female ChR2; 
YFP-control n=6, 1 male, 5 female). The general CPP procedure has been described above. Instead 
of pairing a chamber type with morphine, here we paired it photostimulation of cholinergic PPT 
neurons (50 Hz, 25 x 15 ms light pulse; 19.8-22.3 mW). Animals were placed in either chamber 
type for 30 minutes for a total of 3 exposures to each environment type. Photostimulation-paired 
and unpaired chamber environments were counterbalanced. Animals were tested the next day. 
Testing parameters and data analysis occurred in the same manner described previously (section 
4.2.3.3). During testing animal were tethered, but did not receive light stimulation. 
4.3.2.4 Immunohistochemistry and Imaging 
Prior to perfusion, animals received bilateral 50 Hz light stimulation (25 pulses of 15 ms 
duration/min) for 30 min. Animals were perfused 60-90 min after, as previously described. 
Immunohistochemistry was performed using an antibody for c-FOS (1:1000; polyclonal rabbit, 
Sc-52, Santa Cruz Biotechnology, Dallas, TX, USA) and a secondary antibody Alexaflour594 
(donkey anti-rabbit, ThermoFischer Scientific, Waltham, MA, USA), in order to ensure stimulation 
parameters activated target neurons. This validation of photostimulation has been used in the 
past (see Liu et al., 2012; Yamamoto et al., 2015). In order to verify virus expression in cholinergic 
cells we used an antibody for choline transporter (ChT; 1:500, monoclonal mouse, EMD Millipore, 
Etobicoke, ONT, CAN) and amplified this using the ABC method described previously and tagged 
this using Streptavidin Alexaflour594 conjugate (1:1000, ThermoFischer Scientific, Waltham, MA, 
USA). Staining was identical to that described previously. Co-expression with the fluorescent tag 
EYFP, labelling neurons expressing the ChR2(H134R) protein, was analyzed. Images were 
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acquired using a Leica LSM 800 (Zeiss, Germany) confocal microscope using 20 & 40x 
magnification. Images were scanned using the 488 and 546 nm laser lines individually, and we 
collected wavelengths 490-550 and 560-700 nm, respectively. Images were merged using Zen 
software (Zeiss, Germany).  Analysis of images was described previously (section 4.2.3.5). To 
estimate cellular activation with photostimulation, two individuals counted the number of yellow 
fluorescent protein (YFP)-expressing neurons, and c-FOS positive cells, as well as the number of 
YFP neurons that co-expressed c-FOS for both experimental (ChR2(H134R)-YFP) animals and 
controls (YFP only).  Cell counts were tracked using ImageJ software using the Fiji cell counter 
plug-in (Schindelin et al., 2012; Schneider et al., 2012). The inter-rater reliability between 
counters was calculated using a two-way mixed effects model ICC which revealed an acceptable 
correlation (0.90). Once counted, an average of the two cell counts was used for reporting.  
4.3 Results 
The results of this chapter are broken into three sections. The first examines if the Cre-
ChAT transgenic ratline is a valid model to use for sensory filtering and sensorimotor gating 
testing. The second examines the effects of inhibition of cholinergic PPT neurons on these 
processes, whereas the final section examines the effect of activation of these neurons. For all 
these experiments, both male and female rodents were used; while this factor was always 
included in our statistical analysis (except for optogenetic experiments), we only graphed groups 
according to sex when it was determined to significantly influence our results.   
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4.3.1 Validation of Cre-ChAT Transgenic Rats as an Appropriate Model  
In order to achieve cell-type specificity we used a transgenic rodent model (Long Evans-
Tg(Chat-Cre)5.1Deis). This animal model was generated using a BAC containing the genomic 
sequence for the Cre protein right after the ChAT promoter (Witten et al., 2011). Using this model 
allowed us to use Cre dependent viruses to target solely cholinergic cells. Transgenic mice 
previously created with this BAC have a greatly enhanced cholinergic tone which has been shown 
to alter cognitive function (Kolisnyk et al., 2013). This was due to the BAC which contained the 
open reading frame for the vesicular acetylcholine transporter (VAChT) protein between the first 
and second exon of the ChAT gene. VAChT is the rate limiting factor for ACh release, so over-
expression of VAChT may increase ACh release. Therefore, it was important to investigate if 
sensory filtering and sensorimotor gating processes were normal in transgenic rats.    
4.3.1.1 Startle Reactivity in the Cre-ChAT Transgenic Rat Model 
Prior to habituation and PPI testing, transgenic rats (Cre-ChAT n=16, 7 male,  9 females) 
and WT littermates (n=16, 8 males, 8 females) had their startle reactivity assessed using an I/O 
function. This function documented the changes (if any) in startle magnitude with increased 
auditory stimulus intensity (65-120 dB SPL). 
A three way ANOVA (sex × genotype × sound level) revealed that both genotypes showed 
increasing startle magnitudes  in response to increasing sound intensities (Greenhouse-Geisser 
corrections applied; F(3.6,97.2)=29.6, p<0.001). Most importantly, both genotypes began to startle 
at the same stimulus level (85 dB SPL, see figure 4.4A), however transgenic animals reached a 
maximum startle magnitude that was lower than that of WT littermates. While there was no 
significant effect of sex (F(1,27)=2.2, p=0.15) or genotype (F(1,27)=2.2, p=0.15), and no significant 
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interaction between genotype, sex, and sound intensity (F(3.6,97.2)=2.4, p=0.23), there was a 
significant sex by genotype interaction (F(1,27)=5.6, p=0.03).  As shown in figure 4.4B, WT males 
showed a greater maximal startle magnitude compared to female counterparts (F(1,14)=6.4, 
p=0.02). This sex difference was absent in Cre-ChAT animals (F(1,13)=0.5, p=0.49). Differences in 
weight, which could influence the range of signal detection of our startle measurements, did not 
contribute to this finding, as both sexes’ weights were similar across genotypes (WT female: 280g 
±5, Cre female: 275g ±6g, WT male: 455g ±14, Cre male: 453g ±8). 
However, as Cre-ChAT rats of both sexes showed increased  startle magnitudes with 
increasing stimulus intensity, had a similar startle threshold at around 80-85 dB SPL, and reached 
a maximal startle amplitude that was both robust and at similar sound levels to that of WT 
females, we believed their startle reactivity was still appropriate for sensory filtering testing. 
 
Figure 4.4 Startle Reactivity of Transgenic Cre-ChAT Rats Compared to Wild-type Littermates 
As shown in A), both genotypes increased their startle amplitude with increasing sound intensity. 
Additionally, both genotypes began to display a robust startle response at the same stimulus level 
(~80-85 dB SPL), however the transgenic animals reached a maximum startle magnitude that was 
lower than that of wild-type. Further analysis determined that this was due to sex differences. As 
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shown in B) WT males and females show a difference in maximal startle amplitude, which is 
absent in Cre-ChAT rats (Cre-ChAT n=16, 7 males 9 females, WT n=16, 8 males, 8 females). 
 
4.3.1.2 Short-Term Habituation of the ASR in the Cre-ChAT Transgenic Rat Model 
Startle amplitude was plotted across trials in order to examine short-term habituation of 
the ASR (figure 4.5A). This was analyzed using a three way repeated measures ANOVA (genotype 
× sex × trial) which revealed that both genotypes showed progressively decreased startle 
magnitudes as there was a significant effect of trial (F(29,754)=6.11, p<0.001). There was no impact 
of genotype (F(1,26)=0.2, p=0.66) or sex (F(1,26)=1.18, p=0.29), and no interaction between trial, 
genotype, and sex (F(29,754)=1.03, p=0.43) which indicated that the rate of habituation in 
transgenic rats was not different from WT. 
We quantified the total reduction in startle magnitude using a short-term habituation 
(STH) Ratio. This reflected the final startle amplitude relative to the initial startle. As shown in 
figure 4.5B, both genotypes displayed equal ratios (F(1,26)=2.34, p=0.13), with WT showing 
reduced responses to 0.65 (±0.08) of initial magnitude and Cre-ChAT rats  to 0.55 (±0.05). In 
contrast to the analysis above, which examined the progression of habituation, we found a 
significant effect of sex (F(1,26)=0.22, p=0.64) when we compared the habituation score. This effect 
was equal in both genotypes as there was no sex by genotype interaction (F(1,26)=0.41, p=0.53) or 
effect of genotype (F(1,26)=2.3, p=0.14). In both cases, males showed significantly more short-term 
habituation, as shown in figure 4.5C.    
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Figure 4.5 Short-Term Habituation of the ASR is Unaltered in Cre-ChAT Rats 
A) The progressive decrease in startle amplitude across trials in both genotypes was not different. 
The total reduction in startle amplitude for each animal was normalized using an STH Ratio (B 
&C). Both genotypes showed decreased startle to ~0.55-0.65 of initial response magnitude 
(shown in B), however, in both genotypes, the different sexes displayed significantly different 
amounts of habituation (shown in C). In general, males tended to show stronger reduction of 
startle (Cre-ChAT n=16, 7 males, 9 females, WT n=16, 8 males, 8 females). 
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4.3.1.3 Short-Term Habituation of Locomotor Behaviour in the Cre-ChAT Transgenic Rat Model 
We found no difference in the short-term habituation of locomotion or locomotor 
behaviour of transgenic Cre-ChAT rats (figure 4.6). The distance travelled during 5 minute blocks 
of open field testing was analysed using a three way repeated measures ANOVA (genotype × sex 
× time). Both groups showed decreased activity during the 20 min exploration as we observed a 
significant effect of time (F(3,81)=224.8, p<0.001), indicative of short-term habituation. Both 
genotypes travelled to a similar degree as we saw no effect of genotype (F(1,27)= 0.1, p=0.75). We 
did uncover a significant effect of sex (F(1,27)=5.3, p=0.03) but no interaction between sex, 
genotype, and time (F(1,27)=3.8, p=0.07), which indicates that the influence of sex was equal across 
genotypes.  
To further uncover the effect of sex, we calculated the cumulative distance travelled by 
each genotype and sex throughout the duration of the test and examined this using a two-way 
ANOVA (sex × genotype). As shown in figure 4.6B females travelled to a greater degree than their 
male counterparts in both genotypes (F(1,27)=10.4, p<0.01).  
To further ensure transgenic rats displayed normal open field behaviour, we calculated 
the total time spent in the perimeter versus the center of the open field (figure 4.6C). This ratio 
is also indicative of anxiety-like behaviour, since anxious animals tend to stay closer to the walls. 
Consistent with previous studies (Lamprea et al., 2008), we documented that both genotypes 
displayed a strong preference for the perimeter of the open-field (three way repeated measures 
ANOVA sex × genotype × area: F(1,27)=522, p<0.001).  This was equal across genotypes (F(1,27)=0.1, 
p=0.75) and sexes (F(1,27)=0.14, p=0.71), and there was no interaction between any of these 
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factors (F(1,27)=1.3, p=0.26).  Overall this revealed that locomotor activity of the transgenic rats 
was not different from WT animals.  
 
 
 
Figure 4.6 Short-Term Habituation of Locomotor Behaviour in Cre-ChAT Rats 
A) Short-term habituation of exploratory behaviour was not different between WT and 
transgenic rats. B) Overall, female rats were significantly more active than males (B), but that this 
was equal across genotypes. C) Transgenic rats displayed the same strong preference for the 
perimeter as WT littermates, indicative of normal thigmotactic behaviour (Cre-ChAT n=16, 7 
males, 9 females, WT n=16, 8 males, 8 females). 
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4.3.1.4 Prepulse Inhibition of the ASR in the Cre-ChAT Transgenic Rat Model 
As our hypothesis was mainly centered upon sensorimotor gating of the ASR, it was 
critical to ensure that PPI was normal in Cre-Chat transgenic rats. Displayed in figure 4.7 is the 
percent of inhibition induced by a prepulse (%PPI) across genotypes. A four way ANOVA 
(genotype × sex × prepulse dB SPL × ISI) showed that both genotypes showed similar startle 
inhibition by a prepulse as we detected no main effect of genotype (F(1,27)=0.03, p=0.86) or sex 
(F(1,27)=0.12, p=0.73), or interaction between genotype and sex (F(1,27)=0.91, p=0.34).   
In general, we saw PPI of 65-79% in both genotypes (depending on ISI). Using a 75 or 85 
dB SPL prepulse resulted in similar PPI (F(1,27)=0.6, p=0.44), however at both prepulse levels, we 
saw a significant difference according to ISI (F(2,54)=6.3, p<0.01). We tended to observe maximal 
PPI using the 30 ms ISI (see figure 4.7A). 
Baseline startle during the PPI block of testing was not different between genotypes (two 
way ANOVA genotype × sex: F(1,27)=0.72, p=0.40), or sex (F(1,27)=0.28, p=0.60). There was also no 
interaction between group and sex on baseline startle amplitude (F(1,27)=0.47, p=0.5). Baseline 
startle was measured using individually calibrated movement-sensitive platform (gain values; see 
section 4.2.2.1). Together, this data implies that PPI was not different between transgenic and 
WT animals (figure 4.7B).  
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Figure 4.7 Prepulse Inhibition is Normal in Cre-ChAT Transgenic Rats 
A) The amount of PPI in transgenic and WT rats. The data is plotted as %PPI, which reflects the 
amount of inhibition relative to baseline startle amplitude. Both genotypes showed similar startle 
inhibition by a prepulse. B) Baseline startle magnitude (calculated from startle pulse alone trials 
during PPI measurements) of WT and transgenic animals showed no difference between 
genotypes (Cre-ChAT n=16, 7males, 9 females, WT n=16, 8 males, 8 females). 
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4.3.1.5 Summary of Behavioural Validation of the Cre-ChAT Transgenic Rat Model 
Overall, we observed that transgenic rats had similar startle reactivity, short-term 
habituation and PPI of the ASR as their WT littermates. Additionally, locomotor activity and short-
term habituation of non-reflexive behaviours were not significantly altered in this rat model. 
Therefore, I concluded that these rodents were an appropriate model to use for the remainder 
of our studies.  
4.3.2 DREADD-Induced Inhibition of Cholinergic PPT Neurons 
For chemogenetic inhibition of cholinergic PPT neurons we injected a Cre-dependent 
DREADD virus (rAAV8-hSyn-DIO-hM4Di-mCherry; n=12, 7 males, 5 females) or control virus 
(rAAV8-hSyn-DIO-mCherry; n=12, 7 males, 5 females) into the PPT of Cre-ChAT rats. Animals were 
tested using a 10 mg/kg dose of CNO (IP, 18% DMSO) or vehicle.  This dose of CNO was chosen 
based on pilot data (Appendix A). 
4.3.2.1 Startle Reactivity of hM4Di Expressing Rats Compared to mCherry Controls 
Prior to conducting startle testing, all animals completed an I/O function. There was no 
administration of CNO or vehicle prior to this, so we included data from our pilot group 
(n=16/group, 7 females, 9 males). We used a 3-way repeated measures ANOVA (virus × sex × dB 
SPL) to analyze unamplified startle amplitudes. 
 Both groups showed an increase in startle magnitude as sound level increased 
(F(6.6,178)=26.5, p<0.001). Surprisingly, we observed a significant effect of virus (F(1,27)=8.0, p=0.01), 
but no effect of sex (F(1,27)=1.4, p=0.31). As clearly shown in figure 4.8, startle magnitude of the 
hM4Di expressing animals was consistently greater than mCherry expressing control animals. As 
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we found no interaction between virus type, sex, and sound intensity (F(6.6,178)=0.6, p=0.73), 
which suggested that there was greater startle responses in hM4Di animals, but that the relative 
increase in this response with sound intensity was equal to that of controls. In other words, the 
startle-reactivity curve between each virus group progressed similarly, but the hM4Di curve 
reached a higher maximum level.  
 
 
Figure 4.8 Startle Reactivity in hM4Di Expressing Animals is Altered 
Both groups of transgenic animals showed increased startle magnitudes with increasing sound 
intensity; however the hM4Di expressing animals, on average, displayed significantly higher 
startle amplitudes, while startle threshold and sound level for maximum startle amplitude 
remained the same. It is important to note that this test was run without CNO administration 
(n=16/group, 7 females, 9 males).  
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4.3.2.2 Short-term Habituation of the ASR Following Inhibition of Cholinergic Neurons of the 
PPT 
In order to quantify habituation, startle amplitudes were normalized to the average of 
the first two trials for each animal. This helped to remove the differences in absolute startle 
reactivity observed between individual animals and virus types (see figure 4.8), while also 
reducing the impact of any long-term habituation that may occur across testing sessions. One 
female rat from each group (mCherry and hM4Di) was removed from this analysis as they were 
outliers (STH ratio: ±3 standard deviations). Animals received CNO (10 mg/kg IP) or vehicle (18% 
DMSO) prior to testing.  As revealed by the repeated measures ANOVA (virus × sex × drug x trial), 
both hM4Di and mCherry control animals showed progressively decreased startle across trials, 
indicative of short-term habituation (F(29,522)=4.4, p<0.001). There was no main effect of sex 
(F(1,18)=0.9, p=0.35), or drug (F(1,18)=0.74, p=0.78); however there was a significant effect of virus 
(F(1,18)=4.90, p=0.04), as well as a significant interaction between virus, drug and trial (F(29,522)=1.8, 
p<0.01).  A follow up repeated measures ANOVA (trial × sex × drug) within each group revealed 
that CNO administration significantly impacted the short-term habituation in hM4Di expressing 
animals (F(1,9)=5.90, p=0.04), but not in mCherry controls (F(1,9)=1.33, p=0.27).  
As shown in figure 4.9A, it appeared that CNO administration improved short-term 
habituation in the hM4Di expressing animals. This was further quantified using STH Ratios, as 
shown in figure 4.9B. In control animals startle responses were reduced to about half of their 
initial magnitude when given vehicle or CNO (0.53 ± 0.06, 0.52 ± 0.08, respectively). With vehicle 
administration, hM4Di expressing animals showed decreased responding by the same amount 
(0.53 ± 0.09), however, when given CNO, this ratio decreased to 0.37 (±0.05) which indicated 
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improved habituation.  A repeated measures ANOVA (sex × virus × drug) on STH ratios revealed 
that this trend failed to reach statistical significance, as we saw no effect of drug (F(1,18)=1.90 
p=0.19), virus (F(1,18)=1.05, p=0.32), or sex (F(1,18)=1.77, p=0.2), and no interaction these factors 
on STH ratios (F(1,18)=0.78, p=0.39).   
Overall, this suggests that inhibition of cholinergic PPT neurons altered short-term 
habituation as our ANOVAs revealed that the habituation curve of hM4Di animals was 
significantly changed when given CNO. During cholinergic PPT inhibition, hM4Di animals showed 
a greater and more prolonged gradual decrement in startle before reaching a stable level of 
responding (by around trial 20) compared to control groups (figure 4.9A). This also resulted in a 
slightly lower STH ratio in the hM4Di animals when given CNO (figure 4.9B), however, the latter 
failed to reach statistical significance. Thus, it appeared that the greatest effect of DREADD-
inhibition was detected in the slope of the STH curve, which reflects a faster rate of habituation.  
4.3.2.3 Short-term Habituation of Locomotion Following Inhibition of Cholinergic Neurons of 
the PPT 
For analysis of locomotion only male rats were used (n=6/group). We saw normal short-
term habituation in exploratory behaviour in both mCherry and hM4Di expressing rats. 
Ambulatory distance decreased greatly across time, as revealed by a three way repeated 
measures ANOVA (time × drug × virus). There was a significant effect of time (Greenhouse-
Geisser corrections applied: F(2.3,20)=67.8, p<0.001), and at each time point, both groups travelled 
to a similar degree as there was no effect of virus type (F(1,9)=0.2, p=0.67), or CNO administration 
(F(1,9)=0.9, p=0.37), and no interaction between these factors (F(5,45)=0.6, p=0.7). Overall, this 
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suggests that inhibition of the cholinergic PPT neurons do not influence the short-term 
habituation of non-reflexive behaviours, as displayed in figure 4.9C.  
As an important control we calculated the cumulative distance travelled, shown in figure 
4.9D, and analysed this using a two way ANOVA (virus × drug). We found that total distance 
travelled did not differ between virus groups (F(1,9)=0.1, p=0.76). We observed no main effect of 
drug (F(1,9)=0.4, p=0.54), or interaction between these  factors (F(1,9)=4.0, p=0.08), which denoted 
normal activity levels after cholinergic PPT inhibition.  
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Figure 4.9 Cholinergic Inhibition of the PPT Improves Short-Term Habituation of the ASR but 
not Locomotion 
A) All groups showed short-term habituation of startle as there was a progressive decrease in 
normalized startle magnitude (data normalized to the first 2 trials within each animal). However, 
there was a significant increase in habituation in hM4Di expressing animals when administered 
CNO. B) In hM4Di expressing animals there was a trend toward further decreased STH ratios, 
which failed to reach statistical significance (n=11/group, 7 males, 4 females). C) Both virus 
groups showed reduced exploration of the open field across time, indicative of normal 
habituation. This decrease was unaffected by CNO administration. D) Displays total distance 
travelled, which did not differ between virus groups or with CNO treatment (n=6 males/group). 
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4.3.2.4 Prepulse Inhibition of the ASR Following Inhibition of Cholinergic Neurons of the PPT 
Overall, we did not find an influence on PPI during inhibition of the cholinergic cells of the 
PPT, in contrast to our initial hypothesis. A repeated measures ANOVA (virus × sex × drug × ISI × 
dB SPL) on %PPI values revealed no effect of drug (F(1,20)=1.1, p=0.3), virus type (F(1,20)=0.7, p=0.49) 
or sex (F(1,20)=0.8, p=0.48). Silencing cholinergic PPT neurons did not influence PPI across ISIs or 
prepulse intensity as we found no interaction between virus, drug, sex, prepulse intensity, and 
ISI (F(2,40)=0.2, p=0.82).  
Consistent with past PPI studies, we observed a significant effect of prepulse intensity 
(F(1,20)=11.42, p<0.005), as shown in figure 4.10A, with greater PPI following the more intense 
prepulse (85 dB SPL). We also observed a significant effect of ISI (F(1,40)=9.48, p=0.001), and 
maximum PPI occurred using a 30 ms ISI. At this ISI (and a 85 dB SPL prepulse), control animals 
displayed 83% (±4%) inhibition with vehicle administration and 79% (±4%) with CNO; similarly 
hM4Di expressing animals showed 84% (±2%) inhibition with vehicle and 85% (±2%) with CNO. 
As shown in figure 4.10B, we observed that inhibition of cholinergic PPT neurons 
impacted baseline startle magnitude. Although our three-way repeated measures ANOVA (virus 
× sex × drug) revealed a trend towards an effect of drug (F(1,20)=4.3, p=0.05), we saw no effect of 
virus, (F(1,20)=0.5, p=0.47), sex (F(1,20)=0.1, p=0.86), or interaction between drug, sex and virus 
(F(1,20)=1.0, p=0.31). However, we did observe a significant interaction between drug and virus 
(F(1,20)=4.7, p=0.04). Post-hoc t-tests revealed that CNO selectively decreased baseline startle in 
the hM4Di expressing group (t11=2.6, p=0.02) but not in mCherry controls (t11=0.36, p=0.72).  
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Figure 4.10 Inhibition of Cholinergic PPT Neurons did not Impair Prepulse Inhibition, but did 
Alter Startle Magnitude 
Contrary to the major predictions of the field, inhibiting the cholinergic cells of the PPT did not 
disrupt PPI, as shown in A). Prepulse inhibition is plotted as % PPI, which reflects the amount of 
inhibition induced by a prepulse. We saw no difference in %PPI between control expressing 
mCherry animals and hM4Di infected animals, and no effect of systemic CNO administration 
across all testing conditions. During PPI testing, we did observe a decrease in baseline startle 
magnitude selectively in the hM4Di expressing group when given CNO, shown in B). This suggests 
that cholinergic inhibition of PPT cells may influence startle reactivity (n=12/group, 5 female, 7 
male). 
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4.3.2.5 In vitro Patch Clamp Recordings of hM4Di Expressing Neurons 
In order to determine the efficacy of our DREADD-induced inhibition on a cellular level, in 
vitro patch clamp recordings of PPT neurons expressing the viral tag mCherry were performed in 
the current clamp mode (mCherry n=2, hM4Di n=4). Cells were held at a resting membrane 
potential of -50 mV by a constant current. Prior to CNO administration, firing frequency was 1.96 
Hz (±0.11) in mCherry expressing control cells and 1.95 Hz (±0.11) in hM4Di expressing cells. After 
being bathed in CNO (5 µM in 1% DMSO) the firing frequency of mCherry cells was unchanged 
(1.96 Hz (±0.21), whereas the firing of hM4Di expressing cells was greatly reduced (0.19 Hz ± 0.06; 
figure 4.11). This reduction was statistically significant as a two way repeated measures ANOVA 
(virus × drug) revealed a significant effect of drug (F(1,4)=37.04, p=0.004), and interaction between 
drug and virus (F(1,4)=37.56, p=0.004). Overall this shows on the cellular level that CNO effectively 
inhibits hM4Di expressing neurons. 
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Figure 4.11 hM4Di Expressing Neurons are Strongly Inhibited by CNO In Vitro 
A) A representative trace of electrophysiological in vitro patch clamp recordings of mCherry 
positive neurons in the PPT in control mCherry and hM4Di-mCherry neurons before and after 
CNO treatment. B) Both types of neurons showed similar spontaneous firing rates when the 
membrane potential was held at -50 mV. When treated with CNO, hM4Di neurons showed a 
drastic decrease in firing frequency, whereas mCherry control neurons were unaffected 
(mCherry n=2, hm4Di n=4 slices).  
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4.3.2.6 In vivo Electrophysiological Recordings of the PPT Following hM4Di-Induced Inhibition of 
the Cholinergic PPT Neurons 
In order to observe the effects of DREADD-induced inhibition of the cholinergic PPT 
neurons at the population level, and to determine if this inhibition impacts auditory processing, 
we performed in vivo electrophysiological recordings (mCherry n=5, hM4Di n=4 animals). For 
each animal, we normalized individual multi-unit cluster activity to pre-CNO levels 
(%Change=activity with CNO/activity pre-CNO, 100%=no change). As shown in figure 4.12C, we 
saw that spontaneous activity was slightly, but significantly, decreased after systemic CNO 
administration in hM4Di animals as their spontaneous firing frequency was 93% (±4) of pre-CNO 
levels, whereas the mCherry controls firing frequency was 106% (±3; t6=3.6, p=0.01). Moreover, 
the proportion of multi-units within each animal that displayed a decrease in activity post-CNO 
(%Change<0) was also significantly greater in hM4Di animals (70% ±8) compared to mCherry 
controls (41% ±4; t6=3.63, p=0.01). This is displayed in figure 4.12D.  As we expected to inhibit 
only a subset of neurons within the PPT, i.e. cholinergic, but not glutamatergic or GABAergic cells, 
our slight but significant inhibition of multi-unit spontaneous activity confirms our DREADD 
system is functional at a population level in vivo.  
Interestingly, the auditory-evoked multi-unit activity to an 85 dB SPL noise burst was 
unchanged after cholinergic inhibition by CNO administration (t6=1.7, p=0.14).  Control animals’ 
auditory-evoked activity was 103% (±3) of pre-CNO levels, whereas hM4Di animals displayed 95% 
(±8) of pre-CNO activity. The proportion of auditory-evoked multi-unit responses within each 
animal that showed a decrease (%Change >0) was not different between groups either (t6=1.5, 
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p=0.18), with 40% ± 9.5 in mCherry animals and 57% ±14 in hM4Di animals (figure 4.12E & F). 
Overall this suggests that auditory responsive cells in the PPT are mainly non-cholinergic. 
 
 
Figure 4.12 The Spontaneous Activity of Multi-Unit Clusters is Reduced in hM4Di Animals via 
CNO 
A) Depicts the target area of recording within the PPT. Image was adapted from Paxinos and 
Watson (2005). B) The orange trace shows where the recording electrode, coated with DiI, was 
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placed, red cells are mCherry positive cells. Included in this analysis are animals with recording 
sites verified within the PPT and close to mCherry positive cells. Scale bar is 200 µm. C) The 
activity of each multi-unit was normalized to pre-CNO levels (100%, as indicated by the dotted 
line) and averaged within each animal to create an overall average for each group.  The 
spontaneous activity of multi-units in hM4Di expressing animal’s post-CNO was significantly 
lower than controls (mCherry: 109%, hM4Di: 93%). D) Additionally, the average proportion of 
multi-units that decreased their activity (%Change <0) was significantly greater in hM4Di animals. 
E) Relative activity of multi-units to auditory stimulation (85 dB SPL, 4 ms white noise) post CNO 
(pre-CNO = 100%, as indicated by the dotted line). Auditory responsiveness was not different 
between groups post CNO. F) The proportion of multi-units that displayed decreased activity 
(%Change <0) post CNO was also not different between groups. This suggests that auditory 
responsiveness was intact in hM4Di animals, despite inhibition of cholinergic neurons (hM4Di 
n=4, mCherry n=5). 
 
4.3.2.7 Conditioned Place Preference Following Cholinergic Inhibition of the PPT (Positive 
Behavioural Control) 
Although the experiments above provide strong evidence that our DREADD system 
inhibited cholinergic PPT neurons at the cellular and population level, it was important to prove 
that our inhibition was also able to alter behaviour. Therefore, as a positive behavioural control, 
we performed morphine-induced CPP. A subset of male rats used in ASR testing were used for 
CPP testing (n=6/group). Pre-treatment with CNO was given 30 min prior to all conditioning 
sessions (morphine and saline-paired environments). On the test day the time spent in each 
chamber was analysed using a three way repeated measures ANOVA (virus × drug × environment 
type).  
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We observed that DREADD-induced inhibition of cholinergic neurons disrupted the 
development of CPP. We found a significant effect of drug (F(1,10)=5.9 , p=0.03) and interaction 
between drug and virus type (F(1,10)=5.3, p=0.04). Post hoc t-tests revealed that on average, 
control animals spent more time exploring a morphine-paired environment compared to the 
saline-paired (t5=3.6, p=0.02). There was no place preference in the hM4Di animals (t5=0.06, 
p=0.94), as shown in figure 4.13A. We further quantified this using a preference score (time in 
morphine-paired environment/time in saline; 1=no preference). As shown in figure 4.13B, 
mCherry expressing control animals displayed a preference score of 3.96 (±0.7) which was 
significantly greater than one (one sample t-test; t5=2.9, p=0.02), indicating a strong preference 
for morphine. Again, this was absent in hM4Di animals who had a score of 1.20 (±0.34; one 
sample t-test t5=0.8, p=0.23). Overall this suggests that our DREADD-induced inhibition of 
cholinergic PPT neurons was effective at preventing the development of CPP. 
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Figure 4.13 Morphine-Induced Conditioned Place Preference is Blocked by Inhibition of 
Cholinergic PPT Neurons 
A) During the conditioning phase, both groups were pre-treated with CNO 20 min prior to 
exposure to saline- or morphine-paired environments.  We observed that inhibition of cholinergic 
neurons disrupted the development of CPP. On test day hM4Di animals spent equal time in both 
environments, whereas mCherry controls spent more time in the morphine-paired environment, 
exhibiting CPP. B) CPP within each animal was quantified using a preference score (time spent in 
Morphine-paired environment/time in Saline, 1=no preference as indicated by the dotted line). 
Animals expressing mCherry displayed a preference score significantly greater than 1, but hM4Di 
animals did not (n=6 males/group).  
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4.3.2.8 Verification of DREADD Virus Expression 
Bilateral expression of the viral-tag mCherry in the PPT was verified for all animals 
included in this study. Figure 4.14 displays a representative image of virus expression throughout 
the PPT. We examined mCherry expression within the PPT for five representative slices (see 
figure 4.14). Then, the proportion of animals expressing mCherry at that representative slice was 
calculated (n=12 animals total; # of animals expressing mCherry/12). In general, most injections 
(90%+) targeted the mid to caudal aspect of the PPT, however good expression occurred through 
the majority of the PPT. In some animals, uni-or-bilateral expression was also observed in the LDT 
(mCherry n=2, hM4Di n=1) and PGB (mCherry n=4, hM4Di n=5). Overall, expression patterns did 
not differ substantially between mCherry control animals (data not shown) and hM4Di expressing 
animals. 
To determine the proportion of cholinergic cells targeted by the virus, we performed 
immunohistochemistry for the viral-tag mCherry and examined the co-expression with the 
cholinergic midbrain marker, NADPH. The hM4Di protein (or mCherry control) seemed to be 
trafficked well throughout the cell as clear labelling of the fibers could be seen.  We counted the 
number of cells labelled with mCherry (DAB-brown), NADPH (blue) and cells labelled with both. 
Overall, we estimated that the hM4Di-mCherry protein was expressed in 89% of PPT cholinergic 
neurons (mCherry control=87%). Representative images are shown in figure 4.15C and D. Of note 
there was a small percentage of neurons that were only mCherry positive (%mCherry cells that 
were cholinergic: hM4Di=88%, mCherry=90%), roughly half of these mCherry only cells were very 
small with a diameter of less than 10 µm.  
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All our behavioural and electrophysiological data was collected during the 21-35 day time-
point and so we included only animals sacrificed at these time points for co-expression analysis 
as this more accurately represented viral expression during our experiments (mCherry n=4, 
hM4Di n=5). Animals sacrificed past this date had very strong expression of mCherry, with very 
heavy expression in areas the cholinergic PPT neurons project to (supplemental figure A.3). Using 
a fluorescent mCherry antibody, it was clear that this was due mCherry being expressed heavily 
by the axons and terminals of infected neurons. This occurred with both virus types. It may also 
be due to accumulated fluorescent toxicity, as has been suggested previously (Liu et al., 1999; for 
review see Allen et al., 2015).  
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Figure 4.14 Expression of the hM4Di-mCherry Protein Throughout the PPT 
To determine the efficacy of our viral injection we examined the expression of the viral tag 
mCherry in hM4Di expressing animals and plotted this across representative images of the PPT.  
We determined if mCherry expression within the PPT for each representative slice was present 
for each animal. Then the proportion of animals expressing mCherry at that representative slice 
was calculated (n=12). The highest proportion of animals (90%+) expressed mCherry in the 
caudal aspect of the PPT, and the lowest in the anterior (>20%). Some animals displayed 
mCherry expression in non-targeted regions, including the LDT (caudal aspect, shown in slice -
8.16) and PGB (anterior aspect, -7.4-6.84 mm). The expression of control animals did not differ 
substantially (data not shown). Images were adapted from (Paxinos and Watson, 2005).  
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Figure 4.15 The hM4Di-tag mCherry is Co-expressed with the Cholinergic Marker, NADPH 
In both images mCherry was labelled in brown (DAB), whereas NADPH (blue) marked midbrain 
cholinergic neurons. A) Representative image of mCherry and NADPH expression in the PPT (2x 
magnification). The scale bar represents 500 µm. B) Representative image of co-expression of 
NADPH and hM4Di-mCherry in the PPT at 20x magnification. Dually-labelled neurons appeared 
very dark blue, almost black, compared to cholinergic neurons not expressing mCherry (indicated 
by the red arrow). Overall, we determined that hM4Di-mCherry was expressed in 89% of 
cholinergic neurons. Here, the scale bar represents 25 µm.  
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4.3.2.9 Summary of Inhibition of the Cholinergic Neurons of the PPT  
Overall, we saw that DREADD-induced inhibition of cholinergic cells using CNO improved 
short-term habituation of the ASR, and reduced baseline startle magnitude. We did not observe 
an impact on PPI or habituation of non-reflexive behaviours. Our control experiments show that 
DREADD-induced inhibition was effective at a cellular and population level as demonstrated by 
in vitro patch clamp recordings and in vivo electrophysiology. Furthermore we observed that 
multi-unit auditory responsiveness in the PPT was unaltered by DREADD-induced inhibition, 
complementing our finding of no impairment of auditory PPI. Finally, we confirmed that our 
DREADD-induced inhibition was able to alter behaviour as inhibiting cholinergic neurons of the 
PPT blocked morphine-induced CPP.  
4.3.3 Activation of Cholinergic PPT Neurons Using Optogenetics 
For this experiment we injected a Cre-dependant optogenetic virus (rAAV5-EF1α-DIO-
ChR2(H134R)-EYFP, n=7, 1 male, 6 female), or the respective control virus (rAAV5-EF1α-DIO-
EYFP, n=6, 1 male, 5 female) into the PPT and implanted a light fiber. Cells expressing 
ChR2(H134R) were activated by blue light. In this section, sex was not included as a factor in our 
statistical analysis because of the low number of males (n=1/group).  
4.3.3.1 Startle Reactivity of ChR2 Expressing Animals 
Prior to sensorimotor gating testing, all animals completed an I/O function, which 
assessed startle reactivity with increasingly intense auditory stimuli. During testing animals were 
tethered to the LED commutator, but received no light stimulation. As revealed by a two way 
repeated measures ANOVA (virus type × sound intensity) on unamplified startle amplitudes, both 
YFP only expressing controls and ChR2 animals show increasing startle magnitudes concordantly 
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with increasing sound intensity. We found a significant effect of sound level (F(9,90)=9.2, p<0.001), 
but no effect of virus type (F(1,10)=0.9, p=0.37) or interaction between virus and sound level 
(F(9,90)=0.4, p=0.91). This indicates normal startle reactivity in both groups, without optogenetic 
stimulation, as shown in figure 4.16. 
 
 
 
Figure 4.16 Startle Reactivity is Normal in ChR2 Expressing Animals 
Both YFP controls and ChR2 expressing animals showed increasing startle responses with 
increasing sound intensity.  This suggests that the expression of ChR2 - in contrast to DREADD 
expression - does not alter startle reactivity (YFP n=6, ChR2 n=7). 
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4.3.3.2 Activation of Cholinergic PPT Neurons and its Effects on Startle Magnitude  
To see the effect of cholinergic PPT neuron activation on startle magnitude, we 
photostimulated these neurons simultaneously with the presentation of an auditory startle 
pulse. We individually normalized startle amplitudes by calculating a startle magnitude ratio 
(ratio: average startle magnitude with photostimulation/average startle magnitude without 
photostimulation). Differences from 1 indicated that photostimulation altered startle magnitude. 
As displayed in figure 4.17A, the control animals showed no change in startle magnitude with 
photostimulation as they had a ratio of 1.05 (±0.5), whereas ChR2 expressing animals had a ratio 
of 1.82 (±0.32), indicative of an increased startle magnitude with photostimulation. This 
difference in ratio was statistically significant (independent samples t-test: t11=2.23, p=0.04).  
Interestingly this effect became greater as the number of consecutive trials with 
photostimulation progressed. This is shown in figure 4.17B.  One animal was removed from ChR2 
group as it was an outlier. 
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Figure 4.17 Photostimulation of Cholinergic PPT Neurons Increased Startle Magnitude  
A) For each animal, we normalized startle amplitudes after photostimulation (Ratio: average 
startle amplitude with photostimulation/average without, 1=no change as indicated by the 
dotted line). ChR2 animals showed significantly increased startle magnitudes during stimulation 
compared to YFP controls. As shown in B) this increase appeared to be progressive. Startle 
magnitude was normalized to the first three trials prior to photostimulation for each animal.  
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4.3.3.3 Optogenetically-Induced PPI 
If PPI is mediated by the activation of cholinergic PPT neurons inhibiting the startle 
pathway, we predicted we could induce PPI by activating these neurons prior to a startling sound. 
In order to investigate this, we administered several photostimulation frequencies and 
intensities, in both unilateral or bilateral stimulation paradigms, prior to the startle pulse (see 
appendix A for more detail). Within each testing session, we also presented trials with an auditory 
prepulse as a control condition (see figure 4.3). 
Bilateral photostimulation of cholinergic PPT neurons at 50 Hz did not induce any 
inhibition of startle. In fact, similar to concurrent photostimulation, prior activation of cholinergic 
neurons facilitated startle and caused negative %PPI values, as shown in figure 4.18. We analysed 
this using a three way repeated measures ANOVA (type of prepulse × ISI × virus) and found a 
significant difference in %PPI depending on whether  a optogenetic or auditory prepulse was 
administered (F(1,11)=1106, p<0.001). Most importantly, we found a significant interaction 
between virus and prepulse type (F(1,11)=97, p<0.001), which suggested that photostimulation 
influenced ChR2 animals and controls differently.  
A follow-up ANOVA (virus × ISI) on %PPI using photostimulation prepulse conditions only, 
revealed that stimulation produced significantly different effects on ChR2 compared to YFP 
control animals across all ISIs  (F(1,5)=17, p<0.01). This effect was greatest at 15 ms, which induced 
an increase of startle magnitude by 86% (±13%) of baseline startle magnitude. Unilateral 
stimulation produced an increase in startle roughly half to bilateral stimulation (supplemental 
figure A.4), indicating that there is a dose effect depending on the amount of photostimulation 
administered before the startle stimulus.  
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As a control, within each testing session, auditory PPI was also assessed. Auditory 
prepulses (85 dB SPL) induced normal PPI in both ChR2 and control animals. We analyzed this 
using a follow up two way repeated measures ANOVA (virus × ISI) which showed no effect of virus 
type on PPI (F(1,11)=0.4, p=0.54). In control animals PPI ranged from 67-85% depending on the ISI; 
similarly in ChR2 animals it ranged from 69-87% (figure 4.18), indicating that the lack of 
optogenetically-induced PPI was not due to a general PPI deficit in these animals.  
  
 
 
  169 
 
 
 
 
 
 
 
Figure 4.18 Activation of Cholinergic PPT Neurons as a Prepulse Induces Startle Facilitation 
Bilateral activation of cholinergic PPT neurons induced a facilitation of startle magnitude in ChR2 
expressing animals, which resulted in negative %PPI values (denoted startle amplitude with a 
prepulse relative to startle amplitude without). This effect was not present in YFP expressing 
control animals. The greatest facilitation of startle was observed at the 15 ms ISI (as denoted by 
a, which references that %PPI was statistically different at 200 vs 15 ms). Auditory prepulses (85 
dB SPL) produced normal %PPI values in both ChR2 and YFP expressing animals, this suggests that 
our failure to optogenetically-induce PPI was not due to a general PPI impairment in these 
animals (ChR2 n=7, YFP n=6).  
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4.3.3.4 Optogenetically-Induced Startle Facilitation was Blocked by Systemic Nicotinic 
Antagonism 
In order to gain some insight into what kind of ACh receptor subtype mediates the 
increase in startle by photostimulation, we examined if blockade of nicotinic receptors could 
prevent this increase across both photostimulation paradigms (photostimulation as a prepulse 
OR simultaneous photostimulation during a startling sound). Animals were injected with saline 
or the nAChR antagonist mecamylamine (3 mg/kg IP) one week apart, before they were re-tested 
with 50 Hz photostimulation. 
We analyzed startle magnitude following photostimulation of the PPT as a prepulse using 
a three way repeated measures ANOVA (drug × virus × ISI). We reconfirmed that ChR2 expressing 
animals showed significantly increased  startle during photostimulation as there was a main 
effect of virus type (F(1,11)=13.5, p<0.01). We also found a significant difference between 
mecamylamine treatment and saline (F(1,11)=15.6, p<0.01), and a significant interaction between 
drug and virus type (F(1,11)=13.8, p<0.01). Post hoc t-tests revealed that, in ChR2 expressing 
animals, startle magnitude (measured by -%PPI values) significantly differed when give 
mecamylamine compared to saline (t6=4.4, p<0.01); whereas in YFP controls this was not the case 
(t5=1.0, p=0.18). Again, this effect was most prominent at the 15 ms ISI, where startle magnitude 
was facilitated by 37% by photostimulation under saline treatment (%PPI: -37 ±7%), but 
photostimulation had negligible effects under mecamylamine treatment as startle was 
magnitude was similar to baseline values without a prepulse (%PPI: 6 ±10%). Overall, in ChR2 
animals, mecamylamine blocked the increase in startle magnitude by photostimulation across 
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ISIs as there was no interaction between drug and interstimulus interval (F(3,33)=0.8, p=0.5;  figure 
4.19A). 
As a control, we examined if baseline startle magnitude or auditory PPI was impacted by 
mecamylamine treatment. Basal startle amplitude (prior to photostimulation) was not different 
in ChR2 expressing animals when given saline or mecamylamine (t6=1.7, p=0.14). With saline, raw 
startle values were 1335 mV (±240) and with nicotinic antagonism it was 1626 mV (±265). 
Additionally, auditory PPI was also unaffected by mecamylamine treatment (figure 4.19B). In a 
separate three way ANOVA (virus × drug × ISI) that examined auditory PPI, we found no effect of 
drug (F(1,11)=1.0, p=0.34), or virus type (F(1,11)=1.5, p=0.25) or interaction between these variables 
(F(3,33)=0.1, p=0.96). This demonstrated that mecamylamine’s actions were specific to blocking 
the startle facilitating effect via photostimulation of cholinergic PPT neurons. 
Similar results were obtained using concurrent photostimulation of cholinergic PPT 
neurons with an acoustic startle sound (figure 4.19C). We analyzed individually normalized startle 
amplitudes (Ratio: photostimulation startle amplitude/startle without) using a two way repeated 
measures ANOVA (virus × drug). Again, we re-confirmed that 50 Hz stimulation caused a 
significant enhancement of startle magnitude in ChR2 animals, but not controls, as there was a 
significant effect of virus (F(1,11)=6.9, p=0.02). The amount of enhancement with saline treatment, 
1.70 (±0.31), was almost identical to that previously observed with our 50 Hz testing, 1.80 
(±0.32), which demonstrated the stability of this effect (compare see figure 4.19C with 4.18A). 
Most importantly however, we found that there was a significant interaction between drug and 
virus type (F(1,11)=6.2, p=0.03). Post-hoc tests revealed that mecamylamine treatment completely 
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blocked the optogenetically induced increase in startle in the ChR2 animals (t6=2.5, p=0.04), 
whereas there was no effect of drug in YFP controls (t6=1.0, p=0.36). 
 
 
 
Figure 4.19 Nicotinic Antagonism Blocked Optogenetically-Induced Startle Facilitation 
A) ChR2 and YFP control animals received an IP injection of saline (SAL) or mecamylamine (MEC), 
before undergoing photostimulation of cholinergic PPT neurons prior to a startling sound. 
Positive %PPI indicates startle inhibition, whereas negative values indicate startle facilitation. 
Photostimulation enhanced startle magnitude relative to when no prepulse was present in ChR2 
animals. This was blocked by administration of mecamylamine. B) Presentation of an auditory 
prepulse prior to a startling pulse induced robust PPI in all animals, which was unaffected by 
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mecamylamine treatment in all groups.  C) Mecamylamine was also able to prevent startle 
facilitation by concurrent photostimulation of cholinergic PPT neurons in ChR2 animals (YFP n=6, 
ChR2 n=7). 
 
4.3.3.5 Optogenetically-Induced Conditioned Place Preference (Positive Behavioural Control) 
It has been demonstrated previously that pairing optogenetic PPT stimulation with a 
context induces conditioned place preference (Xiao et al., 2016). To ensure that our 
photostimulation paradigm was effective at activating cholinergic PPT neurons we 
optogenetically induced CPP in ChR2 expressing animals as a positive behavioural control. 
Animals were repeatedly exposed to two different environments; one was paired with bilateral 
photostimulation of the PPT and the other was not. One animal from the ChR2 group was 
eliminated from analysis as it was unable to complete testing. 
 On test day, animals freely roamed the test chamber and the time spent in each 
environment type was recorded. We analysed this using a two way repeated measures ANOVA 
(environment × virus). Animals expressing ChR2 tended to spend more time in the 
photostimulation-paired environment (287 ± 26 s) compared to no stimulation-paired (215 ± 20s, 
see figure 4.20A). Control YFP animals spent a similar amount of time in the stimulation-paired 
environment as the unpaired (198 ± 24s and 238 ± 24s, respectively). However this trend just 
failed to reach statistical significance as we saw no effect of virus (F(1,10)=4.3, p=0.06), 
environment (F(1,10)=0.14, p=0.71) or interaction between these factors (F(1,10)=2.3, p=0.16). 
An individual preference score was calculated for each animal (time spent in paired/time 
spent in unpaired, 1=no preference). On average ChR2 animals had a preference score of 1.42 
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(±0.2), which was significantly different from 1 (one-tailed, one sample t-test: t5=2.3, p=0.03). 
Control YFP animals had a preference score of 0.94 (±0.2), which was not significantly different 
from 1 (t5=0.2, p=0.42; figure 4.20B). This suggests that photostimulation-induced a mild 
conditioned place preference in ChR2 animals but not controls. 
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Figure 4.20 Activation of Cholinergic PPT Cells is Sufficient to Induce Mild CPP 
Animals were exposed to two different environments, one paired with photostimulation of the 
PPT and one without. A) On test day, ChR2 animals tended to spend more time in the side paired 
with activation of cholinergic PPT neurons, however, this just failed to reach statistical 
significance (p=0.06). B) A preference score was calculated for each individual animal (time spent 
in stimulation-paired environment/time in non-stimulated environment, 1=no preference as 
indicated by the dotted line). ChR2 displayed a significant preference for the paired side, whereas 
YFP controls did not (n=6/group).  
  
 
 
  176 
 
 
4.3.3.6 Verification of ChR2 Expression and Photostimulation Efficacy using c-FOS 
All of the animals included in this analysis had bilateral expression of the either the virus 
containing the ChR2(H134R) opsin or YFP control. Placements of the light fiber implants were 
also verified to be within (or just above) the PPT (see figure 4.21). Although there was some 
spread in terms of the location of the light fiber, in general, most targeted the mid PPT.  
We examined the expression of the viral-tag YFP and the co-expression with the 
cholinergic marker ChT or the cellular activation marker, c-FOS. The ChR2(H134R) protein (or YFP 
control) seemed to be trafficked through the cell well as clear labelling of many fibers could be 
seen.  We counted the number of cells labelled with YFP, ChT (red) and cells labelled with both. 
Overall we estimated that the ChR2(H134R)-YFP protein was expressed in 70% of PPT cholinergic 
neurons (YFP control=73%). Inversely, 95% of YFP expressing neurons were cholinergic 
(ChR2(H134R), YFP controls: 89%). An example image is shown in figure 4.22A. This confirmed 
that ChR2 was expressed in the majority of PPT cholinergic neurons, but not in non-cholinergic 
neurons. 
We then analysed the co-expression of YPF with the cellular activation marker, c-FOS. We 
found that our stimulation parameters induced c-FOS expression in 71% of ChR2(H134R)-YFP 
expressing neurons, whereas in YFP controls only  8% of YFP expressing cells also expressed c-
FOS. An example image is shown in figure 4.22B. In both YFP control and ChR2(H134R) animals 
non-YFP labelled cells were also expressing c-FOS. This could be due to basal levels of expression, 
as animals were awake and mobile in their home-cages during photostimulation. We cannot rule 
out however, that the heat or light activated off-target cells. Overall however, our staining 
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indicated a good expression level of the optogenetic virus specifically in cholinergic cells, and that 
our photostimulation paradigm was sufficiently activating these cells. 
 
 
 
 
Figure 4.21 Placement of Bilaterally Implanted Light Fibers 
A) This image displays the sagittal view of the PPT (medial/lateral plane: ±2.1). Shown in blue are 
the placements of the light fiber tips in ChR2(H134R) expressing animals, and black represents 
YFP controls. Triangles denote placement on the right side and dots on the left. It appeared that 
in both groups, the hits varied throughout the PPT, denoting good placement and stimulation. 
Images were adapted from (Paxinos and Watson, 2005). B) Is a representative image of the tracts 
of implanted light fibers. Scale bar is 500 µm. 
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Figure 4.22 ChR2(H134R) is Expressed in Cholinergic Neurons and Photostimulation is Effective 
A) Expression of ChR2(H134R and its co-expression with a cholinergic marker, ChT. Overall we 
estimated that the virus was expressed in 70% of cholinergic neurons within the PPT (YFP 
controls: 73%). Furthermore, we verified our photostimulation was effective using the cellular 
activation marker, c-FOS, shown in panel shown in panel B). Expression of c-FOS and 
ChR2(H134R)-YFP neurons: 71% of ChR2(H134R)-YFP neurons expressed c-FOS, (YFP control 
animals: 8%)  
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4.3.3.7 Summary of Cholinergic PPT Activation  
Overall, we observed that activation of cholinergic PPT neurons facilitated startle. This 
was reliably observed if activation was during a startling sound or if activation was used as a 
prepulse. This enhancement was blocked by the nicotinic antagonist mecamylamine. We 
validated our optogenetic manipulations by recapitulating the previously reported induction of 
CPP through PPT cholinergic activation, as well as increased c-FOS activation in infected 
cholinergic neurons. 
4.4 Discussion 
The goal of these studies was to decipher the role of PPT cholinergic neurons in startle 
and startle modulation. The anatomical and cell-type specificity necessary for these experiments 
required the use of a transgenic rat model. As previously discussed, it is important to ensure that 
the transgene expression does not alter basal sensory filtering or sensorimotor gating abilities. 
As a first step, we therefore tested transgenic animals in comparison with WT littermates. We 
found that transgenic males had slightly lower maximal startle amplitude than their WT 
counterparts (figure 4.4B). The transgenic male’s startle magnitude was still very robust, 
detectable, and identical to that of WT females.  Additionally, all transgenic animals had the same 
startle threshold as WT (~85-90 dB SPL, figure 4.4A). This difference in maximum startle 
amplitude was not due to an effect of weight on signal detection as males from both genotypes 
weighed approximately the same. Regardless of this difference in startle reactivity, I found no 
differences in habituation (figure 4.6) or PPI (figure 4.7) of the ASR in transgenic rats. Moreover, 
we found no differences in the habituation of motivated behaviours or general locomotor 
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behaviour (figure 4.6). Therefore, I concluded that these animals were an appropriate model to 
study sensory filtering and sensorimotor gating mechanisms using optogenetics and DREADDS.  
This study used two complimentary approaches to investigate cholinergic PPT 
contributions to startle, PPI and locomotor behaviour: neuronal silencing by DREADDS and 
optogenetic activation. We validated that methods were functional using electrophysiological 
recordings (figure 4.11 & 4.13) or c-FOS labelling (figure 4.22). Functionality at a cellular level, 
however, does not necessarily equate that a system will be sufficient to impact behaviour. 
Therefore, we included CPP a positive behavioural control. Inhibition of these neurons disrupted 
morphine-induced CPP (figure 4.13), whereas activation of these neurons were sufficient to 
induce CPP (Xiao et al., 2016, also see Gut & Winn, 2016 for discussion). We confirmed these 
findings (figures 4.13 and 4.20); as these served as a positive control measure, they will not be 
discussed further. Together, the control experiments across different levels of analysis suggest 
that both the DREADD inhibition and optogenetic activation were functional.  
4.4.1 Prepulse Inhibition 
According to the current hypothesis of the majority of sensorimotor gating literature, the 
major mechanism of PPI is an inhibition provided by cholinergic neurons of the PPT to startle-
mediating areas of the brainstem, the PnC. To test this directly, we inhibited these neurons during 
sensorimotor gating testing using DREADDs. We found no impairment of PPI (figure 4.10A). 
Instead, we found that in hM4Di-expressing animals, CNO induced a general decrease in startle 
magnitude (figure 4.10B). The lack of PPI impairment following cholinergic PPT inhibition was not 
due to a dysfunctional DREADD system. We confirmed our cholinergic PPT inhibition was 
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functional through in vitro recordings at the neuronal level and observed robust inhibition (figure 
4.11). Additionally when we performed in vivo electrophysiological recordings we saw a slight 
reduction in the spontaneous activity of multi-unit clusters following CNO administration (figure 
4.12C & D). This was fitting with select inhibition of a subset of neurons within the PPT. We also 
examined auditory-evoked activity and found that cholinergic inhibition did not significantly alter 
auditory responsiveness within the PPT (figure 4.12E & F). If these neurons were critical for 
auditory PPI, we should have observed a decrease in auditory responsiveness.   
Intact auditory processing and PPI post CNO administration provided a cohesive rationale 
for our findings and past studies (e.g. MacLaren et al., 2014), however it must be acknowledged 
that we inhibited these neurons, not irreversibly silenced them. Activation of the hM4Di protein 
hyperpolarizes neurons via activation of potassium channels (Armbruster et al., 2007) and 
inhibits presynaptic neurotransmitter release (Stachniak et al., 2014). It cannot be ruled out that 
suprathreshold stimuli may have overpowered this inhibition. However, our complimentary 
optogenetic data suggests this was not a large factor. In general, our findings mirror the effects 
of a cholinergic lesion by a diphtheria toxin-fusion protein as reported by MacLaren et al. (2014), 
however, their reduction in startle magnitude was much more profound. Our hM4Di tag, 
mCherry, was highly expressed by cholinergic neurons and expression spread throughout the 
majority of the PPT (figures 4.15 and 4.16), much like the spread and efficacy of the previously 
reported lesions. Therefore, differences in the magnitude of startle reduction between these two 
studies may highlight the difference between temporary inhibition compared to total removal of 
these neurons. 
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To further address the role of cholinergic PPT neurons in PPI, we also attempted to induce 
PPI by optogenetically activating these neurons prior to a startling sound – basically to see if 
photostimulation could replace the acoustic prepulse. Instead of inhibiting startle, we found 
activation of these neurons enhanced startle, resulting in negative PPI values, or startle 
facilitation.  The lack of optogenetically-induced PPI was not due to an impairment of PPI in 
general as auditory prepulses reliably induced PPI (figure 4.18). Moreover, when we 
photostimulated these neurons during a startle response, this also increased startle magnitude 
(figure 4.17A). This nicely compliments our hM4Di-induced reduction in startle, indicating that 
cholinergic neurons in the PPT can indeed modulate startle responses, but they seem to facilitate 
startle rather than inhibit it, ruling out any major role in the mediation of PPI.  
Our findings add to the growing body of more recent literature that has started to suggest 
that PPT cholinergic neurons are not the primary mechanism underlying PPI. While this 
contradicts the majority of the traditional predictions within the field, there is now converging 
evidence using both acute (current study) and chronic manipulations (Machold, 2013; MacLaren 
et al., 2014) of spatially restricted cholinergic function. Therefore, we suggest that ACh modulates 
PPI, presumably at the level of the PPT, but it does not mediate PPI. It is likely that other cells, 
within the PPT and/or even outside of it, play a more important role than previously assumed. 
Future studies should seek to re-examine the neural circuitry of PPI and test if GABAergic and/or 
glutamatergic PPT neurons are responsible for PPI. 
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4.4.2 Modulation of Startle Magnitude  
Both of our complimentary methods found that cholinergic PPT neurons modulated 
startle reactivity: inhibition reduced startle magnitude whereas activation increased it. Thus, the 
role of cholinergic midbrain neurons seems to be to maintain or enhance startle reactivity. This 
is fitting with the cholinergic PPT neuron’s role in arousal. These neurons have been 
demonstrated to be critical in sleep-wake transitions (Van Dort et al., 2015), and are part of the 
Ascending Reticular Activating System. Increased startle reactivity may be a reflection of 
increased arousal. Overall, based on our findings, we predict that the PPT acts as an integration 
point to modulate startle magnitude. 
Stimulation of cholinergic PPT neurons enhanced startle magnitude (figure 4.17B & figure 
4.18A), fitting with sensitization and/or PPF. Our observed improvement of short-term 
habituation of the ASR was surprising when examined in within the scope of previous literature 
as ACh has not been linked short-term habituation of the ASR. However, our results would be 
very logical if these neurons are involved in sensitization of startle. According to the dual process 
theory, behavioural output is the sum of the opposing forces: habituation and sensitization 
(Groves and Thompson, 1970). Inhibition of these neurons could have inhibited sensitization, 
resulting in improved short-term habituation. Indeed, our observed enhancement of short-term 
habituation had the greatest influence on the rate of habituation, i.e. at early trials, which are 
supposedly influenced by sensitization to a greater degree than later trials, where sensitization 
subsides (Pilz and Schnitzler, 1996). Additionally,  cholinergic drugs have been known to generally 
enhance startle magnitude (see Chapter 3 or Acri et al., 1995; Philippens et al., 1997), but little 
research has investigated if these types of effects contribute to the mechanism of startle 
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sensitization. Furthermore, as these studies have used systemic manipulations it is unclear to 
what extent cholinergic effects on startle magnitude are due to modulatory brain regions, or due 
to side effects on motor systems. Our evidence highlights a potential central mechanism of 
sensitization that involves the cholinergic cells of the PPT. 
It has been well documented that substance P is involved in the sensitization of the ASR. 
Local infusions of substance P into the PnC increased startle magnitude; furthermore, 
antagonism of this neuropeptide prevented sensitization of startle via foot shocks (Krase et al., 
1993). Interestingly, Kungel et al. (1994) found that the substance P innervation of the PnC mainly 
came from the PPT and LDT. They also observed that substance P’s ability to increase excitability 
of PnC neurons was increased with the co-administration of a cholinergic agonist. An estimated 
30% of cholinergic  neurons in the PPT co-express substance P markers (Standaert et al., 1986).  
At this point, it is unclear if these neurons modulate startle in the same manner as solely 
cholinergic neurons or not. It could be that cholinergic neurons that co-express substance P have 
a role in sensitization and enhance startle magnitude, whereas those that only release ACh are 
important for PPI and inhibit startle magnitude. Both our DREADD and optogenetic methods 
would have infected both types of cholinergic neurons. If this was the case, it appears that 
cholinergic substance P expressing neurons have a dominant effect on startle magnitude that 
overshadowed any inhibition of startle. This would be fitting with the well-documented inhibition 
of giant PnC neurons that occurs in vitro (Bosch and Schmid, 2006, 2008; Pinnock et al., 2015).  
However, there is evidence to suggest that this dual role of cholinergic neurons is not 
feasible.  Our findings of unimpaired auditory processing within the PPT following inhibition of 
cholinergic neurons indicate that non-cholinergic neurons are better suited to provide the 
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inhibition necessary for PPI. Additionally, in vitro recordings of unidentified PnC neurons in the 
cat following electrical stimulation of the PPT caused prolonged excitatory responses which was 
blocked by administration of scopolamine, a muscarinic antagonist, and could be induced using 
an ACh agonist (Homma et al., 2002). Therefore, we propose that ACh may have differential 
effects depending on cell types within the PnC, and/or depending on whether it is synaptically 
released or tonically present. However, it remains undetermined how cells within the PnC 
incorporate various inputs to determine behavioural output, or how other cell types modulate 
giant-neuron activity. Regardless, the dominant effect of midbrain cholinergic regulation 
appeared to be an increase in PnC excitability, which resulted in higher startle amplitudes. 
4.4.3 Nicotinic Receptors and Startle Magnitude 
Our optogenetically-induced enhancement of startle magnitude was blocked by systemic 
administration of the nicotinic antagonist, mecamylamine (figure 4.19A). Although it robustly 
reduced the enhancement of startle, mecamylamine treatment did not alter auditory PPI (figure 
4.19B) consistent with previous studies (Curzon et al., 1994; Higashino et al., 2016). Although 
here we have shown that nicotinic receptors are critical for optogenetically-induced 
enhancement, it is not clear which nAChR subtype is responsible. In general, systemic nicotine 
and nicotinic receptor agonism have been well documented to increase startle magnitude and 
improve PPI (Acri et al., 1994; Acri et al., 1995). In Chapter 3 we suggested that the α7-nAChR is 
critical for the systemic nicotine effect. However, local infusions of nicotine directly into the PnC 
have been shown to disrupt PPI, which appeared to be mediated by α4-β2 nAChRs and not α7-
nAChRs. Therefore, both α4-β2 nAChRs as well as α7-nAChRs seem to modulate startle, although 
apparently at different brain regions. Whereas there is evidence that α4-β2 nAChRs are 
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expressed in the PnC, startle modulation by α7-nAChRs seems to be mediated by higher brain 
structures (Pinnock et al., 2015). Both could be involved in our observed nicotinic-mediated 
modulation of startle reactivity. Moreover, it is important to note that chronic activation of 
nicotine receptors by agonists might lead to receptor internalization, thereby rendering them 
antagonists, hence any study involving the application of nicotine or other agonists must be 
interpreted very carefully.   
Local circuitry within the PnC and PPT is poorly understood. It is important to keep in mind 
that the optogenetic and chemogenetic manipulations of PPT cholinergic neurons could have 
impacted either inhibitory glycinergic or GABAergic interneurons or other excitatory cell types 
within the PPT or PnC, which ultimately promoted excitability of the giant-neurons and enhanced 
startle. Additionally, cholinergic PPT neurons also project to several other areas known to be 
critical for startle, including the inferior colliculus (Semba and Fibiger, 1992) and cochlear nucleus 
(Mellott et al., 2011). For example, it has been shown that cholinergic agonism within the 
cochlear nucleus increased neuronal activity (Chen et al., 1998), which could fit with our observed 
results.  As we have stated before, studies have also shown that within the PnC substance P 
induces excitatory responses of unidentified neuron types, and that was enhanced by cholinergic 
agonism (Kungel et al., 1994). Therefore, it could be that some of our findings are also due to the 
actions of substance P.  
Overall, we conclude that there is no simplistic circuit that could reconcile all observations 
with regards to cholinergic modulation of startle. But regardless of where the mechanism of 
action occurs, it is clear from our data that cholinergic projections from the PPT serve to modulate 
startle, more specifically enhance it, and that this is at least partially mediated though nicotinic 
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receptor activation. Future experiments need to address the details of neural circuitry and 
synaptic mechanisms. 
4.4.4 Habituation of the ASR and Locomotor Behaviour 
In contrast to effect on short-term habituation of the ASR, we did not observe any 
influence on the short-term habituation of the motivated behaviour, i.e. locomotion (figure 4.9C 
& D). Habituation of the ASR and locomotor behaviour have been long known to be differentially 
regulated (Hughes, 1984). Here we provide evidence that sensitization of these behaviours are 
also differentially regulated. Our evidence suggests that sensitization (or enhanced arousal, 
future studies will need to pinpoint the mechanism underlying our observed startle modulation) 
mechanisms do not reflect a global heightening of excitability that robustly enhances all 
behavioural responding. Instead, sensitization of different behaviours appeared to be 
differentially mediated.  
ACh has been previously documented to be important for both the short- and long-term 
habituation of locomotor behaviour (Schildein et al., 2002; Lamprea et al., 2003; Dere et al., 
2008). In particular, cholinergic activity within the nucleus accumbens, an area the PPT projects 
to (Dautan et al., 2014), has been particularly implicated (Schildein et al., 2002). However, our 
data indicates that the midbrain cholinergic neurons are not providing the input necessary for 
this behaviour. Other cholinergic centers may relay this information to the nucleus accumbens. 
Indeed, it has been shown that habituation of locomotor behaviour was more strongly correlated 
with cholinergic activity in the hippocampus (Thiel et al., 1998; Giovannini et al., 2001). 
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Finally, the PPT has been traditionally thought of as a nucleus that is highly important for 
motor control, specifically locomotion. In a recent review it was suggested that the PPT does not 
directly mediate locomotion, but can modulate it through its participation in part of a lower-level 
action selection process (Gut and Winn, 2016). We observed no impairment in locomotion 
following cholinergic inhibition of the PPT (figure 4.9D) and no impact of cholinergic activation 
on locomotor behaviour (data not shown). This is fitting with the newly conceptualized role of 
the PPT as part of a low level action selection circuit, as proposed by Gut and Winn (2016). 
4.4.5 Caveats 
Like any study, our observations should be considered with a few caveats in mind. Firstly, 
although we found no alterations in the sensory filtering or sensorimotor gating capabilities of 
within the transgenic Cre-ChAT rat line, transgenic animal models may not always best reflect 
normal physiological functioning. Transgenic animals can have off-target effects that alter 
behaviour, cognitive, or muscular function (e.g. see Kolisnyk et al., 2013). Although we found no 
major indication that this was the case, and others have published behavioural studies using this 
identical line (Pienaar et al., 2015; Xiao et al., 2016), there could be off-target effects that we are 
not currently aware of. 
With regards to our DREADD-induced inhibition of the cholinergic PPT, we found some 
unexpected data that should be noted. Firstly, we saw that startle magnitude and reactivity was 
different between hM4Di-expressing animals and mCherry controls (figure 4.8). This was of 
special concern because this testing was conducted without administration of CNO. Cre-ChAT 
rats (with no virus injection) show a very similar curve to that of mCherry control Cre-ChAT rats 
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(compare with figure 4.4) indicating that the surgical procedure itself did not impact this. 
Therefore, this implies that the hM4Di receptor potentially had constitutive or basal activity that 
did not require ligand binding.  A recent paper by Roth (2016) has reviewed how high expression 
levels of DREADD proteins may be particularly susceptible to this. As we observed very robust 
inhibition at the neuronal level (figure 4.11) and mCherry labelling was very dark and trafficked 
well throughout the entire neuronal body and processes (figure 4.15), it is likely that this 
accounted for our observed increase in startle reactivity. Furthermore, during our in vivo 
electrophysiological recordings it is possible that we again detected this constitutive activity: the 
signal to noise ratio we observed specifically in hM4Di infected PPT neuronal recordings 
prevented us from being able to isolate single-unit data. This was not a technical issue because 
we were able to decipher single-unit activity in mCherry controls. Why constitutive activity of an 
inhibitory receptor would increase startle reactivity or alter the noise-floor of 
electrophysiological recordings is unknown, but it might be through non-specific effects on any 
signalling pathway within the cell.  
Lastly, it should be noted that although optogenetic stimulation is a powerful tool, the 
stimulation frequency and intensity used in this study likely does not accurately reflect 
endogenous physiological activity of cholinergic PPT neurons. This is a frequent critique of 
optogenetics as it is still a new technology (Boyden, 2015; Deisseroth, 2015). Our stimulation 
paradigm was 50 Hz, but the maximum frequency the ChR2(H134R) opsin can entrain to is likely 
around 40 Hz (Fenno et al., 2011). It is unknown which stimulation frequency would be best 
suited to capture the natural activity of PPT cholinergic neurons, if it is possible at all. Instead, we 
decided to use a stimulation paradigm that presumably induced maximum cholinergic-PPT 
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activation. Therefore, our high photostimulation frequency should induce robust, but not time-
locked, neuronal activity. Future studies should attempt to modulate neuronal activity in a more 
physiologically relevant manner when possible. 
4.4.6 Conclusions 
This study has uncovered an exciting role for midbrain cholinergic neurons in the 
modulation of startle. Fitting with more recent studies by others, we were unable to find any 
alteration of PPI with cholinergic PPT manipulation. Our DREADD and optogenetic systems were 
validated at the neuronal and behavioural level which indicated that the lack of on impact on PPI 
was not due to methodological issues. This adds to the growing evidence suggesting that 
activation of these neurons are not the primary mechanism underlying PPI (see also Machold, 
2013; MacLaren et al., 2014).  Instead, we found that midbrain cholinergic function serves to 
generally modulate startle reactivity. Inhibition of these neurons decreases startle, whereas 
activation reliably enhances it, in accordance to the role of cholinergic PPT neurons in arousal 
and hinting on a potential role in startle sensitization.  There is no impact of these neurons on 
locomotor behaviour. Although we have implicated nicotinic receptors in mediating this 
enhancement of startle magnitude, future studies will have to determine if other receptors play 
a role, and at what part in the startle circuitry this effect occurs. Although we did not discuss the 
role of the cholinergic midbrain in CPP here this is an exciting development. Future studies may 
also want to better examine the impact on VTA and nucleus accumbens dopaminergic signalling, 
and what receptors are responsible for this as well. Again, this may lead to a better understanding 
about how the cholinergic cells serve to encode context, and if this is related to their function in 
arousal.  
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5. Chapter 5: General Discussion 
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5.1 A Summary of Cholinergic Modulations of the Acoustic Startle Response 
Appropriate filtering of unnecessary sensory information is critical for normal cognitive 
functioning. To study sensory filtering, I used prepulse inhibition and habituation of the ASR. I 
manipulated cholinergic activity using a variety of methods including transgenic and KO mice 
models, DREADDs and optogenetics. The results are summarized in Table 1. 
In Chapter 2, I reported that reduced cholinergic tone did not impact PPI or short-term 
habituation, but impaired long-term habituation. I was able to rescue this deficit by enhancing 
remaining cholinergic activity via galantamine. This is the first evidence that ACh is involved in 
long-term habituation of the ASR, as ACh was previously assumed to have no role in habituation 
of reflexive behaviours.  
Next, narrowing my research focus, I investigated which specific cholinergic receptors might 
mediate cholinergic modulation of the ASR. To do so I examined habituation and PPI in an α7-
nAChR KO mouse line (Chapter 3). Disruptions in this receptor have been documented in 
schizophrenic populations and have been correlated with other measures of auditory gating 
(Freedman et al., 1997; Freedman et al., 2000; Leonard et al., 2002). I found normal long- and 
short-term habituation, but mildly impaired PPI in these mice. This suggests that the α7-nAChR 
is not critically involved in mediating PPI. Despite impairments in PPI, I found no correlation with 
higher cognitive spatial abilities in the Barnes maze task. Future studies may want to investigate 
if sensory filtering and sensorimotor gating disruptions correlate better with differential aspects 
of cognition (e.g. sustained attention) to provide an overview of how these processes relate to 
the broad spectrum of cognition (Cyr et al., 2015).  
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I also found exciting evidence that nicotine-induced enhancement of startle magnitude and 
PPI were absent in α7-nAChR KO mice. This is the first evidence that narrows the mechanism of 
this PPI enhancement by nicotine to a single receptor. It also adds another layer to the well 
documented pro-cognitive effects α7-nAChR agonism, further supporting the targeting of these 
receptors as treatment options for individuals with PPI impairments, namely schizophrenia 
(Martin et al., 2004; Olincy et al., 2006). 
Lastly, my goal was to pinpoint to what extent midbrain cholinergic neurons in the PPT are 
responsible for startle modulations using the newly available tools of optogenetics and DREADDs. 
For the first time, this allowed for the transient and specific activation/inactivation of these 
neurons during sensory filtering and sensorimotor gating tasks. The PPT has largely been 
hypothesized to provide inhibitory cholinergic input that mediates PPI (Koch et al., 1993; 
Swerdlow and Geyer, 1993; Fendt et al., 2001). In contrast to this long-standing concept, I found 
that inactivation of these neurons reduces startle magnitude and enhances short-term 
habituation, whereas activation of PPT cholinergic neurons increases startle magnitude. I 
interpreted these results to suggest that cholinergic PPT neurons modulate startle reactivity, but 
not in the way the field traditionally thought. It appears that the dominant effect of cholinergic 
neurons is to enhance, not inhibit, startle. I suggest that this modulation fits well with the general 
role of these neurons in arousal and discuss that this may also be a mechanism of startle 
sensitization. In fact, one possibility is that the PPT may serve as a locus of plasticity and 
integration for long-term modulation of startle (i.e. long-term habituation or sensitization). 
Fitting with its role in arousal and association of environments and rewards (Olmstead and 
Franklin, 1993; Kobayashi et al., 2002; Petzold et al., 2015; Xiao et al., 2016), these cells could 
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serve to tonically regulate startle-mediating PnC excitability. I found no role of these neurons in 
regulating locomotor activity, adding to the growing body of literature that suggests that PPT 
neurons are a center for early action selection rather than a locomotor area (Gut & Winn, 2016).   
 5.1.1 Future Directions 
Overall, my studies did not reveal a substantial role for Ach signaling in PPI, contrary to 
the predominant theories in the field. This may suggest that ACh only modulates, but not 
mediates, PPI. This is clearly illustrated in Table 1: we used several different manipulations of 
cholinergic activity, none of which profoundly impacted PPI. In fact, the only impairment of PPI 
we found was a mild deficit in α7-nAChR KO mice; additionally optogenetic stimulation of 
cholinergic neurons facilitated, not inhibited, startle response magnitude. Therefore, it is likely 
that other neurotransmitters play a more important role than traditionally thought.  
Overall, my evidence suggests that the neural circuitry of PPI may need a new framework 
that remedies its current emphasis on the cholinergic midbrain. Firstly, better understanding the 
independent roles of GABAergic or glutamatergic cells within the PPT is critical as it is probable 
that one, or both, of these cell types are very important for PPI, since general lesions to the PPT 
reliably induced PPI deficits (Koch et al 1993; Swerdlow and Geyer, 1993; MacLaren et al., 2014).  
Additionally, it would be interesting to investigate other potential sources of cholinergic 
input to the PnC or other areas within the startle circuitry that may impact PPI. Better 
understanding of cholinergic inputs to the PnC and other brain regions involved in PPI is the key 
to determining the site of cholinergic modulation of PPI as pharmacological studies have reliably 
documented this effect (Fendt and Koch, 1999; Jones and Shannon, 2000a, b; Yeomans et al., 
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2010; Pinnock et al., 2015). As our evidence suggests that cholinergic PPT neurons may not be as 
critical as traditionally thought, these types of future studies will help us more accurately reframe 
the PPI network (figure 1.3). Future studies should consider examining a recently suggested 
circuit for PPI that entails cholinergic neurons of the ventral nucleus of the trapezoid body 
modulating the activity of cochlear root neurons, a critical junction within the primary startle 
pathway (Gomez-Nieto et al., 2008; Gomez-Nieto et al., 2014, see figure 1.3). 
Furthermore, as my results also suggest a new role for the PPT in startle modulation, i.e. 
maintaining and potentially sensitizing general startle reactivity, this role will need to be further 
studied (see Table 1). Firstly, I hypothesize that the observed results are mediated mainly by the 
subset of cholinergic neurons that co-express Substance P. Differentially examining the role of 
cholinergic neurons that co-express substance P versus those that do not, could uncover a subtle 
network that may exist within the PPT. Secondly, our observed midbrain cholinergic modulation 
of startle magnitude may suggest that this center may be the locus of plasticity necessary for 
long-term habituation. This locus was previously proposed (see Jordan and Leaton, 1983; Leaton 
et al., 1985), however the field has not yet determined the site for this integration. We believe 
the cholinergic midbrain is of particular interest because in Chapter 2 we highlighted that ACh 
was important for long-term habituation. Due to methodological considerations, I was unable to 
include an investigation of long-term habituation in Chapter 4, so ongoing studies are currently 
addressing this.  
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5.2 Differential Cholinergic Modulation of Reflexive vs. Non-Reflexive Behaviours 
It has been well documented that ACh differentially modulates habituation of reflexive 
and non-reflexive behaviours (Hughes, 1984). To examine this issue, I compared the habituation 
of the ASR compared to locomotor behaviour in α7-nAChR KO mice, as well as during inhibition 
of cholinergic PPT neurons. In both cases I did not find an impact on habituation of locomotor 
behaviour. This highlights the potential importance of other cholinergic brain regions, e.g. the 
hippocampus, in this type of behaviour.  
I reported that inhibition of cholinergic PPT neurons improved startle habituation, likely 
via a reduction in sensitization, without impacting locomotor habituation. This suggests that both 
habituation and sensitization of reflexive vs. non-reflexive behaviours is differentially mediated. 
Again, this highlights the complexity of related, but distinct, cognitive processes and shows that 
there is no ubiquitous sensory filtering mechanism. It is important to identify these subtle 
distinctions underlying these processes so that we can identify common treatment targets for 
the shared hallmarks of cognitive dysfunction across diseases.  
5.3 The Role of Nicotinic Receptors in Startle Modulation 
I have reported that nicotinic receptors, particularly the α7-nAChR modulate PPI (Chapter 
3). I have also demonstrated that nicotinic receptors play a key role in the modulation of startle 
magnitude. Nicotine-induced enhancement of startle magnitude was absent in α7-nAChR mice, 
and global nicotinic blockade was able to prevent optogenetically-induced enhancement of 
startle. Future studies should seek to determine at what points within the startle circuitry this 
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modulation is occurring, and what the physiological or behavioural relevance of startle 
magnitude may indicate.  
Many disorders have been documented to have an increase in startle magnitude including 
Post-Traumatic Stress Disorder (Grillon et al., 1996; however, see Morgan et al., 1996) or 
Generalized Anxiety Disorder (Ray et al., 2009). We need to better understand the mechanisms 
underlying enhancement of startle magnitude, including PPF or sensitization, in order to help find 
treatment options for populations like this. However, it should be noted that ACh has not been 
strongly linked to either of these disorders.  
Manipulation 
of Cholinergic 
Activity 
Impact on PPI Impact on 
Baseline Startle 
Magnitude 
Impact on STH Impact on 
LTH 
Global 
Reduction of 
Cholinergic 
Tone (via 
VAChT KD) 
None None None Grossly 
impaired, 
rescued by 
ACh agonism 
Global KO of 
the α7-nAChR 
Mild 
impairment, 
nicotine-
induced 
enhancement 
of PPI is absent 
None, nicotine-
induced 
enhancement of 
startle is absent 
None No Impact 
Chemogenetic 
Inhibition of 
Cholinergic PPT 
Neurons 
None Reduced Slight 
enhancement 
N/A 
Optogenetic 
Activation of 
Cholinergic PPT 
Neurons 
Facilitates 
startle 
response:  
(-%PPI) 
Enhanced, 
blocked by 
nicotinic 
antagonism 
May induce 
sensitization 
N/A 
Table 5.1: A Summary of Results 
Overall, manipulations of cholinergic activity did not impact PPI. While we were able to see a mild 
contribution of nicotinic receptors to PPI, a global knock-down of ACh did not impact PPI. 
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Furthermore, manipulation of cholinergic neurons in the midbrain nucleus, the PPT, impacted 
startle response magnitude in the opposite manner traditionally supposed by the field. Our 
results suggest that ACh plays a minor role in PPI but that future studies should re-examine the 
role of other neurotransmitters in this process. 
5.4 Conclusions 
This thesis highlights the modulatory role of cholinergic activity during the processing of 
the acoustic startle response. My results indicated that cholinergic signaling is not critical for 
mediating PPI, as traditionally hypothesized. Instead, my studies demonstrate that the most 
robust effect of cholinergic modulation is to maintain startle reactivity and potentially regulate 
sensitization of the startle response, which seems to be at least partially mediated through 
nicotinic receptors. This is summarized in Table 1. Future studies should seek to further 
understand if this midbrain cholinergic modulation of the ASR is critical for sensitization and its 
potential role in long-term habituation phenomena.  In addition, my findings would suggest that 
the functional neuronal circuitry underlying PPI needs to be re-evaluated, starting with 
distinguishing GABAergic vs glutamatergic modulations of PPI within the PPT.   
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Figure A.1 Pilot Data Determining Effective CNO Dosage 
Pilot testing demonstrated that only at a 10 mg/kg dose of CNO we were able to see a differential 
effect in hM4Di animals compared to mCherry controls.  At this dose, hM4Di animals show 
significantly decreased startle amplitudes (raw data plotted, t7=3.6, p=0.004). This was not 
apparent in control animals, or at any other dose tested (3 mg/kg in saline or 3 mg/kg in DMSO). 
Therefore, this dose was selected for future experiments (n=4/group). Animals also completed 
habituation and PPI testing. No effect of CNO was observed (data not shown).  
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Figure A.2 Representative In Vivo Electrophysiological Spiking Activity in hM4Di and Control 
Animals  
A) Representative rastor plots (top row) and PSTH (bottom row) of evoked activity to an 85 dB 
SPL noise burst in the PPT of an example mCherry control animal or B) hM4Di expressing animal 
before and after systemic CNO administration. The average firing rate for each trial was 
calculated using the spiking activity during 2-12 ms from stimulus onset. This is plotted in the 
right bar graphs for both example animals. Stimulus onset and duration is noted by the red line 
on rastor and PSTHs. The average spontaneous activity rate was defined by using the last 100 ms 
of each trial. This is shown by the line on the bar graphs labelled SpontR. Most notably, these 
examples recapitulate that in hM4Di animals spontaneous activity was reduced by CNO but 
auditory evoked activity was not. No changes were seen in control mCherry animals. 
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Figure A.3 mCherry Expression Changes with Time 
As time progressed, mCherry expression changed. Shown in brown is mCherry staining (DAB) and 
NADPH staining of cholinergic neurons (blue). The brown appeared to intensify with time 
progression beyond 40 days after surgery. Please note that this was not due to an increase the 
number of labelled neurons, but rather diffuse staining of the neuropil. This could be due to 
improved mCherry trafficking to neuronal processes, or an indicator of fluorescent protein 
accumulative toxicity. All behavioural and electrophysiological experiments were performed 
between days 21-35. Images were taken at 2x magnification, scale bar is 500 µM.  
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Startle Facilitation is Frequency Dependent 
In order to determine the most effective photostimulation paradigm, we ran a subset of 
animals with 10 and 1 Hz stimulation (YFP n=3, ChR2 n=4) in addition to the previously discussed 
50 Hz (YFP n=6, ChR2 n=7). We analysed this using a three-way repeated measures ANOVA (virus 
× frequency × ISI). Again, we confirmed that only ChR2 expressing animals showed a facilitation 
of startle as there was a main effect of virus type(F(1,20)=14, p<0.001). While we observed a main 
effect of stimulation frequency (F(1,20)=8.8, p<0.01), most importantly we also found a significant 
interaction between virus type and frequency (F(1,20)=8.7, p<0.01). This denotes that some 
photostimulation frequencies were more effective than others in the ChR2 expressing animals. 
Post-hoc t-tests with Bonferroni corrections revealed that in ChR2 animals, the 50 Hz stimulation 
was significantly different than the 10 and 1 Hz paradigms (independent samples t-test: t45=5.0, 
p>0.001, t45=3.5, p>0.005 respectively). This highlights 50 Hz photostimulation as the most 
effective, as shown in figure A.4A 
Startle Facilitation is Maximal with Bilateral (vs. Unilateral) Photostimulation 
In a subset of ChR2 expressing animals (n=3), we stimulated at 50 Hz unilaterally in order 
to see whether there are any lateralization affects. A two way repeated measures ANOVA 
(stimulation laterality × ISI) found no statistical difference between unilateral and bilateral 
stimulation on PPI (F(1,2)=3.2, p>0.05) or interaction between interstimulus interval and 
stimulation (F(3,6)=1.7, p>0.05). However, it appeared that within animals unilateral stimulation 
produced roughly half the increase of bilateral stimulation (figure A.4B).  
Startle Facilitation is Light-Intensity Dependant 
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We documented that the facilitation of startle was also dependant on the intensity of LED 
photostimulation. We ran a subset of ChR2 expressing animals (n=3) with high (19.6-22.1 mW) 
or low intensity (1-4 mW) photostimulation. We analysed this using a two-way repeated 
measures ANOVA (photostimulation intensity × ISI). Low intensity photostimulation did not 
enhance startle as effectively as we found a main effect of intensity (F(1,2)=24.8, p<0.05). In this 
group, startle magnitude was always greater in the high intensity stimulation condition as there 
was no interaction between intensity and interstimulus interval (F(3,6)=1.6, p>0.05). Overall this 
indicated that sufficient light intensity, not just presentation of light alone, was necessary to 
facilitate startle, as demonstrated in figure A.4C. 
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Figure A.4 Facilitation of Startle is Dependant on Frequency, Laterality and Light Intensity 
As shown in A) we reconfirmed that photostimulation was only effective in ChR2 expressing 
animals, as denoted by the asterisk. Furthermore, we observed that stimulation frequency 
differentially altered startle magnitude. We found that 50 Hz stimulation produces significantly 
more enhancement of startle compared to 10 (denoted by a) or 1 Hz (denoted by b), across all 
ISIs (50 Hz YFP n=6, ChR2=7, 10 and 1 Hz YFP n=3, ChR2=4).  B) In a subset of animals (n=3), 
unilateral (compared to bilateral) stimulation of the PPT produced a similar, but not quite as 
large, enhancement of startle. However, this trend failed to reach statistical significance. Lastly, 
as shown in C) this enhancement of startle was dependant on the intensity of stimulation. Low 
intensity photostimulation (1-4 MW) failed to increase startle across all ISIs intervals, unlike high 
intensity stimulation (n=3).  
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